{"100-1.\n\u8afe\u7f85\u75c5\u6bd2 (Norovirus) \u5728\u5404\u7d1a\u5b78\u6821\u3001\u8001\u4eba\u4e4b\u5bb6\u3001\u547c\u5438\u7167\u8b77\u75c5\u623f\u3001\u7cbe\u795e\u79d1\u75c5\u623f\u548c\u8eab\u5fc3\u969c\u7919\u6a5f\u69cb\u7b49\u55ae\u4f4d\u53ef\u9020\u6210\u4f4f\u6c11\u96c6\u9ad4\u767c\u751f\u6025\u6027\u8178\u80c3\u708e\u7684\u75ab\u60c5\u3002\u4e0b\u5217\u6709\u95dc\u8afe\u7f85\u75c5\u6bd2\u611f\u67d3\u53ca\u7ba1\u5236\u63aa\u65bd\u4e4b\u6558\u8ff0\u4e2d\uff0c\u4f55\u8005\u6b63\u78ba\uff1f (\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848)\r\n1. \u8afe\u7f85\u75c5\u6bd2\u611f\u67d3\u5c6c\u65bc\u7b2c\u4e09\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u5fc5\u9700\u65bc\u4e00\u9031\u5167\u5411\u75be\u75c5\u7ba1\u5236\u5c40\u901a\u5831\u3002\r\n2. \u8afe\u7f85\u75c5\u6bd2\u901a\u5e38\u70ba\u81ea\u9650\u6027 (self-limited)\u3001\u8f15\u4e2d\u5ea6\u7684\u8178\u80c3\u9053\u611f\u67d3\u75c7\uff0c\u611f\u67d3\u75c5\u6bd2\u91cf\u5fc5\u9700\u9ad8\u65bc1000 particles\u4ee5\u4e0a\u624d\u6709\u9020\u6210\u81e8\u5e8a\u75c7\u72c0\u7684\u53ef\u80fd\u3002\r\n3. \u8afe\u7f85\u75c5\u6bd2\u5c6c\u65bc\u55ae\u93c8RNA\u75c5\u6bd2\uff0c\u5c6c\u65bcCaliciviridae\uff0c\u56e0\u5177\u6709\u5916\u5957\u819c (envelope)\uff0c\u56e0\u6b64\u9069\u7576\u6fc3\u5ea6\u4e4b\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u80fd\u6709\u6548\u7684\u6bba\u6b7b\u8afe\u7f85\u75c5\u6bd2\u3002\r\n4. \u611f\u67d3\u8afe\u7f85\u75c5\u6bd2\u60a3\u8005\u4e4b\u7cde\u4fbf\u3001\u5614\u5410\u7269\u5747\u61c9\u4f7f\u7528\u6f02\u767d\u6c34\u8655\u7406\u5f8c\u518d\u6c96\u5165\u4e0b\u6c34\u9053\u3002\r\n5. \u6f02\u767d\u6c34\u6d88\u6bd2\u6db2\u6fc3\u5ea6\u61c9\u4ee51000ppm\u64e6\u62ed\u5730\u9762\u53ca\u74b0\u5883\uff1b\u82e5\u6709\u8840\u6db2\u9ad4\u6db2\u4e4b\u6c61\u67d3\uff0c\u5247\u4f7f\u75285000ppm\u6d88\u6bd2\u3002\nA. 1+3+4\nB. 4+5\nC. 1+4+5\nD. 2+3+4\nE. 3+4+5\n": "(B)", "100-2.\n\u6709\u95dc\u4e16\u754c\u885b\u751f\u7d44\u7e54 (WHO) \u8207\u53f0\u7063\u75be\u75c5\u7ba1\u5236\u5c40\u76ee\u524d\u5728\u63a8\u52d5\u4e4b\u624b\u90e8\u885b\u751f\u904b\u52d5\u4e2d\uff0c\u6240\u8b02\u6d17\u624b5\u6642\u6a5f\uff0c\u5305\u62ec\u4e0b\u5217\u90a3\u4e9b\u60c5\u5f62\uff1f (\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848)\r\n1.\u5e6b\u75c5\u4eba\u505a\u8eab\u9ad4\u6aa2\u67e5\u524d\u3002\r\n2.\u53ea\u63a5\u89f8\u75c5\u4eba\u8eab\u9ad4\u9ad4\u8868\u4e4b\u4e00\u822c\u6aa2\u67e5\u4e4b\u5f8c\u3002\r\n3.\u63a5\u89f8\u5230\u75c5\u4eba\u8840\u6db2\u6216\u9ad4\u6db2\u4e4b\u5f8c\u3002\r\n4.\u57f7\u884c\u4fb5\u5165\u6027\u6aa2\u67e5\u6234\u7121\u83cc\u624b\u5957\u4e4b\u524d\u3002\r\n5.\u9032\u5165\u75c5\u4eba\u623f\u9593\u53ea\u89f8\u78b0\u5230\u5e8a\u6b04\u687f\u5c31\u96e2\u958b\u75c5\u4eba\u623f\u9593\nA. 1+2+3+4+5\nB. 1+2+3+4\nC. 1+3+4\nD. 2+3+4\nE. 3+4\n": "(A)", "100-3.\n\u4e0b\u5217\u4f55\u7a2e\u72c0\u6cc1\u53ef\u7b26\u5408\"\u611b\u6ecb\u75c5\"\u7684\u8a3a\u65b7\u6a19\u6e96? (\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848)\r\n1.\u767c\u751f\u80ba\u56ca\u87f2\u80ba\u708e\uff0c\u4f46\u611b\u6ecb\u75c5\u6bd2\u6297\u9ad4\u9670\u6027\u3002\r\n2. \u7121\u81e8\u5e8a\u75c7\u72c0\uff0c\u4f46\u611b\u6ecb\u75c5\u6bd2\u6297\u9ad4\u967d\u6027\uff0c\u4e14\u8840\u6db2\u4e2dCD4+\u6dcb\u5df4\u7403\u6578\u5df2\u6301\u7e8c\u5c0f\u65bc200/uL\u3002\r\n3.\u611b\u6ecb\u75c5\u6bd2\u6297\u9ad4\u967d\u6027\uff0c\u8840\u6db2\u4e2dCD4+\u6dcb\u5df4\u7403\u6578\u5927\u65bc200/uL\uff0c\u4f46\u8840\u4e2d\u75c5\u6bd2\u91cf\u5927\u65bc1,000,000 copies/mL\u3002\r\n4.\u611b\u6ecb\u75c5\u6bd2\u6297\u9ad4\u967d\u6027\uff0c\u8840\u6db2\u4e2dCD4+\u6dcb\u5df4\u7403\u6578\u5927\u65bc200/uL\uff0c\u81e8\u5e8a\u4e0a\u50c5\u51fa\u73fe\u6709\u53e3\u8154\u5ff5\u73e0\u83cc\u611f\u67d3\u3002\nA. 2+3+4\nB. 2+3\nC. 2\nD. 1+2+3\nE. 1+2+3+4\n": "(C)", "100-4.\n\u5f9e\u906d\u5230\u611b\u6ecb\u75c5\u6bd2\u611f\u67d3\uff0c\u5230\u4ee5\u6aa2\u6e2c\u8a66\u5291\u53ef\u5075\u6e2c\u5230\u611f\u67d3\u7684\u9019\u7d04\u4e00\u500b\u6708\u7684\u671f\u9593\uff0c\u7a31\u70ba\uff1a\nA. \u7a7a\u7a97\u671f\u3002\nB. \u6f5b\u4f0f\u671f\u3002\nC. \u6062\u5fa9\u671f\u3002\nD. \u60e1\u5316\u671f\u3002\nE. \u4ee5\u4e0a\u7686\u975e\u3002\n": "(A)", "100-5.\n\u4e0b\u5217\u6709\u95dc\u6d41\u884c\u6027\u611f\u5192 (Influenza) \u4e4b\u6558\u8ff0\u4e2d\uff0c\u4f55\u8005\u6b63\u78ba\uff1f\nA. \u6d41\u611f\u75c5\u6bd2 (Influenza virus) \u7684\u57fa\u56e0\u662f\u7531\u516b\u6bb5DNA\u6240\u7d44\u6210\u7684\uff0c\u6545\u5f88\u5bb9\u6613\u91cd\u7d44\u800c\u9020\u6210\u75c5\u6bd2\u767c\u751f\u8b8a\u7570\u3002\nB. 2009\u5e74\u6d41\u884c\u4e4bH1N1\u6d41\u611f\u75c5\u6bd2\uff0c\u5176\u57fa\u56e0\u7247\u6bb5\u662f\u7531\u8c6c\u8207\u4eba\u5169\u7a2e\u6d41\u611f\u75c5\u6bd2\u6240\u7d44\u5408\u800c\u6210\u7684\u65b0\u578b\u6d41\u611f\u75c5\u6bd2\u3002\nC. H5N1\u6d41\u611f\u75c5\u6bd2\u52302011\u5e74\u4ecd\u7136\u6709\u9020\u6210\u4eba\u985e\u7684\u611f\u67d3\u3002\nD. 2010\u5e74\u79cb\u51ac\u5929\u6240\u4f7f\u7528\u4e4b\u5b63\u7bc0\u6027\u6d41\u611f\u75ab\u82d7\u4e26\u672a\u5305\u542b2009\u5e74\u958b\u59cb\u6d41\u884c\u4e4b\u65b0\u578bH1N1\u6d41\u611f\u75c5\u6bd2\u3002\nE. 2009\u5e74\u6d41\u884c\u4e4bH1N1\u6d41\u611f\u75c5\u6bd2\uff0c\u52302011\u5e746\u6708\u5e95\u70ba\u6b62\u5c1a\u672a\u6709Oseltamivir (Tamiflu) \u6297\u85e5\u6027\u4e4b\u75c5\u6bd2\u682a\u51fa\u73fe\u3002\n": "(C)", "100-6.\n\u4e0b\u5217\u5404\u7a2e\u85e5\u7269\u8207\u6cbb\u7642\u4e4b\u7d44\u5408\u4e2d\uff0c\u4f55\u8005\u932f\u8aa4\uff1f\nA. Daptomycin \uff0d MRSA\u4e4b\u6cbb\u7642\u3002\nB. Mefloquine \uff0d Malaria\u4e4b\u6cbb\u7642\u3002\nC. Micafungin \uff0d Candida\u4e4b\u6cbb\u7642\u3002\nD. Efavirenz \uff0d HIV\u4e4b\u6cbb\u7642\u3002\nE. Atazanavir \uff0d Influenza virus\u4e4b\u6cbb\u7642\u3002\n": "(E)", "100-7.\n\u4e0b\u5217\u6709\u95dc\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc (Staphylococcus aureus) \u53ca\u5176\u611f\u67d3\u7684\u6558\u8ff0\u4e2d\uff0c\u4f55\u8005\u6b63\u78ba\uff1f\nA. penicillin\u6297\u85e5\u6027\u4e4b\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u4e3b\u8981\u662f\u56e0\u70ba\u6703\u88fd\u9020penicillinase\u800c\u9020\u6210\u3002\nB. \u5c0d\u65bcmethicillin-susceptible\u7684\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u611f\u67d3\uff0cvancomycin\u7684\u7642\u6548\u4e0d\u5982oxacillin\u3002\nC. \u81e8\u5e8a\u4e0a\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u6240\u5c0e\u81f4\u7684\u611f\u67d3\u4e2d\uff0c\u76ae\u819a\u8207\u76ae\u4e0b\u7d44\u7e54\u662f\u6700\u5e38\u898b\u7684\u611f\u67d3\u90e8\u4f4d\u3002\nD. methicillin\u6297\u85e5\u6027\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc (MRSA)\u4e4b\u611f\u67d3\u5df2\u7d93\u4e5f\u51fa\u73fe\u5728\u793e\u5340\u611f\u67d3\u7684\u500b\u6848\u4e2d\u3002\nE. \u4ee5\u4e0a\u7686\u662f\u3002\n": "(E)", "100-8.\n\u4e0b\u5217\u6709\u95dc\u9b91\u6c0f\u4e0d\u52d5\u687f\u83cc (Acinetobacter baumannii) \u7684\u6558\u8ff0\u4e2d\uff0c\u4f55\u8005\u6b63\u78ba\uff1f\nA. \u81f4\u75c5\u6bd2\u529b (virulence)\u5f37\uff0c\u57281970\u5e74\u4ee3\u521d\u671f\uff0c\u5373\u88ab\u8a8d\u5b9a\u70ba\u4eba\u985e\u7684\u771f\u5be6\u81f4\u75c5\u83cc (true pathogen)\u3002\nB. \u5728\u4e7e\u71e5\u7684\u74b0\u5883\u8868\u9762\u7121\u6cd5\u5b58\u6d3b\u3002\nC. \u5728\u53f0\u7063\u8a31\u591a\u7684\u91ab\u5b78\u4e2d\u5fc3\u3001\u5340\u57df\u91ab\u9662\uff0ccarbapenem\u6297\u85e5\u6027\u7684\u9b91\u6c0f\u4e0d\u52d5\u687f\u83cc\uff0c\u5df2\u9020\u6210\u56b4\u91cd\u7684\u81e8\u5e8a\u554f\u984c\u3002\nD. \u5c0d\u65bccarbapenem\u6297\u85e5\u6027\u7684\u9b91\u6c0f\u4e0d\u52d5\u687f\u83cc\u611f\u67d3\u53ef\u9078\u64c7Linezolid\u52a0\u4ee5\u6cbb\u7642\u3002\nE. \u4ee5\u4e0a\u7686\u662f\u3002\n": "(C)", "100-9.\n\u5c0d\u65bc\u6297\u751f\u7d20\u7684\u4f5c\u7528\u6a5f\u8f49\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f\nA. \u76e4\u5c3c\u897f\u6797 (penicillin) \u985e\u6297\u751f\u7d20\u4f5c\u7528\u65bc\u7d30\u83cc\u7684\u7d30\u80de\u819c\u3002\nB. fluoroquinolone\u985e\u6297\u751f\u7d20\u4f5c\u7528\u65bc\u7d30\u83cc\u7684DNA gyrase\u548ctopoisomerase IV\u3002\nC. aminoglycoside\u985e\u7684\u6297\u751f\u7d20\u4e3b\u8981\u4f5c\u7528\u572850S ribosomal subunit\u4e0a\u3002\nD. vancomycin\u4e3b\u8981\u4f5c\u7528\u6a5f\u8f49\u5728\u6291\u5236\u7d30\u83cc\u7684\u6c27\u5316\u50b3\u905e\u93c8\u3002\nE. \u4ee5\u4e0a\u7686\u662f\u3002\n": "(B)", "100-10.\n\u4e00\u4f4d36\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u5e73\u65e5\u8eab\u9ad4\u5065\u5eb7\u72c0\u6cc1\u826f\u597d\uff0c\u559c\u6b61\u91ce\u5916\u65c5\u904a\uff0c3\u5929\u524d\u525b\u5f9e\u82b1\u6771\u65c5\u904a\u56de\u5230\u53f0\u5317\uff0c2\u5929\u524d\u958b\u59cb\u51fa\u73fe\u767c\u71d2\u3001\u5026\u6020\u611f\u53ca\u982d\u75db\uff0c\u524d\u5f80\u67d0\u8a3a\u6240\u5c31\u8a3a\u5f8c\uff0c\u670d\u7528\u4e00\u4e9b\u611f\u5192\u85e5\u4f46\u4e26\u672a\u9000\u71d2\uff0c\u65bc\u662f\u5230\u67d0\u91ab\u9662\u5c31\u8a3a\uff0c\u8840\u6db2\u6aa2\u67e5\u767c\u73fe\u767d\u8840\u7403\u70ba3,600/\u03bcL\uff0cAST\uff1a66 IU/L\uff0cALT\uff1a58 IU/L\uff0c\u65bc\u53f3\u5074\u814b\u7aa9\u9644\u8fd1\u767c\u73fe\u6709\u4e00eschar\uff0c\u8acb\u554f\u6b64\u6642\u4e0b\u5217\u4f55\u8005\u70ba\u6700\u9069\u7576\u4e4bempirical antibiotic\u9078\u64c7\uff1f\nA. Oxacillin\u3002\nB. Ampicillin\u3002\nC. \u7b2c\u4e09\u4ee3cephalosporin\u3002\nD. Minocycline\u3002\nE. \u7b2c\u4e00\u4ee3cephalosporin\u3002\n": "(D)", "100-11.\n\u9264\u7aef\u87ba\u65cb\u83cc(Leptospires)\u53ca\u5176\u6240\u9020\u6210\u7684\u75be\u75c5(Leptospirosis)\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba? (\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848)\r\n1.\u4eba\u755c\u5171\u901a\u75c5\uff0c\u9f20\u985e\u3001\u91ce\u751f\u54fa\u4e73\u52d5\u7269\u6216\u5bb6\u755c\u7686\u53ef\u70ba\u5bbf\u4e3b\u3002\r\n2.\u8a72\u83cc\u7d93\u5c3f\u6392\u51fa\uff0c\u5728\u6c34\u4e2d\u53ef\u5b58\u6d3b\u9054\u6578\u6708\u3002\r\n3.\u4eba\u7f79\u60a3\u8a72\u75c5\u6f5b\u4f0f\u671f\u901a\u5e38\u57285\u81f314\u5929\u3002\u5927\u591a\u6578\u75c5\u4eba\u6c92\u75c7\u72c0\uff0c\u6709\u75c7\u72c0\u7684\u75c5\u4eba\u4e2d\u7d045~15%\u6703\u5f88\u56b4\u91cd\u3002\r\n4.\u9810\u9632\u65b9\u6cd5\u662f\u907f\u514d\u63a5\u89f8\u6c61\u67d3\u542b\u83cc\u7684\u6c34\u6216\u6ce5\u571f\uff0c\u5c24\u5176\u662f\u6d2a\u6c34\u6216\u662f\u98b1\u98a8\u904e\u5f8c\u7684\u6c34\u60a3\u3002\r\n5.\u5728\u75c5\u767c3\u5929\u5f8c\u4ecd\u7136\u53ef\u4ee5\u6cbb\u7642\uff0c\u56b4\u91cd\u8005\u4ee5penicillin\u6cbb\u7642\uff0c\u8f15\u8005\u4ee5doxycycline\u6cbb\u7642\u3002\nA. 1+2+3+4\nB. 1+3+4\nC. 1+3+4+5\nD. 1+4+5\nE. 1+2+3+4+5\n": "(E)", "100-12.\n\u6d41\u611f\u4f75\u767c\u75c7\u7684\u9ad8\u5371\u96aa\u7fa4\uff1a (\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848)\r\n1.\u5c0f\u5b69\u5f9e\u51fa\u751f\u52304\u6b72\r\n2.\u61f7\u5b55\u5a66\u5973\r\n3.\u6709\u6162\u6027\u5fc3\u80ba\u75be\u75c5\u8005\u3001\u5927\u65bc65\u6b72\u7684\u8001\u5e74\u4eba\u53ca\u5b89\u7642\u990a\u9662\u4f4f\u6c11\r\n4.\u5c0f\u5b78\u751f\r\n5.\u8ecd\u4eba\nA. 1+2+3+4\nB. 1+3+4\nC. 2+3+4+5\nD. 2+3+4\nE. 1+2+3\n": "(E)", "100-13.\n\u8089\u6bd2\u687f\u83cc(Clostridium botulinum)\u53ca\u5176\u4e2d\u6bd2\u75c7(Botulism)\uff1a (\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848)\r\n1.\u662f\u53ad\u6c27\u9769\u862d\u6c0f\u967d\u6027\u83cc\uff0c\u53ef\u5b58\u5728\u571f\u58e4\u548c\u6c34\u4e2d\u3002\r\n2.\u4e2d\u6bd2\u53ef\u56e0\u98df\u7528\u5230\u542b\u83cc\u5b62\u5b50\u6216\u53d7\u6bd2\u7d20\u6c61\u67d3\u7684\u98df\u7269\uff0c\u6216\u50b7\u53e3\u6c61\u67d3\u5230\u75c5\u83cc\u800c\u9020\u6210\uff0c\u81f4\u75c5\u662f\u7531\u795e\u7d93\u6bd2\u7d20(neurotoxin)\u6240\u81f4\u3002\r\n3.\u9020\u6210\u98df\u7269\u4e2d\u6bd2\u7684\u4e3b\u8981\u662f\u5bb6\u5ead\u81ea\u88fd\u852c\u679c\u3001\u8abf\u5473\u4f50\u6599\u4e4b\u7f50\u88dd\u7269\uff0c\u9810\u9632\u7684\u65b9\u6cd5\u662f\u98df\u7528\u524d\u572885\u2103\u52a0\u71b15\u5206\u9418\uff0c\u4ee5\u7834\u58de\u6bd2\u7d20\u3002\u81f3\u65bc\u8981\u5c07\u8089\u6bd2\u687f\u83cc\u5b62\u5b50\u6bba\u6b7b\u5247\u9700\u5728\u9ad8\u58d3\u53ca116~121\u2103\u9ad8\u6eab\u8655\u740610\u5206\u9418\u4ee5\u4e0a\u3002\r\n4.\u8a72\u795e\u7d93\u6bd2\u7d20\u9032\u5165\u8840\u6d41\u7cfb\u7d71\u6703\u88ab\u50b3\u9001\u5230\u672b\u68a2\u795e\u7d93\u53ca\u795e\u7d93\u808c\u8089\u4ea4\u6703\u8655\uff0c\u7d93\u7531\u5206\u89e3\u86cb\u767d\u8cea\u800c\u963b\u65b7\u4eba\u9ad4acetylcholine\u4e4b\u91cb\u653e\uff0c\u9020\u6210\u7531\u9871\u795e\u7d93\u9032\u5c55\u5230\u80a2\u9ad4\u4e4b\u904b\u52d5\u795e\u7d93\u7671\u7613\u3002\r\n5.\u6cbb\u7642\u8457\u91cd\u76e3\u63a7\u547c\u5438\u3001\u8840\u6c27\u53ca\u6297\u6bd2\u7d20\u3002\nA. 1+2+3\nB. 1+2+4\nC. 1+2+4+5\nD. 1+2+3+5\nE. 1+2+3+4+5\n": "(E)", "100-14.\n\u4eba\u985e\u8178\u75c5\u6bd2\u8d85\u904e65\u7a2e\u8840\u6e05\u578b\uff1a (\u61c9\u9078\u51fa\u5168\u90e8\u7b54\u6848)\r\n1.\u8178\u75c5\u6bd2\u5305\u62ecCoxsackievirus A\u3001Coxsackievirus B\u3001Poliovirus\u3001echovirus\u53caEnterovirus\u7b49\u3002\r\n2.\u662f\u55ae\u80a1RNA\u75c5\u6bd2\uff0c\u7121\u8102\u8cea\u5916\u9798\uff0c\u5c0d\u9178\u7a69\u5b9a\uff0c\u53ef\u5728\u5ba4\u6eab\u5b58\u6d3b\u591a\u5929\u3002\r\n3.\u597d\u7684\u6d17\u624b\u7fd2\u6163\uff0c\u4f7f\u7528\u624b\u5957\u3001\u9694\u96e2\u8863\uff0c\u53ef\u9810\u9632\u50b3\u64ad\u3002\r\n4.\u8a72\u75c5\u6bd2\u5c0d\u9152\u7cbe\u654f\u611f\uff0c\u4ee5\u9152\u7cbe\u4e7e\u6d17\u624b\u6db2\u5373\u53ef\u6709\u6548\u6bba\u6b7b\u3002\r\n5.\u5c11\u6578\u91cd\u75c7\u60a3\u8005\u9808\u52a0\u8b77\u652f\u6301\u6cbb\u7642\u3002\nA. 1+2+3\nB. 1+2+3+4\nC. 1+3+5\nD. 1+2+3+5\nE. 1+2+3+4+5\n": "(D)", "100-15.\n\u53f0\u7063\u75be\u75c5\u7ba1\u5236\u5c40\u57282010\u5e74\u70ba\u5f37\u5316\u6297\u85e5\u6027\u7d30\u83cc\u76e3\u6e2c\uff0c\u5c07NDM-1\u8178\u9053\u83cc\u611f\u67d3\u75c7\u5217\u70ba\u7b2c\u56db\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u9019\u985e\u7d30\u83cc\u9020\u6210\u7684\u6297\u85e5\u6027\u57fa\u56e0\u4e3b\u8981\u900f\u904eplasmid\u88fd\u9020\u53ca\u6563\u64ad\uff0cNDM-1\u662f\u4ec0\u9ebc\uff1f\nA. Extended spectrum \u03b2-lactamase\uff0c\u9020\u6210\u5c0d\u7b2c\u4e09\u4ee3\u982d\u5b62\u7d20\u4e4b\u6297\u85e5\u6027\u3002\nB. DNA gyrase\uff0c\u9020\u6210\u5c0dquinolone\u4e4b\u6297\u85e5\u6027\u3002\nC. Metallo-\u03b2-lactamase\uff0c\u9020\u6210\u5c0dcarbapenem\u4e4b\u6297\u85e5\u6027\u3002\nD. Penicillinase\uff0c\u9020\u6210\u5c0dpenicillin\u4e4b\u6297\u85e5\u6027\u3002\nE. \u6539\u8b8a outer membrane protein (porin)\u4e4b\u7d50\u69cb\uff0c\u9020\u6210\u6297\u85e5\u6027\u3002\n": "(C)", "100-16.\n\u624b\u90e8\u885b\u751f\u662f\u9810\u9632\u91ab\u9662\u5167\u4ea4\u53c9\u611f\u67d3\u6700\u6709\u6548\u4e4b\u55ae\u4e00\u65b9\u6cd5\uff0c\u4ee5\u4e0b\u6709\u95dc\u6d17\u624b\uff0c\u54ea\u4e00\u9805\u4e0d\u6b63\u78ba\uff1f\nA. \u5728\u63a5\u89f8\u75c5\u4eba\u6216\u75c5\u4eba\u65c1\u908a\u74b0\u5883\u524d\u5f8c\u61c9\u8a72\u6d17\u624b\u3002\nB. \u624b\u90e8\u6709\u660e\u986f\u5f04\u9ad2\u6216\u6709\u8840\u6db2\u6c61\u67d3\uff0c\u4ee5\u80a5\u7682\u6d17\u624b\u70ba\u539f\u5247\u3002\nC. \u75c5\u623f\u6709Clostridium difficile\u7fa4\u805a\u611f\u67d3\uff0c\u61c9\u8a72\u7528\u80a5\u7682\u6d17\u624b\u3002\nD. \u8178\u75c5\u6bd2\u6d41\u884c\u6642\uff0c\u4ee5\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u6d17\u624b\u3002\nE. \u5927\u90e8\u5206\u7684\u60c5\u6cc1\u53ef\u63a1\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u3002\n": "(D)", "100-17.\n\u51fa\u570b\u65c5\u904a\u6108\u4f86\u6108\u666e\u904d\uff0c\u4ee5\u4e0b\u6709\u95dc\u65c5\u904a\u5230\u843d\u5f8c\u570b\u5bb6\u7684\u6558\u8ff0\u662f\u932f\u8aa4\u7684\uff1f\nA. \u559d\u716e\u904e\u7684\u6c34\u6216\u74f6\u88dd\u6c34\uff0c\u907f\u514d\u98df\u7528\u751f\u7684\u3001\u672a\u719f\u7684\u98df\u7269\u6216\u51b0\u88fd\u54c1\uff0c\u53ef\u9810\u9632\u8179\u7009\u3002\nB. \u82e5\u4e0d\u80fd\u907f\u514d\u6027\u95dc\u4fc2\uff0c\u5247\u5168\u7a0b\u4f7f\u7528\u4fdd\u96aa\u5957\uff0c\u53ef\u907f\u514d\u6027\u75c5\u3002\nC. \u5728\u6de1\u6c34\u6e56\u6216\u6cb3\u5ddd\u6d17\u6fa1\u6e38\u6cf3\u4e26\u4e0d\u6703\u589e\u52a0\u7f79\u60a3\u8840\u5438\u87f2\u75c5(schistosomiasis)\u4e4b\u5371\u96aa\u3002\nD. \u6253\u8d64\u8173\u8d70\u8def\uff0c\u6703\u589e\u52a0\u9264\u87f2\u548c\u7cde\u7dda\u87f2(Strongyloides)\u611f\u67d3\u5371\u96aa\u3002\nE. \u9810\u9632\u868a\u54ac\u53ca\u7627\u75be\u9810\u9632\u7528\u85e5\uff0c\u53ef\u907f\u514d\u7627\u75be\u548c\u87f2\u5a92\u75be\u75c5\u3002\n": "(C)", "100-18.\n2011\u5e74\u5728\u6b50\u6d32\u767c\u751f\u8de8\u8d8a\u591a\u570b\u7684\u8178\u51fa\u8840\u578b(enterohemorrhagic)\u5927\u8178\u687f\u83cc(EHEC)\u611f\u67d3\u75c7\uff0c\u9020\u6210\u4e0d\u5c11\u4eba\u6b7b\u4ea1\u3002\u4ee5\u4e0b\u6558\u8ff0\uff0c\u54ea\u4e00\u9805\u932f\u8aa4\uff1f\nA. \u9019\u6b21EHEC\u4e3b\u8981\u662f\u8840\u6e05\u578bO111\u6240\u9020\u6210\u3002\nB. \u56b4\u91cd\u7684\u75c5\u4eba\u9664\u4e86\u6709\u8840\u5c0f\u677f\u6578\u6e1b\u5c11\u4e4b\u5916\uff0c\u6709\u4e9b\u4f75\u767c\u6eb6\u8840\u6027\u5c3f\u6bd2\u75c7\u5019\u7fa4\u3002\nC. \u6cbb\u7642\u9700\u7528Ampicillin\u3002\nD. EHEC\u6703\u5206\u6cccshiga-like toxin\u3002\nE. \u8d77\u56e0\u8207\u7cde\u4fbf\u6c61\u67d3\u548c\u751f\u98df\u852c\u83dc\u6709\u95dc\u3002\n": "(C)\u6216(A)", "100-19.\n\u6709\u95dc\u767b\u9769\u71b1\u4e4b\u63cf\u8ff0\uff0c\u54ea\u4e00\u9805\u932f\u8aa4\uff1f\nA. \u75c5\u5a92\u868a\u4e3b\u8981\u662f\u57c3\u53ca\u6591\u868a\uff0c\u767d\u7dda\u6591\u868a\u6b21\u4e4b\u3002\nB. \u9810\u9632\u4e3b\u8981\u9760\u5674\u7051\u6bba\u87f2\u5291\u3002\nC. \u6e05\u9664\u5b73\u751f\u6e90\u548c\u7a4d\u6c34\u5bb9\u5668\u662f\u6700\u91cd\u8981\u7684\u9810\u9632\u65b9\u6cd5\u3002\nD. \u6c23\u5019\u8b8a\u9077\u5f71\u97ff\u868a\u5b50\u5206\u5e03\u5340\u57df\uff0c\u4e5f\u6539\u8b8a\u75c5\u6bd2\u5728\u868a\u87f2\u9ad4\u5167\u4e4b\u8907\u88fd\u6642\u9593\u3002\nE. 50%\u81f390%\u7684\u75c5\u4eba\u611f\u67d3\u4e4b\u75c7\u72c0\u4e0d\u660e\u986f\u3002\n": "(B)", "101-1.\n\u4ee5\u4e0b\u6709\u95dc\u767c\u71d2\u548c\u76ae\u75b9\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba\uff1f\r(1)\u4e8c\u671f\u6885\u6bd2\u7684\u76ae\u75b9\u6700\u5e38\u51fa\u73fe\u5728\u624b\u638c\u5fc3\u548c\u8173\u5e95\r(2)\u5c48\u516c\u75c5\uff08Chikungunya fever\uff09\u6700\u5e38\u898b\u76ae\u75b9\u5728\u4e0a\u80a2\u548c\u81c9\u90e8\uff0c\u5e38\u4f34\u96a8\u5c0f\u95dc\u7bc0\u75bc\u75db\r(3)\u767b\u9769\u71b1\u7d0450%\u6703\u6709\u76ae\u75b9\uff0c\u5e38\u7531\u8ec0\u5e79\u958b\u59cb\uff0c\u7e7c\u800c\u6563\u81f3\u80a2\u9ad4\u548c\u81c9\u90e8\r(4)\u6059\u87f2\u75c5\u7684\u76ae\u75b9\u5e38\u7531\u80a2\u7aef\u958b\u59cb\uff0c\u800c\u5f8c\u64f4\u53ca\u8ec0\u5e79\u548c\u81c9\u90e8\r(5)\u9ebb\u75b9\u7684\u76ae\u75b9\u5e38\u7531\u81c9\u90e8\u5f80\u4e0b\u64f4\u5c55\uff0c\u6700\u7d42\u5230\u624b\u638c\u5fc3\u548c\u8173\u638c\u5fc3\nA. (1)+(2)+(3)+(4)\nB. (1)+(2)+(3)+(5)\nC. (1)+(2)+(4)+(5)\nD. (1)+(2)+(3)\nE. (1)+(3)+(4)\n": "(D)", "101-2.\n\u4e00\u540d\u7537\u5b50\u5728\u5927\u9678\u5de5\u4f5c\u6642\u56e0\u5916\u51fa\u906d\u91ce\u72ac\u54ac\u50b7\u8173\u8dbe\uff0c\u7576\u6642\u672a\u5c31\u91ab\uff0c\u4e00\u500b\u591a\u6708\u5f8c\u51fa\u73fe\u4e0b\u534a\u8eab\u7570\u5e38\u7662\u3001\u9ebb\u75db\u3001\u5614\u5410\u3001\u541e\u56a5\u56f0\u96e3\u53ca\u5589\u56a8\u816b\u75db\u7b49\u75c7\u72c0\uff0c\u4e26\u6709\u6050\u6c34\u4e4b\u73fe\u8c61\uff0c\u5c31\u91ab\u5f8c\u56e0\u7591\u4f3c\u72c2\u72ac\u75c5(rabies) \u800c\u5165\u9662\uff0c\u95dc\u65bc\u6b64\u75c5\uff0c\u8acb\u554f\u4ee5\u4e0b\u63cf\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u75c5\u60a3\u6050\u6c34\u4e4b\u73fe\u8c61\u662f\u56e0\u54bd\u5589\u90e8\u808c\u8089\u4e4b\u75d9\u6523\u6240\u5f15\u8d77\u3002\nB. \u53f0\u7063\u81ea\u6c11\u570b\u56db\u5341\u516b\u5e74\u8d77\u53f0\u7063\u5730\u5340\u5373\u4e0d\u518d\u6709\u4eba\u7684\u672c\u571f\u75c5\u4f8b\uff0c\u6c11\u570b\u4e94\u5341\u5e74\u4e00\u6708\u5f8c\u5373\u672a\u518d\u51fa\u73fe\u52d5\u7269\u7684\u75c5\u4f8b\u3002\u76ee\u524d\u5728\u53f0\u7063\u88ab\u672c\u5730\u7684\u72d7\u3001\u8c93\u54ac\u50b7\uff0c\u539f\u5247\u4e0a\u4e0d\u5fc5\u65bd\u6253\u4eba\u7528\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u6216\u75ab\u82d7\u3002\nC. \u5982\u9700\u524d\u5f80\u72c2\u72ac\u75c5\u75ab\u5340\uff0c\u5efa\u8b70\u884c\u524d\u81f3\u5c11\u4e00\u500b\u6708\uff0c\u63a5\u7a2e\u4e09\u5291\u75ab\u82d7\u4ee5\u7522\u751f\u514d\u75ab\u4fdd\u8b77\u3002\nD. \u5728\u75ab\u5340\u88ab\u52d5\u7269\u54ac\u50b7\u5f8c\uff0c\u5b9c\u5fb9\u5e95\u5730\u6e05\u6d17\u3001\u6d88\u6bd2\u50b7\u53e3\uff0c\u8fc5\u901f\u63a5\u53d7\u4eba\u7528\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u53ca\u63a5\u7a2e4\u5291\u75ab\u82d7\u3002\nE. \u82e5\u672a\u6cbb\u7642\uff0c\u6b64\u75c5\u81f4\u6b7b\u7387\u7d04\u70ba45%\u3002\n": "(E)", "101-3.\n\u738b\u5927\u660e\u662f\u4e00\u4f4d20\u6b72\u7684\u5927\u5b78\u4e8c\u5e74\u7d1a\u5b78\u751f\uff0c\u7531\u65bc\u4ed6\u662f\u5728\u6821\u5712\u5167\u4e00\u4f4d\u50b3\u67d3\u6027\u7d50\u6838\u75c5\u4eba(\u8010\u9178\u62b9\u7247\u967d\u6027\u4e14\u7d50\u6838\u83cc\u57f9\u990a\u967d\u6027)\u7684\u5bc6\u5207\u63a5\u89f8\u8005\uff0c\u67d0\u65e5\u4ed6\u62ff\u8457\u516c\u5171\u885b\u751f\u7684\u8f49\u4ecb\u55ae\u4e14\u5305\u542b\u7d50\u6838\u83cc\u7d20\u6e2c\u9a57\u7d50\u679c\u70ba20 mm\u4f86\u5230\u4f60\u7684\u9580\u8a3a\uff0c\u8a62\u554f\u4f60\u6709\u95dc\u7d50\u6838\u75c5\u548c\u6f5b\u4f0f\u611f\u67d3(latent tuberculosis infection)\u7684\u554f\u984c\u3002\u4e0b\u5217\u7d44\u5408\u4f55\u8005\u6b63\u78ba\uff1f\r(1)\u9019\u4f4d\u540c\u5b78\u7684\u7d50\u6838\u83cc\u7d20\u6e2c\u9a57\u7d50\u679c\u70ba\u967d\u6027\uff0c\u53ef\u4ee5\u8a8d\u70ba\u4ed6\u5c31\u662f\u7d50\u6838\u75c5\u767c\u75c5\u500b\u6848\uff0c\u4e5f\u6703\u50b3\u67d3\u7d66\u5176\u4ed6\u4eba\u3002\r(2)\u51fa\u751f\u6642\u7684\u5361\u4ecb\u82d7\u63a5\u7a2e\u4e00\u5b9a\u6703\u8b93\u9019\u4f4d\u540c\u5b78\u7684\u7d50\u6838\u83cc\u7d20\u6e2c\u9a57\u7d50\u679c\u5448\u73fe\u507d\u967d\u6027\uff0c\u6240\u4ee5\u4e0d\u7528\u64d4\u5fc3\u7d50\u6838\u75c5\u767c\u75c5\u98a8\u96aa\u3002\r(3)\u512a\u5148\u9032\u884c\u75c5\u53f2\u8a62\u554f\u662f\u5426\u6709\u6162\u6027\u54b3\u55fd\u8d85\u904e\u4e09\u9031\u7b49\u75c7\u72c0\u3001\u7406\u5b78\u6aa2\u67e5\u548c\u80f8\u90e8X\u5149\u4f86\u8a55\u4f30\u662f\u5426\u70ba\u6d3b\u52d5\u6027\u7d50\u6838\u75c5\u75c5\u4eba\u3002\r(4)\u5047\u8a2d\u738b\u540c\u5b78\u6c92\u6709\u75c7\u72c0\u4e14\u80f8\u90e8X\u5149\u6b63\u5e38\uff0c\u53ef\u4f7f\u7528isoniazid 300 mg \u6cbb\u76429\u500b\u6708\u4ee5\u6e1b\u5c11\u767c\u75c5\u98a8\u96aa\uff0c\u662f\u76ee\u524d\u5c0d\u65bc\u6f5b\u4f0f\u611f\u67d3\u6cbb\u7642\u7684\u5efa\u8b70\u3002\r(5)\u885b\u6559\u9019\u4f4d\u540c\u5b78\u63a5\u89f8\u8005\u767c\u75c5\u7684\u98a8\u96aa\u548c\u4e00\u4f46\u51fa\u73fe\u7d50\u6838\u75c5\u76f8\u95dc\u75c7\u72c0\uff0c\u76e1\u901f\u5c31\u91ab\u4e26\u61c9\u63d0\u9192\u91ab\u5e2b\u66fe\u70ba\u63a5\u89f8\u8005\u3002\nA. (1)+(3)\nB. (2)\nC. (3)+(4)\nD. (3)+(4)+(5)\nE. (4)+(5)\n": "(D)", "101-4.\n\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u75c5(multidrug-resistant tuberculosis, MDRTB)\u662f\u76ee\u524d\u5168\u7403\u7d50\u6838\u75c5\u9632\u6cbb\u7684\u91cd\u5927\u6311\u6230\u3002\u4e0b\u5217\u7d44\u5408\u4f55\u8005\u70ba\u662f\uff1f\r(1)\u53f0\u7063\u7684\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u76e3\u6e2c\u767c\u73fe\uff1a\u5728\u7d50\u6838\u75c5\u65b0\u75c5\u4eba\u70ba1%\uff0c\u518d\u6cbb\u75c5\u4eba(\u5305\u542b\u5fa9\u767c\u3001\u6cbb\u7642\u5931\u6557\u548c\u5931\u843d)\u70ba6-8%\u3002\u76f8\u8f03\u65bc\u5468\u908a\u7684\u4e2d\u570b\u5927\u9678(\u5206\u5225\u70ba5.7%\u548c25.6%)\u53ca\u6771\u5357\u4e9e\uff0c\u53f0\u7063\u75ab\u60c5\u8f03\u8f15\u5fae\u3002\r(2)\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u7684\u5be6\u9a57\u5ba4\u6aa2\u67e5\u53ea\u80fd\u4f9d\u8cf4\u50b3\u7d71\u85e5\u7269\u654f\u611f\u6027\u8a66\u9a57\u7d50\u679c\uff0c\u76ee\u524d\u65b0\u7684\u5206\u5b50\u5feb\u901f\u8a3a\u65b7\u7684\u65b9\u6cd5\uff0c\u5982\uff1aHain test \u6216Xpert\uff0c\u4ecd\u5c1a\u5728\u8a55\u4f30\u4e2d\u3002\r(3)\u4e00\u822c\u7d50\u6838\u75c5\u7684\u6cbb\u7642\u61c9\u5408\u4f75\u591a\u7a2e\u85e5\u7269\u3001\u5291\u91cf\u8db3\u5920\u3001\u4e14\u6709\u8db3\u5920\u7684\u6cbb\u7642\u671f\uff0c\u4e26\u52f8\u75c5\u4eba\u52a0\u5165\u90fd\u6cbb(directly observed therapy) \u78ba\u4fdd\u670d\u85e5\u9806\u5f9e\u6027\uff0c\u53ef\u6e1b\u5c11\u7522\u751f\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u75c5\u7684\u98a8\u96aa\u3002\r(4)\u4e00\u65e6\u70ba\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u75c5\u4eba\uff0c\u6cbb\u7642\u9700\u8003\u616e\u5408\u4f754\u7a2e\u4ee5\u4e0a\u7684\u6709\u6548\u85e5\u7269\uff0c\u4f46\u4e0d\u9808\u5ef6\u9577\u6cbb\u7642\u8d85\u904e\u75f0\u9670\u8f4918\u500b\u6708\u3002\r(5)\u591a\u91cd\u6297\u85e5\u7d50\u6838\u75c5\u4eba\u4f7f\u7528\u7684\u4e8c\u7dda\u85e5\u7269\u526f\u4f5c\u7528\u6bd4\u4e00\u7dda\u6297\u7d50\u6838\u85e5\u7269\u591a\uff0c\u5efa\u8b70\u75c5\u4eba\u8f49\u4ecb\u7d66\u5177\u7d93\u9a57\u7684\u591a\u91cd\u6297\u85e5\u75c5\u4eba\u7167\u8b77\u5718\u968a\u91ab\u9662\u3002\nA. (1)+(3)+(5)\nB. (2)+(4)\nC. (2)+(3)+(4)\nD. (1)+(2)+(5)\nE. (1)+(4)+(5)\n": "(A)", "101-5.\n\u6709\u95dc\u6d41\u611f\u75ab\u82d7\u63a5\u7a2e\u526f\u4f5c\u7528\u8207\u7981\u5fcc\u75c7\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f\r(1)\u5c0d\u96de\u86cb\u56b4\u91cd\u904e\u654f\u8005\u70ba\u63a5\u7a2e\u6d41\u611f\u75ab\u82d7\u4e4b\u7981\u5fcc\u3002\r(2)\u9664\u4e86\u7f8e\u570b1976\u5e74H1N1\u8c6c\u6d41\u611f\u75ab\u82d7\u5916\uff0c\u63a5\u7a2e\u5b63\u7bc0\u6d41\u611f\u75ab\u82d7\u5f8c\u767c\u751fGuillain-Barre syndrome\u4e4b\u6a5f\u7387\u6975\u4f4e\u3002\r(3)\u5c0f\u65bc6\u500b\u6708\u4e4b\u5b30\u5152\u4e0d\u5b9c\u63a5\u53d7\u6d41\u611f\u75ab\u82d7\u65bd\u6253\u3002\r(4)\u90e8\u5206\u6d41\u611f\u75ab\u82d7\u4e2d\u542b\u6709\u7532\u57fa\u6c5e\u8207\u4e59\u57fa\u6c5e\u7528\u4ee5\u4fdd\u5b58\u75ab\u82d7\uff0c\u7532\u57fa\u6c5e\u8207\u4e59\u57fa\u6c5e\u5747\u53ef\u70ba\u4eba\u9ad4\u6240\u4ee3\u8b1d\u3002\r(5)\u5728\u5224\u65b7\u6d41\u611f\u75ab\u82d7\u63a5\u7a2e\u5f8c\u4e0d\u826f\u4e8b\u4ef6\u8207\u75ab\u82d7\u63a5\u7a2e\u4e4b\u56e0\u679c\u95dc\u4fc2\u6642\uff0c\u8a72\u4e0d\u826f\u4e8b\u4ef6\u4e4b\u6b7b\u4ea1\u6216\u91cd\u75c7\u6bd4\u7387\u662f\u91cd\u8981\u7684\u89c0\u5bdf\u6307\u6a19\u3002\nA. (1)+(2)+(3)\nB. (1)+(2)+(4)\nC. (1)+(3)+(4)\nD. (1)+(3)+(5)\nE. (1)+(2)+(3)+(5)\n": "(E)", "101-6.\n\u95dc\u65bc\u897f\u5c3c\u7f85\u71b1\uff08West Nile Fever\uff09\u53ca\u5c48\u516c\u71b1\uff08Chikungunya fever\uff09\uff0c\u4ee5\u4e0b\u4f55\u8005\u662f\u6b63\u78ba\u7684\uff1f\nA. \u6b64\u5169\u7a2e\u75be\u75c5\u53ef\u7d93\u7531\u75c5\u5a92\u868a\u53ee\u54ac\u50b3\u67d3\u7d66\u4eba\u985e\u3002\u65c5\u904a\u9632\u868a\u53ef\u9078\u64c7\u542b\u6575\u907f(DEET)\u7684\u9632\u868a\u7522\u54c1\uff0c\u6548\u679c\u6700\u597d\u3002\nB. \u9ce5\u985e\u662f\u897f\u5c3c\u7f85\u75c5\u6bd2\u65bc\u81ea\u7136\u754c\u4e3b\u8981\u5bbf\u4e3b\u3002\nC. \u53ef\u80fd\u50b3\u64ad\u897f\u5c3c\u7f85\u71b1\u53ca\u5c48\u516c\u71b1\u7684\u75c5\u5a92\u868a\uff0c\u4e5f\u5927\u91cf\u5206\u4f48\u65bc\u53f0\u7063\u3002\nD. \u65c5\u5ba2\u81ea\u897f\u5c3c\u7f85\u75c5\u6bd2\u6d41\u884c\u5340\u96e2\u5883\u56de\u53f0\u4e00\u500b\u6708\u5167\uff0c\u61c9\u66ab\u7de9\u6350\u8840\uff0c\u4ee5\u9632\u7bc4\u8f38\u8840\u50b3\u67d3\u897f\u5c3c\u7f85\u75c5\u6bd2\u3002\nE. \u4ee5\u4e0a\u7686\u6b63\u78ba\n": "(E)", "101-7.\n\u8fd1\u5e74\u4e2d\u570b\u5927\u9678\u5728\u6cb3\u5357\u3001\u5c71\u6771\u3001\u6e56\u5317\u3001\u5b89\u5fbd\u3001\u6c5f\u8607\u548c\u907c\u5be7\u7701\u88ab\u767c\u73fe\u5c0e\u81f4\u300c\u767c\u71d2\u4f34\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4\uff08severe fever with thrombocytopenia syndrome\uff09\u300d\uff0c\u6709\u95dc\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f\nA. \u81f4\u75c5\u539f\u5c6c\u65bc\u5e03\u5c3c\u4e9e\u75c5\u6bd2\u79d1\uff08Bunyaviridae\uff09\u3002\nB. \u6b64\u75c5\u6bd2\u7684\u50b3\u64ad\u6a21\u5f0f\u53ef\u900f\u904e\u8731\uff08tick\uff09\u7684\u53ee\u54ac\u3002\nC. \u50b3\u64ad\u4ea6\u53ef\u900f\u904e\u76f4\u63a5\u63a5\u89f8\u60a3\u8005\u7684\u8840\u6db2\u6216\u542b\u8840\u5206\u6ccc\u7269\u3002\nD. \u60a3\u8005\u4ee5\u8077\u696d\u8fb2\u6c11\u70ba\u4e3b\uff0c\u6b7b\u4ea1\u7387\u905410%\u4ee5\u4e0a\u3002\nE. \u4ee5\u4e0a\u7686\u6b63\u78ba\u3002\n": "(E)", "101-8.\n\u611b\u6ecb\u75c5\u6bd2\uff08HIV\uff09\u50b3\u64ad\u4e4b\u98a8\u96aa\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u662f\uff1f\nA. \u7531\u65bc\u76f4\u8178\u9ecf\u819c\u7684\u89e3\u5256\u7d50\u69cb\u5f88\u8584\uff0c\u5177\u6613\u53d7\u50b7\u4e4b\u7279\u6027\uff0c\u672a\u63a1\u4fdd\u8b77\u63aa\u65bd\u7684\u7537\u6027\u6216\u5973\u6027\u809b\u9580\u6027\u4ea4\u63a5\u53d7\u8005\uff0c\u5176\u611f\u67d3HIV\u4e4b\u98a8\u96aa\u6700\u9ad8\u3002\nB. \u672a\u63a1\u4fdd\u8b77\u4e4b\u9670\u9053\u6027\u4ea4\u63a5\u53d7\u8005\uff0c\u4ea6\u662f\u611f\u67d3HIV\u4e4b\u9ad8\u5371\u96aa\u8005\u3002\nC. \u7576\u6709\u751f\u6b96\u5668\u5b98\u6027\u75c5\u3001\u7522\u751f\u5c3f\u9053\u708e\u3001\u526f\u776a\u708e\u6216\u6f70\u760d\u7b49\u60c5\u6cc1\uff0c\u7531\u65bc\u767c\u708e\u90e8\u4f4d\u6703\u4f7f\u6dcb\u5df4\u7403\u548c\u55ae\u6838\u7403\u6578\u76ee\u589e\u52a0\uff0c\u6703\u589e\u52a0\u7cbe\u6db2\u4e2d\u7684HIV\u75c5\u6bd2\u91cf\u3002\nD. \u50b3\u64adHIV\u6a5f\u7387\u6700\u9ad8\u7684\u6642\u6a5f\u662fHIV\u65e9\u671f\u611f\u67d3\u53caHIV\u672b\u671f\u611f\u67d3\u3002\nE. \u4ee5\u4e0a\u7686\u6b63\u78ba\n": "(E)", "101-9.\n\u6709\u95dc\u7d50\u6838\u83cc(Mycobacterium tuberculosis)\u611f\u67d3\u4e4b\u9673\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u7d50\u6838\u83cc\u611f\u67d3\u8005\u7d42\u5176\u4e00\u751f\u767c\u75c5\u7684\u6a5f\u6703\u7d04\u70ba10%\u3002\nB. \u521d\u6b21\u611f\u67d3\u7d50\u6838\u83cc\u5f8c\uff0c\u4ee5\u611f\u67d3\u5f8c\u524d\u4e00\u5e74\u767c\u75c5\u7684\u53ef\u80fd\u6a5f\u6703\u6700\u9ad8\u3002\nC. \u5178\u578b\u4e4b\u7d50\u6838\u83cc\u6dcb\u5df4\u817a\u708e\u75c7\u72c0\u70ba\u7121\u75db\u6027(painless)\u9838\u5f8c\u6dcb\u5df4\u817a\u708e\u6216\u9396\u9aa8\u4e0a\u6dcb\u5df4\u817a\u708e\u3002\nD. \u7d50\u6838\u75c5\u60a3\u8005\u5373\u4f7f\u5728\u5b8c\u6210\u6cbb\u7642\u5f8c\uff0c\u4ecd\u6709\u7d0450%\u60a3\u8005\u6dcb\u5df4\u7d50\u6709\u7d50\u6838\u83cc\u6f5b\u4f0f\uff0c\u4e0d\u6613\u6839\u6cbb\uff0c\u5fa9\u767c\u6a5f\u7387\u9ad8\u3002\nE. \u7d50\u6838\u83cc\u75f0\u62b9\u7247\u967d\u6027\u767c\u75c5\u4e4b\u60a3\u8005\uff0c\u82e5\u672a\u63a5\u53d7\u6cbb\u7642\uff0c5\u5e74\u5167\u7684\u6b7b\u4ea1\u7387\u7d04\u70ba65%\u3002\n": "(D)", "101-10.\n\u75a5\u7621(scabies)\u662f\u5e38\u767c\u751f\u65bc\u5b89\u990a\u4e2d\u5fc3\u6216\u7cbe\u795e\u91ab\u7642\u9662\u6240\u7684\u50b3\u67d3\u6027\u75be\u75c5\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?\r(1)Burrow(\u5730\u9053)\u5e38\u4f4d\u65bc\u624b\u8155\u5167\u5074\u3001\u6307\u9593\u53ca\u751f\u6b96\u5668(\u9670\u8396)\u90e8\u5206\u3002\r(2)Burrow\u4e2d\u6709\u96cc\u6027\u75a5\u87f2\uff0c\u7d44\u7e54\u75c5\u7406\u6aa2\u67e5\u4e3b\u8981\u70ba\u4e2d\u6027\u767d\u8840\u7403(neutrophil)\u4e4b\u6d78\u6f64\u3002\r(3)\u632a\u5a01\u578b\u75a5\u7621(Norwegian scabies)\u597d\u767c\u65bc\u514d\u75ab\u4e0d\u5168\u75c5\u60a3\uff0c\u75a5\u87f2\u6578\u91cf\u4e0d\u591a\uff0c\u6cbb\u7642\u5bb9\u6613\u3002\r(4)\u611f\u67d3\u75a5\u87f2\u5f8c\u81f3\u767c\u75c5\u75c7\u72c0\u51fa\u73fe\u4e4b\u6f5b\u4f0f\u671f\u53ef\u9577\u90546\u9031\u3002\r(5)\u514d\u75ab\u6b63\u5e38\u7684\u65cf\u7fa4\u611f\u67d3\u75a5\u87f2\u7684\u6578\u91cf\u7d04\u5728\u6bcf\u4eba15\u96bb\u4ee5\u4e0b\u3002\nA. (1)+(4)+(5)\nB. (1)+(2)+(4)\nC. (2)+(3)+(5)\nD. (2)+(3)+(4)\nE. (2)+(4)+(5)\n": "(A)", "101-11.\n19\u6b72\u7537\u6027\u5728\u53f0\u7063\u767b\u5c71\u65c5\u904a\u5f8c\u958b\u59cb\u51fa\u73fe\u767c\u71d2\u3001\u982d\u75db\u3001\u5168\u8eab\u808c\u8089\u9178\u75db\uff0c\u65bc\u9580\u8a3a\u6642\u767c\u73fe\u75c5\u4eba\u53f3\u817f\u5167\u5074\u6709\u4e00\u7126\u75c2(eschar)\uff0c\u4e14\u9f20\u8e4a\u6dcb\u5df4\u817a\u816b\u5927\uff0c\u8840\u6db2\u6aa2\u67e5\u767d\u8840\u7403\u6578\u70ba3150/\u03bcL\u3001GOT 112 IU/L\u3001GPT184 IU/L\uff0c\u5c0d\u65bc\u6b64\u75c5\u4f8b\u4e4b\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?\nA. \u6b64\u75be\u75c5\u70ba\u6059\u87f2\u75c5scrub typhus\uff0c\u81f4\u75c5\u83cc\u70baOrientia tsutsugamushi\nB. \u6b64\u81f4\u75c5\u83cc\u662f\u7531\u8768(louse)\u6240\u50b3\u64ad\nC. \u53f0\u7063\u6d41\u884c\u6b64\u611f\u67d3\u7684\u5730\u5340\u5728\u6771\u90e8\u5730\u5340\u53ca\u96e2\u5cf6\nD. \u6cbb\u7642\u7684\u9996\u9078\u85e5\u7269\u662fdoxycycline\nE. \u6b64\u75c5\u4e4b\u6f5b\u4f0f\u671f(incubation period)\u7d04\u70ba9\u81f318\u5929\n": "(B)", "101-12.\n\u6709\u95dc\u56b4\u91cd\u6557\u8840\u75c7\u6642\u75c5\u60a3\u4e4b\u81e8\u5e8a\u8655\u7406\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?\nA. \u4e2d\u5fc3\u975c\u8108\u58d3(central venous pressure)\u61c9\u7dad\u6301\u57288-12 cmH2O\u3002\nB. \u975c\u8108\u8f38\u6db2\u6ef4\u6ce8\u61c9\u4f7f\u6bcf\u5c0f\u6642\u5c3f\u6db2\u51fa\u7dad\u6301\u5927\u65bc0.5 ml/kg\u9ad4\u91cd\uff0c\u5fc5\u8981\u6642\u4f7f\u7528\u5229\u5c3f\u5291\u3002\nC. \u4f4e\u8840\u58d3\u4f11\u514b\u767c\u751f\u6642\uff0c\u7de9\u6162\u7d66\u4e88\u751f\u7406\u98df\u9e7d\u6c341000 ml\u81f32000 ml\uff0c\u6ef4\u6ce8\u6642\u9593\u7dad\u6301\u7d043\u5c0f\u6642\u4ee5\u907f\u514d\u80ba\u6c34\u816b\u3002\nD. \u6210\u4eba\u8840\u7d05\u7d20\u4f4e\u65bc7 g/dL\u6642\uff0c\u5408\u7406\u7684\u8f38\u8840\u76ee\u6a19\u61c9\u9054\u52309 g/dL\u4ee5\u4e0a\u3002\nE. Bicarbonate \u5728\u4ee3\u8b1d\u6027\u9178\u4e2d\u6bd2(\u52d5\u8108\u8840pH<7.2)\u53ef\u8003\u616e\u7d66\u4e88\uff0c\u4f46\u76ee\u524d\u4ecd\u7f3a\u4e4f\u53ef\u6539\u5584\u8840\u5faa\u52d5\u529b(hemodynamics)\u7684\u5be6\u8b49\u3002\n": "(C)", "101-13.\n\u4e00\u4f4d35\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u56e0\u767c\u71d2\u754f\u5bd22\u5929\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u624b\u8155\u6709\u8a31\u591a\u904e\u53bb\u6ce8\u5c04\u91dd\u5b54\u7684\u50b7\u53e3\uff0c\u5fc3\u81df\u807d\u8a3a\u6709\u660e\u986f\u6536\u7e2e\u5fc3\u96dc\u97f3\uff0c\u5fc3\u81df\u8d85\u97f3\u6ce2\u767c\u73fe\u4e09\u5c16\u74e3\u4e0a\u6709\u8d05\u751f\u7269(vegetation)\uff0c\u8840\u6db2\u57f9\u990a2\u5957\u5747\u70ba\u70ba\u9769\u862d\u6c0f\u9670\u6027\u83cc\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u662f\u6700\u6709\u53ef\u80fd\u7684\u81f4\u75c5\u83cc?\nA. Staphylococcus aureus(\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc)\nB. Klebsiella pneumoniae(\u514b\u96f7\u67cf\u6c0f\u687f\u83cc)\nC. Listeria monocytogenes(\u674e\u65af\u7279\u83cc)\nD. Pseudomonas aeruginosa(\u7da0\u81bf\u687f\u83cc)\nE. Acinetobacter baumannii(\u9b91\u66fc\u4e0d\u52d5\u687f\u83cc)\n": "(D)", "101-14.\n\u4e0b\u5217\u6709\u95dc\u5316\u81bf\u6027\u809d\u81bf\u760d\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u53f0\u7063\u5730\u5340\u539f\u767c\u6027\u5316\u81bf\u6027\u809d\u81bf\u760d\u81f4\u75c5\u83cc\u4ee5Klebsiella pneumoniae\u6700\u5e38\u898b\nB. \u53f0\u7063\u5730\u5340\u539f\u767c\u6027\u5316\u81bf\u6027\u809d\u81bf\u760d\u75c5\u60a3\u5e38\u6709\u7cd6\u5c3f\u75c5\u6216\u9157\u9152\u75c5\u53f2\nC. \u5316\u81bf\u6027\u809d\u81bf\u760d\u81f4\u75c5\u539f\u53ef\u80fd\u8840\u5faa\u8f49\u79fb\u81f3\u8166\u90e8\u3001\u9aa8\u9abc\u7b49\u8655\nD. \u8840\u6db2\u751f\u5316\u6aa2\u67e5\u4ee5\u809d\u8f49\u63db\ufffdCALT\u3001AST\u7d04\u670970%\u60a3\u8005\u5347\u9ad8\u6700\u70ba\u5e38\u898b\nE. \u6297\u751f\u7d20\u52a0\u4e0a\u7d93\u76ae\u5c0e\u7ba1\u5f15\u6d41\u70ba\u6709\u6548\u6cbb\u7642\u65b9\u6cd5\n": "(D)", "101-15.\n\u6709\u95dc\u91ab\u7642\u7167\u8b77\u611f\u67d3\u75c5\u539f\u4e4b\u50b3\u64ad\u9014\u5f91\uff0c\u4e0b\u5217\u914d\u5c0d\u4f55\u8005\u932f\u8aa4?\nA. \u591a\u91cd\u6297\u85e5\u6027\u83ccAcinetobacter baumannii - \u63a5\u89f8\u6c61\u67d3\u7684\u807d\u8a3a\u5668\u6216\u8840\u58d3\u8a08\nB. B\u578b\u53caC\u578b\u809d\u708e\u75c5\u6bd2 - \u611f\u67d3\u8005\u8840\u7ba1\u5c0e\u7ba1\u7559\u7f6e\u91dd\u982d\u76ae\u819a\u91dd\u624e\nC. Legionella pneumophila(\u9000\u4f0d\u8ecd\u4eba\u83cc) - \u6c61\u67d3\u7684\u6c34\u6e90\u6216\u6c23\u9727\u5438\u5165\nD. Group A Streptococcus(A\u578b\u93c8\u7403\u83cc) - \u63a2\u8a2a\u8005\u3001\u7167\u9867\u8005\u4e4b\u54b3\u55fd\u98db\u6cab\nE. Aspergillus fumigatus(\u771f\u83cc) - \u6c61\u67d3\u7684\u91ab\u7642\u4eba\u54e1\u624b\u63a5\u89f8\u50b3\u67d3\n": "(E)", "101-16.\n\u4e00\u4f4d70\u6b72\u7537\u6027\u60a3\u8005\uff0c\u56e0\u8166\u4e2d\u98a8\u5e38\u7559\u7f6e\u5c3f\u6db2\u5c0e\u7ba1(Foley catheter)\uff0c\u56e0\u8840\u5c3f\u53ca\u767c\u71d2\u4e09\u5929\u81f3\u672c\u9662\u6025\u8a3a\uff0c\u5169\u5957\u8840\u6db2\u57f9\u990a\u5747\u9577\u51faEnterococcus faecalis\uff0c\u82e5\u5c0d\u6297\u751f\u7d20\u7686\u5177\u6709\u611f\u53d7\u6027\u6642(susceptible)\uff0c\u6b64\u6642\u4e0b\u5217\u4f55\u7a2e\u85e5\u7269\u6cbb\u7642\u662f\u6700\u4f73\u8003\u616e\u9996\u9078?\nA. Oxacillin + gentamicin\nB. Ceftriaxone (3rd generation cephalosporin)\nC. Ampicillin + gentamicin\nD. Cefazolin + gentamicin (1st generation cephalosporin)\nE. Vancomycin\n": "(C)", "101-17.\n\u4e00\u4f4d29\u6b72\u61f7\u5b55\u5a66\u5973\uff0c\u56e0\u767c\u71d2\u4f4f\u9662\u9700\u4f7f\u7528\u6297\u5fae\u751f\u7269\u88fd\u5291\uff0c\u8acb\u554f\u4e0b\u5217\u6297\u5fae\u751f\u7269\u88fd\u5291\u4f55\u8005\u662f\u5c6c\u65bc\u61f7\u5b55\u85e5\u7269\u5b89\u5168\u5206\u985eClass C\u6216D\u7d1a\u85e5\u7269\uff0c\u61c9\u907f\u514d\u4f7f\u7528?\r(1)Erythromycin estolate\r(2)Metronidazole\r(3)Meropenem\r(4)Clarithromycin\r(5)Gentamicin\nA. (1)+(5)\nB. (2)+(3)\nC. (2)+(5)\nD. (3)+(4)\nE. (4)+(5)\n": "(E)", "101-18.\n18\u6b72\u5973\u6027\uff0c\u7a81\u7136\u767c\u71d2\u3001\u982d\u75db\u53ca\u5614\u5410\uff0c\u4f4f\u9662\u5f8c\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u75c5\u4eba\u55dc\u7761\u53ca\u9838\u90e8\u50f5\u786c\uff0c\u56db\u80a2\u53ef\u898b\u591a\u8655\u7d2b\u6591\u51fa\u8840\u75b9\u3001\u8840\u6db2\u767d\u8840\u7403\u70ba18000/\u03bcl\uff0c\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\u767c\u73fe\u767d\u8840\u74031100/\u03bcl\uff0cneutrophil\u4f5492\uff05\uff0c\u8461\u8404\u7cd611 mg/dl\u3002\u4ee5\u4e0b\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u81f4\u75c5\u539f?\nA. Neisseria meningitidis\nB. Enterovirus type 71\nC. Haemophilus influenzae\nD. Listeria monocytogenes\nE. Herpes simplex virus\n": "(A)", "101-19.\n\u4e0b\u5217\u6709\u95dcVaricella-zoster virus \u75c5\u6bd2\u611f\u67d3\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba?\nA. \u6b64\u75c5\u6bd2\u70ba\u96d9\u80a1RNA\u75c5\u6bd2\uff0c\u521d\u6b21\u611f\u67d3\u9014\u5f91\u4e3b\u8981\u70ba\u547c\u5438\u9053\u50b3\u64ad\nB. \u521d\u6b21\u611f\u67d3\u5f8c\u6f5b\u4f0f\u5728\u810a\u9ad3\u8179\u6839\u795e\u7d93(ventral root ganglia)\uff0c\u6613\u5fa9\u767c\u65bc\u80f8\u690e\u81f3\u8170\u690e\u76ae\u7bc0\nC. \u76ee\u524d\u5c1a\u7121\u9069\u7576\u7684\u75ab\u82d7\u53ef\u7528\u65bc\u9810\u9632Varicella zoster virus\u4e4b\u611f\u67d3\nD. \u8166\u708e\u767c\u751f\u6642\u5bb9\u6613\u6709\u5c40\u90e8\u51fa\u8840\u6027\u58de\u6b7b\uff0c\u8207Herpes simplex virus\u8166\u708e\u81e8\u5e8a\u8868\u73fe\u985e\u4f3c\uff0c\u6b7b\u4ea1\u7387\u9ad8\nE. Ramsay-Hunt syndrome\u53ef\u5728\u5916\u8033\u9053\u898b\u5230\u6c34\u6ce1\uff0c\u820c\u982d\u524d\u4e09\u5206\u4e4b\u4e8c\u5931\u53bb\u5473\u89ba\n": "(E)", "102-1.\n\u6709\u95dc\u80ba\u708e\u81f4\u75c5\u539f\u4e4b\u8a3a\u65b7\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f\r(1)\u6709\u81e8\u5e8a\u610f\u7fa9\u4e4b\u75f0\u6db2\u53d6\u6a23\uff0c\u5fc5\u9808\u7b26\u5408\u6bcf\u4e00\u986f\u5fae\u93e1\u9ad8\u500d\u8996\u91ce(high power field\uff0cHPF 400X) \u53ef\u898b\u9769\u862d\u6c0f\u67d3\u8272\uff1e25\u500b\u55dc\u4e2d\u6027\u767d\u8840\u7403/HPF\uff0c\uff1c10\u500b\u4e0a\u76ae\u7d30\u80de/HPF (2)\u5373\u4f7f\u8840\u6db2\u57f9\u990a\u78ba\u8a8d\u967d\u6027\u4e4b\u80ba\u708e\u7403\u83cc (Streptococcus pneumoniae) \u80ba\u708e\uff0c\u5728\u75f0\u6db2\u57f9\u990a\u7387\u4e5f\u50c5\u6709\u6700\u591a50\uff05\u967d\u6027\u7387 (3)\u5c3f\u6db2Legionella\u6297\u539f\u967d\u6027\u4f86\u8a3a\u65b7\u70ba\u9000\u4f0d\u8ecd\u4eba\u75c7\u4e4b\u654f\u611f\u6027(sensitivity)\u53ca\u7279\u7570\u6027(specificity)\u53ef\u905490\uff05 (4)\u5c3f\u6db2Legionella antigen\u53ef\u4ee5\u6aa2\u9a57\u51fa\u591a\u7a2eLegionella serogroups (5)\u4ee5\u6c23\u7ba1\u5167\u75f0\u6db2\u5206\u6ccc\u7269\u62bd\u5438(endotracheal\raspirate)\u65b9\u5f0f\u57f7\u884c\u5b9a\u91cf\u7d30\u83cc\u57f9\u990a\u5206\u6790\uff0c\u914d\u5408\u81e8\u5e8a\u75c7\u72c0\uff0c\u53ef\u4ee5\u7528\u4f86\u5340\u5206\u611f\u67d3(infection)\u6216\u79fb\u751f(colonization)  (\u61c9\u5beb\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\nA. (1)+(3)+(5)\nB. (1)+(3)+(4)\nC. (1)+(2)+(3)\nD. (2)+(3)+(5)\nE. (1)+(2)+(3)+(4)+(5)\n": "(D)", "102-2.\n\u6709\u95dc\u56b4\u91cd\u6557\u8840\u6027\u4f11\u514b\u75c5\u60a3\u4e4b\u8655\u7406\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f\r(1).\u70ba\u4f7f\u5668\u5b98\u704c\u6d41\u8db3\u5920\uff0c\u5e73\u5747\u52d5\u8108\u58d3(mean arterial blood pressure) \u76ee\u6a19\u61c9\u7dad\u6301\u572865mmHg\u4ee5\u4e0a\uff0c\u6536\u7e2e\u58d3(systolic pressure)\u572890mmHg\u4ee5\u4e0a (2).\u7d66\u4e88\u975c\u8108\u8f38\u6db2\u7dad\u6301\u5728\u4e2d\u5fc3\u975c\u8108\u58d3(central venous pressure)\u572815 - 20mmHg\uff0c\u4ee5\u907f\u514d\u80ba\u6c34\u816b (3).\u7d66\u4e88\u975c\u8108\u8f38\u6db2\u7dad\u6301\u5728\u5c3f\u6db2\u8f38\u51fa\u91cf(urine output rate)\u5927\u65bc0.5ml/kg/hr\uff0c\u5fc5\u8981\u6642\u7d66\u4e88\u5229\u5c3f\u5291(furosemide) (4).\u82e5\u56e0\u5fc3\u808c\u6536\u7e2e\u529f\u80fd\u4e0d\u5168(myocardial dysfunction)\u800c\u5c0e\u81f4\u4f4e\u5fc3\u81df\u8f38\u51fa\u91cf(low cardiac output)\uff0c\u53ef\u4ee5\u512a\u5148\u4f7f\u7528norepinephrine\u6ef4\u6ce8\uff0c\u4ee5\u52a0\u5f37\u5fc3\u81df\u8f38\u51fa\u91cf\r(5).\u8655\u7406\u4f4e\u8840\u58d3\u6557\u8840\u6027\u4f11\u514b\u6642\uff0c\u751f\u7406\u98df\u9e7d\u6c341000ml\u81f32000ml\u61c9\u7de9\u6162\u975c\u8108\u6ef4\u6ce83\u5c0f\u6642\uff0c\u4ee5\u907f\u514d\u80ba\u6c34\u816b\u767c\u751f\nA. (1)+(3)\nB. (1)+(2)\nC. (3)+(4)\nD. (2)+(3)\nE. (4)+(5)\n": "(A)", "102-3.\n\u6709\u95dc\u65b0\u8208\u50b3\u67d3\u75c5H7N9\u6d41\u611f\u4e4b\u6d41\u884c\u75c5\u5b78\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u6839\u64da\u4e2d\u570b\u5927\u9678\u516c\u4f48\u4e4bH7N9\u75c5\u4f8b\uff0c\u611f\u67d3\u5f8c\u9020\u6210\u80ba\u708e\u4e4b\u6b7b\u4ea1\u7387\u7d04\u70ba30\uff05\u3002\nB. \u53f0\u7063\u5df2\u6709\u5883\u5916\u79fb\u5165\u4e4bH7N9\u611f\u67d3\u500b\u6848\u3002\nC. H7N9\u611f\u67d3\u500b\u6848\u8d85\u904e\u534a\u6578\u6709\u6162\u6027\u7cfb\u7d71\u6027\u75be\u75c5\uff0c\u5982\uff1a\u9ad8\u8840\u58d3\u3001\u7cd6\u5c3f\u75c5\u3001\u6162\u6027\u80ba\u708e\u6216\u6162\u6027\u5fc3\u80ba\u75be\u75c5\u7b49\u3002\nD. H7N9\u611f\u67d3\u500b\u6848\u4ee5\u5bb6\u65cf\u7fa4\u805a\u70ba\u4e3b\uff0c\u5c11\u6578\u500b\u6848\u70ba\u63a5\u89f8\u6d3b\u79bd\u53f2\u3002\nE. H7N9\u6d41\u611f\u8a3a\u65b7\u4e4b\u78ba\u5b9a\u9700\u4f9d\u8cf4\u75c5\u6bd2\u6838\u9178\u9451\u5b9a\u5206\u6790(rRT-PCR)\u3002\n": "(D)", "102-4.\n\u6709\u95dc\u65b0\u8208\u50b3\u67d3\u75c5H7N9\u6d41\u611f\u4e4b\u81e8\u5e8a\u8868\u73fe\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u6b64\u75c5\u4e4b\u6f5b\u4f0f\u671f\u53ef\u905410 - 14\u5929\u3002\nB. \u75c7\u72c0\u4e3b\u8981\u70ba\u767c\u9ad8\u71d2\u3001\u54b3\u55fd\u3001\u547c\u5438\u5598\uff0c\u5c11\u6578\u6709\u8179\u7009\u75c7\u72c0\u3002\nC. \u80f8\u90e8X\u5149\u51fa\u73fe\u96d9\u5074\u80ba\u90e8\u6d78\u6f64\u70ba\u91cd\u75c7\u8868\u73fe\u3002\nD. \u8840\u6db2\u6aa2\u67e5\u53ef\u898b\u767d\u8840\u7403\u589e\u591a(leukocytosis)\u53ca\u8840\u5c0f\u677f\u4f4e\u4e0b(thrombocytopenia)\uff0c\u6dcb\u5df4\u7403\u4ea6\u5448\u589e\u52a0(lymphocytosis)\u3002\nE. \u6025\u6027\u547c\u5438\u7a98\u8feb\u75c7(ARDS)\u9020\u6210\u4e4b\u7f3a\u6c27\u5c0e\u81f4\u591a\u91cd\u5668\u5b98\u8870\u7aed\u70ba\u4e3b\u8981\u6b7b\u56e0\u3002\n": "(D)", "102-5.\n\u4e00\u4f4d30\u6b72\u7537\u6027\uff0c\u5728\u53c3\u52a0\u559c\u5bb4\u5f8c3\u5c0f\u6642\u958b\u59cb\u767c\u751f\u4e0a\u5410\u4e0b\u7009\u4e4b\u75c7\u72c0\uff0c\u8acb\u554f\u6700\u6709\u53ef\u80fd\u8207\u4e0b\u5217\u4f55\u7a2e\u75c5\u539f\u76f8\u95dc\uff1f\nA. Staphylococcus aureus\nB. Shigella spp.\nC. Vibrio cholerae\nD. Salmonella spp.\nE. Enterohemorrhagic E.coli\n": "(A)", "102-6.\n\u6709\u95dc\u5bbf\u4e3b\u4e4b\u514d\u75ab\u529b\u8207\u6613\u611f\u53d7\u81f4\u75c5\u539f\u611f\u67d3\u4e4b\u914d\u5c0d\u95dc\u4fc2\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u80c3\u9178\u5206\u6ccc\u6e1b\u5c11 \uff0d \u6c99\u9580\u6c0f\u83cc (Salmonella) \u611f\u67d3\nB. \u767d\u8840\u7403\u541e\u566c\u80fd\u529b\u4e0b\u964d \uff0d \u80ba\u708e\u7403\u83cc(Streptococcus pneumoniae) \u611f\u67d3\nC. \u813e\u81df\u5207\u9664 \uff0d \u79bd\u578b\u5206\u679d\u687f\u83cc(Mycobacterium avium complex) \u611f\u67d3\nD. C5-C8\u88dc\u9ad4\u7f3a\u4e4f \uff0d \u5948\u745f\u6c0f\u8166\u819c\u708e\u7403\u83cc(Neisseria meningitidis) \u611f\u67d3\nE. T\u6dcb\u5df4\u7d30\u80de\u7f3a\u9677 \uff0d \u674e\u65af\u7279\u83cc(Listeria monocytogenes) \u611f\u67d3\n": "(C)", "102-7.\n\u6709\u95dc\u6ccc\u5c3f\u9053\u611f\u67d3(urinary tract infection; UTI)\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f(1)\u65b0\u751f\u5152\u968e\u6bb5(neonatal period)\uff0c\u6ccc\u5c3f\u9053\u611f\u67d3\u7684\u767c\u751f\u7387\u5973\u6027\u9060\u9ad8\u65bc\u7537\u6027 (2)E.coli\u662f\u6700\u5e38\u898b\u7684\u8907\u96dc\u6027\u6ccc\u5c3f\u9053\u611f\u67d3(complicated UTI)\u81f4\u75c5\u539f (3)\u6709\u75c7\u72c0\u7684\u6025\u6027\u8180\u80f1\u708e(acute cystitis)\uff0c\u82e5\u5c3f\u6db2\u57f9\u990a\u83cc\u843d\u5927\u65bc100 \u83cc\u843d\u6578/ml\u5c3f\u6db2\uff0c\u53ef\u8a3a\u65b7\u70ba\u81f4\u75c5\u539f (4)\u814e\u79fb\u690d\u4e4b\u63a5\u53d7\u8005\uff0c\u82e5\u6aa2\u9a57\u70ba\u7121\u75c7\u72c0\u4e4b\u83cc\u5c3f\u75c7(\u2267100,000\u83cc\u843d\u6578/ml\u5c3f\u6db2)\uff0c\u9700\u8981\u9032\u884c\u6297\u751f\u7d20\u6cbb\u7642 (5)\u6025\u6027\u814e\u76c2\u814e\u708e\u4e4b\u75c5\u60a3\u670960\uff05\u81f370\uff05\u60a3\u8005\u6703\u5408\u4f75\u83cc\u8840\u75c7(bacteremia)\nA. (1)+(2)+(3)\nB. (3)+(4)+(5)\nC. (2)+(4)+(5)\nD. (1)+(2)+(5)\nE. (2)+(3)+(4)\n": "(E)", "102-8.\n\u4e00\u4f4d\u53f0\u5546\u81f3\u5927\u9678\u5de5\u4f5c\uff0c\u5728\u91ce\u5916\u5c71\u5340\u88ab\u91ce\u72d7\u54ac\u50b7\u624b\u6307\uff0c\u7576\u6642\u4e26\u672a\u5c31\u91ab\uff0c\u4e09\u9031\u5f8c\u56de\u570b\u51fa\u73fe\u982d\u75db\u3001\u767c\u71d2\u3001\u54ac\u50b7\u80a2\u9ad4\u9ebb\u75fa\u3001\u541e\u56a5\u56f0\u96e3\u3001\u6050\u6c34\u7b49\u75c7\u72c0\u800c\u81f3\u6025\u8a3a\uff0c\u6709\u95dc\u6b64\u75be\u75c5\u4e4b\u9810\u9632\u8207\u6cbb\u7642\u7167\u8b77\uff0c\u4e0b\u5217\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u5728\u53f0\u7063\u6b64\u75be\u75c5\u5c6c\u65bc\u7b2c\u4e00\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u9700\u65bc24\u5c0f\u6642\u5167\u901a\u5831\u3002\nB. \u82e5\u81f3\u6b64\u75be\u75c5\u4e4b\u611f\u67d3\u98a8\u96aa\u4e4b\u75ab\u5340\u53ef\u80fd\u6709\u63a5\u89f8\u91ce\u751f\u52d5\u7269\u767c\u751f\u98a8\u96aa\uff0c\u61c9\u65bc\u51fa\u767c\u524d\u4e00\u500b\u6708\u63a5\u7a2e\u4e09\u5291\u75ab\u82d7\u3002\nC. \u75c5\u60a3\u5728\u6025\u8a3a\u4e4b\u7167\u8b77\u671f\u9593\u91ab\u8b77\u4eba\u54e1\u61c9\u56b4\u7981\u63a5\u89f8\u60a3\u8005\u4e4b\u547c\u5438\u9053\u5206\u6ccc\u7269\u3002\nD. \u75c5\u60a3\u61c9\u65bc\u53d7\u50b7\u5f8c\uff0c\u5118\u901f\u6e05\u6d17\u6d88\u6bd2\u50b7\u53e3\u3001\u65bd\u6253\u75ab\u82d7\u53ca\u4f7f\u7528\u514d\u75ab\u7403\u86cb\u767d\u65bc\u50b7\u53e3\u6d78\u6f64(infiltration)\u8207\u6ce8\u5c04\u3002\nE. Ribavirin\u53ef\u505a\u70ba\u6b64\u75c5\u4e4b\u6cbb\u7642\u85e5\u7269\u3002\n": "(E)", "102-9.\n\u627f\u4e0a\u984c\uff0c\u6b64\u75be\u75c5\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u767c\u751f\u6025\u6027\u795e\u7d93\u75c7\u5019\uff0c80\uff05\u500b\u6848\u81e8\u5e8a\u8868\u73fe\u70ba\u8166\u708e(encephalitic)\u70ba\u4e3b\uff0c20\uff05\u500b\u6848\u70ba\u80a2\u9ad4\u9ebb\u75f9(paralytic)\u70ba\u4e3b\u3002\nB. \u6b64\u75c5\u4e4b\u6f5b\u4f0f\u671f\u4e00\u822c\u70ba20\u81f390\u5929\u3002\nC. \u60a3\u8005\u8166\u810a\u9ad3\u6db2(cerebrospinal fluid)\u5206\u6790\u5e38\u898b\u767d\u8840\u7403(pleocytosis)\u9ad8\u65bc1000/\u03bcL\u4ee5\u4e0a\u3002\nD. \u5e38\u898b\u81e8\u5e8a\u75c7\u72c0\u70ba\u6025\u6027\u8166\u810a\u9ad3\u708e\uff0c\u75c7\u72c0\u70ba\u982d\u75db\u3001\u767c\u71d2\u3001\u7126\u8e81\uff0c\u96a8\u5f8c\u4f75\u6709\u7cbe\u795e\u932f\u4e82\u53ca\u62bd\u6410\u3002\nE. \u60a3\u8005\u553e\u6db2\u5206\u6ccc\u904e\u591a(hypersalivation)\u539f\u56e0\u70ba\u81ea\u4e3b\u795e\u7d93\u53d7\u75c5\u6bd2\u4fb5\u72af\u5c0e\u81f4\u529f\u80fd\u7570\u5e38(autonomic dysfunction)\u3002\n": "(C)", "102-10.\n\u4e00\u4f4d60\u6b72\u764c\u75c7\u75c5\u4eba\u4f4f\u9662\u63a5\u53d7\u5316\u5b78\u6cbb\u7642\uff0c\u56e0\u6ccc\u5c3f\u9053\u611f\u67d3\u4f7f\u7528\u6297\u751f\u7d20Ceftriaxone\u4e8c\u9031\uff0c\u51fa\u9662\u5f8c\u75c5\u60a3\u958b\u59cb\u51fa\u73fe\u767c\u71d2\u3001\u8179\u75db\u53ca\u8179\u7009\u7684\u75c7\u72c0\uff0c\u7d93\u5927\u8178\u93e1\u6aa2\u67e5\u5982\u5716\u793a\uff0c\u6709\u95dc\u6b64\u75be\u75c5\u4e4b\u767c\u751f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f\nA. \u6b64\u83cc\u53ef\u5728\u793e\u5340\u4eba\u7fa4\u5e36\u539f\uff0c\u65b0\u751f\u5152\u7121\u75c7\u72c0\u8178\u9053\u5e36\u83cc\u7387\u53ef\u9ad8\u905450%\u3002\nB. \u6b64\u83cc\u7522\u751f\u4e4b\u6bd2\u7d20A\u70ba\u7d30\u80de\u6bd2\u7d20(cytotoxin)\uff0c\u70ba\u4e3b\u8981\u6bd2\u529b\u56e0\u5b50(virulence factor)\u3002\nC. \u6b64\u75be\u75c5\u5e38\u5408\u4f75\u8089\u773c\u53ef\u898b\u4e4b\u8840\u4fbf\u8179\u7009\u3002\nD. \u6ce8\u5c04\u842c\u53e4\u9ef4\u7d20(vancomycin)\u70ba\u7b2c\u4e00\u7dda\u85e5\u7269metronidazole\u6cbb\u7642\u5931\u6557\u5f8c\u4e4b\u9996\u9078\u6cbb\u7642\u3002\nE. \u4ee5\u6838\u9178\u9451\u5b9a(PCR)\u65b9\u5f0f\u5075\u6e2c\u7cde\u4fbftoxin C gene\u53ef\u5feb\u901f\u8a3a\u65b7\u6b64\u75c5\u3002\n": "(A)", "102-11.\n\u4e00\u4f4d50\u6b72\u7684\u5a66\u5973\u5403\u4e86\u81ea\u5df1\u9183\u88fd\u7684\u852c\u83dc\uff0c2\u5929\u5f8c\u958b\u59cb\u51fa\u73fe\u8178\u80c3\u4e0d\u9069\u3001\u4fbf\u79d8\u4ee5\u53ca\u80a2\u9ad4\u9ebb\u75fa(descending flaccid paralysis)\u88ab\u9001\u81f3\u6025\u8a3a\uff0c\u60a3\u8005\u4e26\u88ab\u767c\u73fe\u6709\u8907\u8996(diplopia)\u3001\u53e3\u9f52\u4e0d\u6e05(dysarthria)\u53ca\u541e\u56a5\u56f0\u96e3(dysphagia)\uff0c\u7406\u5b78\u6aa2\u67e5\u5728\u54bd\u5589\u53cd\u5c04(gag reflex)\u53ca\u6df1\u90e8\u808c\u8171\u53cd\u5c04(deep tendon reflexes)\u6e1b\u5f31\uff0c\u5c0d\u6b64\u75be\u75c5\u7684\u6558\u8ff0\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f\nA. \u57f7\u884c\u8840\u6db2\u57f9\u990a\uff0c\u5927\u591a\u53ef\u57f9\u990a\u51fa\u6b64\u81f4\u75c5\u83cc\u3002\nB. \u6b64\u75c5\u60a3\u4e4b\u4fbf\u7955\u662f\u56e0\u70ba\u8178\u80c3\u7684\u795e\u7d93\u9ebb\u75fa(paralytic ileus)\u6240\u5c0e\u81f4\u3002\nC. \u81e8\u5e8a\u75c7\u72c0\u901a\u5e38\u5408\u4f75\u767c\u9ad8\u71d2\u53ca\u754f\u5bd2\u3002\nD. \u6b64\u83cc\u7522\u751f\u4e4b\u6bd2\u7d20(toxin)\u8207\u795e\u7d93\u5143\u7d50\u5408\u5c6c\u65bc\u4e0d\u53ef\u9006\u6027(irreversible)\u4e4b\u8b8a\u5316\uff0c\u56e0\u6b6495\uff05\u4ee5\u4e0a\u7684\u75c5\u60a3\u6703\u767c\u751f\u6c38\u4e45\u4e0d\u53ef\u9006\u7684\u795e\u7d93\u5b78\u7570\u5e38\u3002\nE. \u6b64\u75be\u75c5\u4e4b\u4e3b\u8981\u6cbb\u7642\u65b9\u5f0f\u70ba\u7d66\u4e88\u9ad8\u5291\u91cfPenicillin\u6ce8\u5c04\u3002\n": "(B)", "102-12.\n\u842c\u53e4\u9ef4\u7d20\u6297\u85e5\u6027\u8178\u7403\u83cc(Vancomycin-resistant Enterococcus)\u662f\u9662\u5167\u611f\u67d3\u5e38\u898b\u7684\u81f4\u75c5\u83cc\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f\nA. \u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2(70\uff05-80\uff05 Alcohol)\u7121\u6cd5\u6bba\u6b7b\u6b64\u83cc\u3002\nB. \u82e5\u7121ampicillin\u4e4b\u6297\u85e5\u6027\u5247\u4ee5ampicillin\u9ad8\u5291\u91cf(12g/\u5929)\u55ae\u4e00\u6cbb\u7642Enterococcus\u5fc3\u5167\u819c\u708e\u53ef\u4ee5\u6709\u5f88\u597d\u7684\u6cbb\u7642\u7387\u3002\nC. E. faecium\u6bd4E. faecalis\u5c0dampicillin\u6216vancomycin\u4e4b\u6297\u85e5\u6027\u66f4\u5e38\u898b\u3002\nD. \u982d\u5b62\u5b50\u83cc\u7d20(cephalosporin)\u985e\uff0c\u5982cefepime\uff0c\u662f\u6b64\u83cc\u611f\u67d3\u7684\u4e3b\u8981\u6cbb\u7642\u85e5\u7269\u3002\nE. \u6b64\u83cc\u4e4b\u611f\u67d3\u7ba1\u5236\u70ba\u843d\u5be6\u98db\u6cab\u9694\u96e2\u9632\u8b77(droplet isolation precaution)\u3002\n": "(C)", "102-13.\n\u4e0b\u5217\u95dc\u65bc\u6d41\u884c\u6027\u8166\u810a\u9ad3\u819c\u708e\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba?\nA. \u53f0\u7063\u548c\u5176\u4ed6\u570b\u5bb6\u6d41\u884c\u7684\u578b\u5225\u985e\u4f3c\uff0c\u7686\u4ee5A, C, Y, W135\u8840\u6e05\u578b\u70ba\u4e3b\uff0c\u53f0\u7063\u7684\u767c\u751f\u7387\u548c\u975e\u6d32\u7684\"\u6d41\u8166\u5e36(meningitis belt)\"\u6492\u54c8\u62c9\u6c99\u6f20\u4ee5\u5357\u5340\u57df\u63a5\u8fd1\u3002\nB. \u6f5b\u4f0f\u671f\u5c0f\u65bc\u4e03\u5929\uff0c\u50c5\u6709\u5b69\u7ae5\u6703\u51fa\u73fe\u56b4\u91cd\u7684\u75c7\u72c0\uff0c\u4e14\u767c\u751f\u8166\u819c\u708e\u7684\u98a8\u96aa\u8f03\u767c\u751f\u83cc\u8840\u75c7\u70ba\u4f4e\u3002\nC. \u76ee\u524d\u53f0\u7063\u6709\u591a\u91a3\u9ad4\u56db\u50f9\u75ab\u82d7\u53ef\u4f7f\u7528\uff0c\u800c\u4e14\u5c0d\u65bcSerogroup B\u4e5f\u6709\u6709\u6548\u4fdd\u8b77\u4f5c\u7528\u3002\nD. \u904e\u53bb\u66fe\u6709\u81f3\u9ea5\u52a0\u671d\u8056\u9020\u6210\u6d41\u884c\u6027\u8166\u810a\u9ad3\u819c\u708e\u7fa4\u805a\u4e8b\u4ef6\u7684\u767c\u751f\uff0c\u56e0\u6b64\u524d\u5f80\u9ea5\u52a0\u671d\u8056\u7684\u65c5\u5ba2\u9808\u51fa\u793a\u4e09\u5e74\u5167\u63a5\u7a2e\u6d41\u884c\u6027\u8166\u810a\u9ad3\u819c\u708e\u75ab\u82d7\u4e4b\u63a5\u7a2e\u8b49\u660e\u3002\nE. \u5c0d\u65bc\u5bc6\u5207\u63a5\u89f8\u8005\u7684\u66b4\u9732\u5f8c\u9810\u9632\uff0c\u50c5\u6709rifampin \u53ef\u4f7f\u7528\uff0c\u4e14\u9808\u4f7f\u7528\u8d85\u904e\u5169\u9031\u4ee5\u4e0a\u3002\n": "(D)", "102-14.\n\u95dc\u65bc\u9ec3\u71b1\u75c5\u6bd2\u5c6c(Flavivirus)\u6240\u5f15\u8d77\u7684\u4eba\u985e\u75be\u75c5\u4e4b\u6b63\u78ba\u63cf\u8ff0\uff0c\u9664\u4e86:\nA. \u5305\u542b\u9ec3\u71b1\u75c5\u3001\u767b\u9769\u71b1\u3001\u65e5\u672c\u8166\u708e\u3001\u897f\u5c3c\u7f85\u71b1\u7b49\u3002\nB. \u9ec3\u71b1\u75c5\u5df2\u6709\u6709\u6548\u7684\u6e1b\u6bd2\u6d3b\u6027\u75ab\u82d7\u53ef\u4ee5\u4f7f\u7528\uff0c\u76ee\u524d\u7684\u7814\u7a76\u8a8d\u70ba\u5176\u6297\u9ad4\u4fdd\u8b77\u529b\u53ef\u7dad\u6301\u5341\u5e74\u4ee5\u4e0a\u6216\u7d42\u8eab\u3002\nC. \u9ec3\u71b1\u75c5\u3001\u767b\u9769\u71b1\u3001\u53ca\u65e5\u672c\u8166\u708e\u4e3b\u8981\u7d93\u7531\u57c3\u53ca\u6591\u868a\u53ca\u767d\u7dda\u6591\u868a\u50b3\u64ad\u3002\nD. \u767b\u9769\u71b1\u4f9d\u8840\u6e05\u578b\u5206\u70ba\u2160\u3001\u2161\u3001\u2162\u3001\u2163\u56db\u7a2e\u578b\u5225\uff0c\u5373\u4fbf\u611f\u67d3\u904e\u5176\u4e2d\u67d0\u7a2e\u8840\u6e05\u578b\uff0c\u4e5f\u7121\u6cd5\u5c0d\u5176\u4ed6\u578b\u5225\u7522\u751f\u4ea4\u53c9\u7684\u4fdd\u8b77\u529b\u800c\u7d42\u8eab\u514d\u75ab\u3002\nE. \u767b\u9769\u71b1\u76ee\u524d\u5c1a\u672a\u6709\u75ab\u82d7\u6216\u9810\u9632\u6027\u85e5\u7269\u4f7f\u7528\uff0c\u56e0\u6b64\u5047\u5982\u6c11\u773e\u524d\u5f80\u6771\u5357\u4e9e\u570b\u5bb6\uff0c\u5982\u6cf0\u570b\u3001\u65b0\u52a0\u5761\u7b49\uff0c\u4ecd\u61c9\u8a72\u885b\u6559\u6c11\u773e\u5982\u4f55\u9032\u884c\u9632\u868a\u63aa\u65bd,\u4f8b\u5982: \u4f7f\u7528\u542b\u6709DEET\u6210\u5206\u7684\u9632\u868a\u7522\u54c1\u3002\n": "(C)", "102-15.\n\u6709\u95dcH7N9\u6d41\u611f\u611f\u63a7\u63aa\u65bd\uff0c\u4f55\u8005\u932f\u8aa4?\nA. \u4ee5\u7a7a\u6c23\u9632\u8b77\u53ca\u63a5\u89f8\u50b3\u64ad\u9632\u8b77\u63aa\u65bd\u70ba\u539f\u5247\u3002\nB. \u57f7\u884c\u53ef\u80fd\u5f15\u767c\u98db\u6cab\u5fae\u7c92 (aerosol)\u7522\u751f\u7684\u6aa2\u9ad4\u63a1\u96c6\u6216\u6cbb\u7642\u63aa\u65bd\u6642\uff0c\u61c9\u914d\u6234N95\u7b49\u7d1a(\u542b)\u4ee5\u4e0a\u53e3\u7f69\u3002\nC. H7N9\u6d41\u611f\u75c5\u60a3\u6536\u6cbb\u4f4f\u9662\u6642\uff0c\u61c9\u512a\u5148\u7f6e\u65bc\u8ca0\u58d3\u75c5\u623f\u6216\u55ae\u4eba\u75c5\u5ba4\u4e26\u7dad\u6301\u623f\u9580\u95dc\u9589\u3002\nD. H7N9\u6d41\u611f\u75c5\u60a3\u9000\u71d2\u5f8c3\u5929\uff0c\u4e14\u9023\u7e8c2\u6b21\u547c\u5438\u9053\u6aa2\u9ad4PCR\u9670\u6027(\u9700\u9593\u969424\u5c0f\u6642)\uff0c\u59cb\u53ef\u89e3\u9664\u9694\u96e2\u3002\nE. \u901a\u5831\u7591\u4f3cH7N9\u6d41\u611f\u75c5\u60a3\u5373\u4f7f\u7576\u5929\u6aa2\u9a57\u7d50\u679c\u9670\u6027\uff0c\u91ab\u5e2b\u4ecd\u53ef\u8996\u75c5\u60c5\u8b8a\u5316\u518d\u5ea6\u63a1\u6aa2\u9001\u6aa2\uff0c\u4e26\u76e1\u91cf\u63a1\u96c6\u75f0\u6db2\u6216\u4e0b\u547c\u5438\u9053\u62bd\u53d6\u6db2\u3002\n": "(A)", "102-16.\n\u6709\u95dc\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba? (1)\t\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u9700\u5118\u91cf\u5728\u52d5\u7269\u6293\u54ac\u50b77\u65e5\u5167\u4f7f\u7528 (2)\t\u4e0d\u53ef\u4ee5\u548c\u75ab\u82d7\u540c\u4e00\u5929\u65bd\u6253\uff0c\u4ee5\u907f\u514d\u5f71\u97ff\u75ab\u82d7\u7684\u6548\u679c (3)\u4f7f\u7528\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u6642\uff0c\u9808\u6ce8\u610f\u53ef\u80fd\u5f15\u8d77\u4e4b\u7acb\u5373\u904e\u654f\u53cd\u61c9 (4)\u4f7f\u7528\u6642\u4ee5\u808c\u8089\u6ce8\u5c04\u70ba\u4e3b\uff0c\u5982\u679c\u6709\u5269\u9918\u7684\u514d\u75ab\u7403\u86cb\u767d\uff0c\u518d\u6ce8\u5c04\u65bc\u50b7\u53e3\u5468\u570d (5)\u82e5\u54ac\u50b7\u4eba\u7684\u52d5\u7269\u7d93\u6aa2\u9a57\u70ba\u72c2\u72ac\u75c5\u967d\u6027\uff0c\u7121\u8ad6\u4ee5\u524d\u6709\u7121\u63a5\u7a2e\u904e\u72c2\u72ac\u75c5\u75ab\u82d7\uff0c\u7686\u9700\u7d66\u4e88\u514d\u75ab\u7403\u86cb\u767d  (\u61c9\u5beb\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\nA. (1)+(4)+(5)\nB. (1)+(3)+(5)\nC. (1)+(3)\nD. (3)+(5)\nE. (1)+(2)+(3)+(5)\n": "(C)", "102-17.\n\u4eba\u985e\u514d\u75ab\u4e0d\u5168\u75c5\u6bd2(Human immunodeficiency virus, HIV)\u611f\u67d3\u7684\u6709\u6548\u9810\u9632\u63aa\u65bd\uff0c\u9664\u4e86?\nA. \u53ef\u7528\u7522\u524d\u7be9\u6aa2\u3001\u5206\u5a29\u524d\u6301\u7e8c\u670d\u85e5\u3001\u9078\u64c7\u5256\u8179\u7522\u3001\u65b0\u751f\u5152\u51fa\u751f\u5f8c\u6295\u85e5\u3001\u63d0\u4f9b\u6bcd\u4e73\u66ff\u4ee3\u54c1\u7b49\u65b9\u5f0f\u9810\u9632\u6bcd\u5b50\u5782\u76f4\u611f\u67d3HIV\u3002\nB. \u53ef\u7528\u53e3\u670d\u66ff\u4ee3\u85e5\u7269(\u5982\u7f8e\u6c99\u51ac)\u3001\u63d0\u4f9b\u6e05\u6f54\u91dd\u5177\u7b49\u65b9\u5f0f\u9810\u9632\u975c\u8108\u6ce8\u5c04\u85e5\u766e\u8005\u611f\u67d3HIV\u3002\nC. \u82e5HIV\u611f\u67d3\u8005\u4f7f\u7528\u96de\u5c3e\u9152\u7642\u6cd5\u59a5\u5584\u63a7\u5236\u75c5\u6bd2\u91cf\uff0c\u53ef\u5927\u5e45\u964d\u4f4e\u6027\u4f34\u4fb6\u611f\u67d3HIV\u6a5f\u7387\u3002\nD. \u7537\u6027HIV\u611f\u67d3\u8005\u5272\u5305\u76ae\uff0c\u53ef\u964d\u4f4e\u5176\u7570\u6027\u6027\u4f34\u4fb6\u6216\u540c\u6027\u6027\u4f34\u4fb6\u611f\u67d3HIV\u6a5f\u7387\u3002\nE. \u56e0\u91ab\u7642\u884c\u70ba\u906dHIV\u6c61\u67d3\u91dd\u5668\u91dd\u624e\u5f8c\u8fc5\u901f\u7d66\u4e88\u66b4\u9732\u5f8c\u9810\u9632\u6027\u6295\u85e5\uff0c\u53ef\u5927\u5e45\u964d\u4f4e\u611f\u67d3HIV\u6a5f\u7387\u3002\n": "(D)", "102-18.\n\u95dc\u65bc\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u75c5\u75f0\u6aa2\u9ad4\u5206\u5b50\u5feb\u901f\u8a3a\u65b7\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4?\nA. \u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u75c5\u7684\u5b9a\u7fa9\u70baisoniazid\u3001rifampin \u548cpyrazinamide\u540c\u6642\u6297\u85e5\u3002\nB. \u82e5\u8a3a\u6cbb\u7684\u7d50\u6838\u75c5\u4eba\uff0c\u75c5\u4eba\u5206\u985e\u70ba\u5fa9\u767c, \u5931\u6557\u6216\u8005\u5931\u843d\u7b49\u518d\u6cbb\u75c5\u4eba\u6642\uff0c\u70ba\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u75c5\u4e4b\u9ad8\u98a8\u96aa\u65cf\u7fa4\uff0c\u61c9\u9001\u9a57 \u3002\nC. \u76ee\u524d\u53f0\u7063\u7684\u7d50\u6838\u75c5\u63a5\u89f8\u8005\uff0c\u5df2\u9010\u6b65\u5efa\u7f6e\u540d\u55ae\u65bc\u75be\u7ba1\u7f72\u7cfb\u7d71\u4e2d\uff0c\u82e5\u5df2\u77e5\u75c5\u4eba\u70ba\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u75c5\u63a5\u89f8\u8005\u767c\u75c5\uff0c\u61c9\u76e1\u901f\u9032\u884c\u6297\u85e5\u6027\u5feb\u901f\u7be9\u6aa2\u3002\nD. \u82e5\u75c5\u4eba\u5c45\u4f4f\u5728\u82b1\u84ee\u7e23\u5353\u6eaa\u3001\u842c\u69ae\u3001\u79c0\u6797\u9109\u6216\u75c5\u4eba\u4e00\u5e74\u5167\u66fe\u505c\u7559\u65bc\u5f9e\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u75c5\u9ad8\u8ca0\u64d4\u570b\u5bb6\u8d85\u904e\u4e00\u500b\u6708\u4ee5\u4e0a\uff0c\u61c9\u76e1\u901f\u9032\u884c\u6297\u85e5\u6027\u5feb\u901f\u7be9\u6aa2\u3002\nE. \u5c0d\u65bc\u591a\u91cd\u6297\u85e5\u6027\u7d50\u6838\u75c5\u7684\u6cbb\u7642\uff0c\u61c9\u6cbb\u7642\u81f3\u75f0\u9670\u8f49\u5f8c\u6eff18\u500b\u6708\u70ba\u6b62\u3002\n": "(A)", "102-19.\n\u4e16\u754c\u885b\u751f\u7d44\u7e54\u65bc2012\u5e749\u6708\u516c\u4f48\u4e2d\u6771\u547c\u5438\u75c7\u5019\u7fa4\uff08Middle East Respiratory Syndrome\uff09\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7\u6848\u4f8b\uff0c\u73fe\u5728\u5df2\u5728\u6c99\u70cf\u5730\u963f\u62c9\u4f2f\u3001\u7d04\u65e6\u3001\u5361\u9054\u3001\u82f1\u570b\u3001\u5fb7\u570b\u3001\u6cd5\u570b\u7b49\u570b\u5bb6\u9678\u7e8c\u767c\u73fe\u78ba\u8a3a\u75c5\u4f8b\uff0c\u4e0b\u4f8b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba? (1)\u53ef\u900f\u904e\u547c\u5438\u9053\u98db\u6cab\u9846\u7c92\uff0c\u76f4\u63a5\u6216\u9593\u63a5\u63a5\u89f8\u611f\u67d3\u8005\u5206\u6ccc\u7269\u50b3\u64ad\uff0c\u800c\u9020\u6210\u7fa4\u805a\u611f\u67d3\u4e8b\u4ef6 (2)\u81e8\u5e8a\u75c7\u72c0\u5305\u62ec\u767c\u71d2\u3001\u54b3\u55fd\u3001\u547c\u5438\u6025\u4fc3\u8207\u547c\u5438\u56f0\u96e3\u4e4b\u80ba\u708e\u8868\u73fe\uff0c\u90e8\u5206\u75c5\u4eba\u51fa\u73fe\u814e\u8870\u7aed\u3001\u5fc3\u5305\u819c\u708e\u3001\u7030\u6f2b\u6027\u8840\u7ba1\u5167\u51dd\u8840\uff0c\u6b7b\u4ea1\u7387\u7d0450\uff05 (3)\u6f5b\u4f0f\u671f\u4e00\u822c\u70ba9\u81f312\u5929 (4)\u91ab\u7642\u5de5\u4f5c\u4eba\u54e1\u662f\u53ef\u80fd\u53d7\u611f\u67d3\u4e4b\u9ad8\u5371\u96aa\u7fa4\r(5)\u6211\u570b\u5217\u70ba\u7b2c\u4e94\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u91ab\u8b77\u4eba\u54e1\u5982\u9047\u300c\u91ab\u8b77\u4eba\u54e1\u767c\u751f\u4e0d\u660e\u539f\u56e0\u80ba\u708e\u300d\u3001\u300c\u81e8\u5e8a\u51fa\u73fe\u80ba\u708e\u4e14\u767c\u75c5\u524d14\u65e5\u5167\u5177\u6709\u4e2d\u6771\u5730\u5340\u65c5\u904a\u53f2\u300d\u3001\u300c\u4e0d\u660e\u539f\u56e0\u80ba\u708e\u7fa4\u805a\u4e8b\u4ef6\u300d\uff0c\u61c9\u63a1\u9069\u7576\u611f\u67d3\u7ba1\u5236\u63aa\u65bd\uff0c\u63a1\u96c6\u547c\u5438\u9053\u53ca\u8840\u6db2\u6aa2\u9ad4\u9001\u75be\u75c5\u7ba1\u5236\u7f72\uff0c\u4e26\u901a\u5831\u6cd5\u50b3(\u5fc5\u9808\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\nA. (1)+(2)+(4)+(5)\nB. (2)+(3)+(4)+(5)\nC. (1)+(3)+(4)+(5)\nD. (1)+(2)+(3)+(4)\nE. (1)+(2)+(3)+(4)+(5)\n": "(E)", "103-1.\n\u6709\u4e00\u4f4d21\u6b72\u7537\u6027\u56e0\u5589\u75db\uff0c\u6bcf\u5929\u767c\u71d2\uff0c\u524d\u984d\u982d\u75db\uff0c\u5168\u8eab\u808c\u8089\u548c\u95dc\u7bc0\u75db6\u5929\u800c\u6c42\u8a3a\u3002\u4ed6\u65bc\u767c\u75c5\u524d\u4e00\u9031\u653e\u5b8c\u6691\u5047\u7531\u9ad8\u96c4\u56de\u5230\u53f0\u5317\u3002\u8eab\u9ad4\u8a3a\u5bdf\u9ad4\u6eab38.7\u00b0C\uff0c\u8840\u58d3 102/70 mmHg\uff0c\u8108\u640f 100/min\uff0c\u547c\u5438 16/min\uff0c\u5f8c\u54bd\u6709\u5145\u8840\u73fe\u8c61\uff0c\u4f46\u7121\u5206\u6ccc\u7269\uff0c\u80f8\u90e8\u3001\u624b\u81c2\u548c\u4e0b\u80a2\u6709 maculopapular rash\uff0c\u800c\u624b\u638c\u548c\u8173\u638c\u5247\u7121\u76ae\u75b9\uff0c\u4e0b\u80cc\u6709\u9178\u75db\uff0c\u5176\u4ed6\u5fc3\u80ba\u548c\u8179\u90e8\u6aa2\u67e5\u5247\u7121\u7570\u5e38\u3002\u5be6\u9a57\u8840\u6db2\u6aa2\u67e5\u767c\u73fe\u767d\u8840\u74033000/uL (3.0x10 9/L)\uff0c\u8840\u5c0f\u677f86000/uL (86.0x10 9/L)\uff0c\u8840\u7d05\u7d2013.8 g/dL\uff0cALT 116 units/L\uff0ctotal billirubin 1.2 mg/dL\u3002 \u8acb\u554f\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u70ba\u4f55?\nA. Leptospirosis\nB. Syphilis\nC. Dengue fever\nD. \u6c34\u75d8\nE. Melioidosis\n": "(C)", "103-2.\n\u6709\u4e00\u4f4d81\u6b72\u5973\u6027\u56e0\u767c\u71d2\u3001\u754f\u5bd2\u53ca\u5614\u5410\u4e00\u5929\u800c\u88ab\u9001\u5230\u6025\u8a3a\u5ba4\u3002\u8eab\u9ad4\u8a3a\u5bdf\u9ad4\u6eab39\u2103\uff0c\u8840\u58d3120/72mmHg\uff0c\u8108\u640f110/min\uff0c\u547c\u543816/min\uff0c\u5fc3\u80ba\u53ca\u8179\u90e8\u6aa2\u67e5\u5448\u73fe\u4e0b\u8179\u90e8\u8f15\u5fae\u58d3\u75db\u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5\u8840\u6db2\u767d\u8840\u740318000/uL(18.0x10 9/L)\uff0cneutrophil 88%\uff1b\u5c3f\u6db2\u6aa2\u67e5\uff1aWBC 100/HPF \u4e14leukocyte esterase (+)\uff0c\u9769\u862d\u6c0f\u9670\u6027\u687f\u83cc\uff1b\u80f8\u90e8X\u5149\u6b63\u5e38\u3002\u75c5\u4eba\u4f4f\u9662\u63a5\u53d7\u7a4d\u6975\u8f38\u6db2\u53ca\u7d93\u9a57\u6027piperacillin-tazobactam\u975c\u8108\u6ce8\u5c04\u6cbb\u7642\u3002\u5165\u9662\u5f8c\u4e09\u5929\uff0c\u8840\u6db2\u53ca\u5c3f\u6db2\u57f9\u990a\u51faKlebsiella pneumoniae\uff0c\u5176\u6297\u751f\u7d20\u611f\u53d7\u6027\u8a66\u9a57\u5448\u73fe\u5c0dpiperacillin-tazobactam, imipenem, ciprofloxacin,\rcefazolin\u548ctrimethoprim/sulfamethoxazole\u654f\u611f\u3002 \u6b64\u6642\u6297\u751f\u7d20\u6cbb\u7642\u6700\u6070\u7576\u7684\u9078\u64c7\u662f\u4ec0\u9ebc\uff1f\nA. \u6301\u7e8c\u7d66\u4e88piperacillin-tazobactam\nB. \u505c\u7528piperacillin-tazobactam\u800c\u6539\u7528cefazolin\nC. \u505c\u7528piperacillin-tazobactam\u800c\u6539\u7528ciprofloxacin\nD. \u505c\u7528piperacillin-tazobactam\u800c\u6539\u7528imipenem\nE. \u505c\u7528piperacillin-tazobactam\u800c\u6539\u7528trimethoprim/sulfamethoxazole\n": "(B)", "103-3.\n\u4e00\u4f4d22\u6b72\u7537\u6027\uff0c\u65bc4\u5929\u524d\u958b\u59cb\u89e3\u5c3f\u6709\u707c\u71b1\u611f\uff0c\u5c31\u8a3a\u524d\u5169\u5929\u5de6\u773c\u6709\u9ec3\u8272\u6db2\u9ad4\u6d41\u51fa\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u9664\u767c\u73fe\u5de6\u773c\u773c\u76ae\u6709\u7d05\u816b\u3001\u5de6\u773c\u6709\u9ec3\u8272\u5206\u6ccc\u7269\u6d41\u51fa\u5916\uff0c\u751f\u6b96\u5668\u4ea6\u53ef\u898b\u9ec3\u8272\u6db2\u9ad4 (\u5982\u5716)\uff0c\u8acb\u554f\u81f4\u75c5\u539f\u6700\u53ef\u80fd\u662f\u4ec0\u9ebc?\nA. \u80ba\u708e\u514b\u96f7\u767d\u6c0f\u687f\u83cc (Klebsiella pneumoniae)\nB. \u5927\u8178\u687f\u83cc (Escherichia coli)\nC. A\u65cf\u93c8\u7403\u83cc (group A streptococcus )\nD. \u6dcb\u75c5\u96d9\u7403\u83cc (Neisseria gonorrhoeae)\nE. \u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc (Staphylococcus aureus)\n": "(D)", "103-4.\n\u4e00\u540d45\u6b72\u7684\u7537\u6027\uff0c\u81f3\u6025\u8a3a\u5ba4\u5c31\u91ab\uff0c\u6709\u4f4e\u5ea6\u767c\u71d2\uff0c\u5168\u8eab\u5026\u6020\u548c\u95dc\u7bc0\u75db\u3002\u5c31\u8a3a6\u9031\u4e4b\u524d\u66fe\u8207\u7537\u6027\u6027\u5de5\u4f5c\u8005\u767c\u751f\u4e0d\u5b89\u5168\u7684\u6027\u884c\u70ba\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\u6709\u591a\u767c\u6027\u4e18\u75b9 (maculopapular rash)\uff0c\u6db5\u84cb\u4ed6\u7684\u6574\u500b\u8eab\u9ad4\uff0c\u5305\u62ec\u624b\u638c (\u5982\u5716)\u548c\u8173\u638c\u3002\u8acb\u554f\u75c5\u60a3\u7684\u8a3a\u65b7\u6700\u53ef\u80fd\u7531\u4e0b\u5217\u7684\u4f55\u7a2e\u6e2c\u8a66\u5f97\u5230\uff1a\nA. HIV Western blot antibody test\nB. Tzanck smear\nC. Gram stain\nD. Fluorescent treponemal antibody absorption test\nE. India ink stain\n": "(D)", "103-5.\n\u4e00\u4f4d65\u6b72\u7537\u6027\u6709\u7cd6\u5c3f\u75c5\u75c5\u53f2\uff0c\u56e0\u70ba\u9ad8\u71d2\u548c\u5bd2\u986b\u88ab\u9001\u81f3\u6025\u8a3a\u5ba4\uff0c\u53f3\u5074\u9f20\u8e4a\u90e8\u4f4d\u51fa\u73fe\u7d05\u816b\u7d04\u56db\u5929\u3002\u8eab\u9ad4\u6aa2\u67e5\u767c\u73fe\uff1a\u9ad4\u6eab39.4\u2103\uff0c\u8840\u58d3100/60mmHg\uff0c\u8108\u640f108/min\u3002\u65bc\u53f3\u5074\u9f20\u8e4a\u90e8\u4f4d\u5ef6\u4f38\u81f3\u53f3\u5074\u5927\u817f\u670912x9 \u516c\u5206\u7684\u767c\u7d05\uff0c\u8b8a\u786c\uff0c\u816b\u8139\u75bc\u75db\u7684\u75c5\u7076\u3002\u5728\u8a72\u75c5\u7076\u4e0a\u7de3\u9084\u6709\u5169\u500b\u51fa\u8840\u6027\u7684\u6c34\u6ce1(\u5982\u5716)\u3002\u9aa8\u76c6\u8154\u7684\u96fb\u8166\u65b7\u5c64\u986f\u793a\uff1a\u5927\u817f\u8655\u8edf\u7d44\u7e54\u7684\u58de\u6b7b\u53ca\u5c11\u91cf\u6c23\u9ad4\u7522\u751f\u3002\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u662f\u6b64\u75c5\u60a3\u6700\u6025\u8feb\u7684\u6cbb\u7642?\nA. Surgical exploration and debridement\nB. Anti-staphylococcal antibiotics\nC. Anti-pseudomonal antibiotics\nD. Hyperbaric oxygen therapy\nE. Blood transfusion\n": "(A)", "103-6.\n2014\u5e74\u897f\u975e\u4f0a\u6ce2\u62c9\u75c5\u6bd2\u611f\u67d3 (Ebola virus disease)\u901a\u5831\u8d85\u904e1700\u4f8b\uff0c\u6b7b\u4ea1\u903e900\u4f8b\uff0c\u903e50\u4f4d\u91ab\u7642\u4eba\u54e1\u611f\u67d3\uff0c\u4e0b\u5217\u76f8\u95dc\u6558\u8ff0\u4f55\u8005\u6b63\u78ba? (1) \u6b64\u75be\u75c5\u5728\u6211\u570b\u5217\u70ba\u7b2c\u4e94\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u901a\u5831\u6642\u6548\u70ba24\u5c0f\u6642\u5167\u5b8c\u6210 (2) \u81f4\u75c5\u75c5\u6bd2\u4e4b\u5929\u7136\u5bbf\u4e3b\u4e3b\u8981\u662f\u99f1\u99dd\u548c\u9f20\u985e (3) \u6b64\u75c5\u6bd2\u53ef\u7d93\u7531\u53d7\u611f\u67d3\u52d5\u7269\u76f4\u63a5\u50b3\u7d66\u4eba\uff0c\u800c\u4eba\u50b3\u4eba\u4e3b\u56e0\u662f\u76f4\u63a5\u63a5\u89f8\u5230\u88ab\u611f\u67d3\u8005\u6216\u5176\u5c4d\u9ad4\u4e4b\u8840\u6db2\u3001\u5206\u6ccc\u7269\u3001\u5668\u5b98\uff0c\u6216\u9593\u63a5\u63a5\u89f8\u88ab\u6c59\u67d3\u4e4b\u74b0\u5883\u800c\u611f\u67d3 (4) \u75be\u75c5\u6f5b\u4f0f\u671f2\u81f321\u5929\uff0c\u7576\u75c5\u4eba\u4e09\u9031\u5167\u6709\u76f8\u95dc\u65c5\u904a\u6216\u63a5\u89f8\u53f2\uff0c\u4e00\u65e6\u6709\u767c\u71d2\u3001\u982d\u75db\u3001\u808c\u8089\u75db\u3001\u5641\u5fc3\u3001\u5614\u5410\u3001\u8179\u7009\u3001\u8179\u75db\uff0c\u6216\u4e0d\u660e\u539f\u56e0\u51fa\u8840\u3001\u6b7b\u4ea1\u7b49\u4efb\u4e00\u9805\u6642\uff0c\u5373\u61c9\u901a\u5831\u4e14\u63a1\u6aa2\u9001\u9a57  (5)\r\u6536\u6cbb\u75c5\u4eba\u65bc\u8ca0\u58d3\u9694\u96e2\u75c5\u623f\uff0c\u91ab\u8b77\u4eba\u54e1\u6234N95\u53e3\u7f69\u6700\u70ba\u91cd\u8981  (\u61c9\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\nA. (1)+(2)+(3)\nB. (2)+(3)+(4)\nC. (1)+(3)+(4)\nD. (1)+(4)+(5)\nE. (1)+(5)\n": "(C)", "103-7.\n\u4e0b\u5217\u6709\u95dc\u75c5\u4eba\u8179\u7009\u5371\u96aa\u56e0\u7d20/\u75c7\u72c0\u53ca\u75c5\u56e0\u4e4b\u7d44\u5408\uff0c\u6b63\u78ba\u70ba\u4f55\u8005? (1) \u8840\u4fbf--- Shigella, Salmonella, E. coli O157 (2) \u5c0f\u5b69\u990a\u70cf\u9f9c\u3001\u8725\u8734--- Salmonella (3) \u5403\u751f\u86cb--- Salmonella (4) \u642d\u90f5\u8f2a\u65c5\u904a--- Norovirus (5) \u5bb6\u4e2d\u5c0f\u8c93\u5c0f\u72d7\u8179\u7009--- Campylobacter (\u61c9\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\nA. (1)+(2)+(3)\nB. (2)+(3)+(4)\nC. (3)+(4)+(5)\nD. (1)+(2)+(3)+(4)\nE. ()1+(2)+(3)+(4)+(5)\n": "(E)", "103-8.\n\u70ba\u964d\u4f4e\u91ab\u7642\u6a5f\u69cb\u5167\u591a\u91cd\u6297\u85e5\u6027\u75c5\u539f\u4e4b\u4ea4\u53c9\u611f\u67d3\uff0c\u75be\u75c5\u7ba1\u5236\u7f72\u97ff\u61c9\u4e16\u754c\u885b\u751f\u7d44\u7e54 (WHO)\u4e4b\u5021\u5c0e\u91ab\u8b77\u4eba\u54e1\u624b\u90e8\u885b\u751f\u904b\u52d5\u3002\u6709\u95dc\u624b\u90e8\u885b\u751f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?\r(1) \u4f9d\u6587\u737b\u53ca\u5be6\u9a57\u986f\u793a\uff0c\u4f7f\u7528\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u9032\u884c\u624b\u90e8\u885b\u751f\uff0c\u5728\u6e05\u6f54\u6548\u679c\u3001\u4f7f\u7528\u6642\u6a5f\u3001\u82b1\u8cbb\u6642\u9593\u3001\u5c0d\u76ae\u819a\u7684\u5f71\u97ff\u3001\u5b89\u5168\u6027\u8003\u91cf\u53ca\u6d17\u624b\u9075\u5f9e\u6027\u7b49\u65b9\u9762\uff0c\u5747\u6bd4\u4f7f\u7528\u80a5\u7682\u6216\u6db2\u614b\u7682\u9032\u884c\u6fd5\u6d17\u624b\u7684\u6548\u679c\u70ba\u4f73\u3002\r(2) WHO\u63a8\u52d5\u7684\u91ab\u8b77\u4eba\u54e1\u624b\u90e8\u885b\u751f\u904b\u52d5\uff0c\u5f37\u8abf\u91ab\u8b77\u4eba\u54e1\u5728\u624b\u90e8\u7121\u660e\u986f\u9ad2\u6c59\u6642\uff0c\u512a\u5148\u4f7f\u7528\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u6e05\u6f54\u624b\u90e8\uff0c\u4e7e\u6d17\u624b\u4e4b\u6d17\u624b\u6280\u8853\u5168\u7a0b\u970040-60\u79d2\u3002\r(3) \u624b\u90e8\u6709\u660e\u986f\u9ad2\u6c61\u6216\u6cbe\u6709\u8840\u6db2/\u9ad4\u6db2\u6642\uff0c\u5efa\u8b70\u4f7f\u7528\u80a5\u7682\u548c\u6e05\u6c34\u4e4b\u6fd5\u6d17\u624b\u6280\u8853\u6d17\u624b\u3002\r(4) \u70ba\u63d0\u9ad8\u624b\u90e8\u885b\u751f\u8a2d\u5099\u7684\u53ef\u8fd1\u6027\uff0c WHO\u5ba3\u5c0e\u5728\u7167\u8b77\u9ede\u666e\u904d\u8a2d\u7f6e\u6216\u96a8\u8eab\u651c\u5e36\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u65b9\u5f0f\uff0c\u53ef\u9054\u5230\u7b26\u5408\u5728\u7167\u8b77\u9ede\u4f38\u624b\u53ef\u53ca\u61c9\u6709\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u7684\u76ee\u6a19\u3002\r(5) \u70ba\u907f\u514d\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u4e4b\u7522\u54c1\u9152\u7cbe\u6fc3\u5ea6\u4e0d\u8db3\uff0c\u5f71\u97ff\u91ab\u8b77\u4eba\u54e1\u57f7\u884c\u624b\u90e8\u885b\u751f\u4e4b\u6210\u6548\uff0c\u91ab\u7642\u6a5f\u69cb\u65bc\u8cfc\u8cb7\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\uff0c\u61c9\u9078\u64c7\u9152\u7cbe\u6210\u5206\u8d8a\u9ad8\u7684\u8d8a\u597d\u3002\r (\u61c9\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\nA. (1)+(2)+(3)+(4)+(5)\nB. (1)+(2)+(3)\nC. (2)+(4)+(5)\nD. (2)+(3)+(4)\nE. (1)+(3)+(4)\n": "(E)", "103-9.\n\u767c\u71d2\u4f75\u8840\u5c0f\u677f\u6e1b\u5c11\u75c7\u5019\u7fa4 (severe fever with thrombocytopenia syndrome)\u5728\u4e2d\u570b\u5927\u9678\u53ca\u65e5\u672c\u5df2\u6709\u5831\u544a\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u6b63\u78ba?  (\u61c9\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\r(1) \u81f4\u75c5\u539f\u662f\u65b0\u5e03\u5c3c\u4e9e\u75c5\u6bd2 (novel bunyavirus)\r(2) \u7531\u9577\u89d2\u8840\u8731 (Haemaphysalis longicornis)\u53ee\u54ac\u800c\u50b3\u64ad\r(3) \u6025\u6027\u671f\u75c5\u4eba\u53ca\u5c4d\u9ad4\u8840\u6db2\u3001\u8840\u6027\u5206\u6ccc\u7269\u5177\u50b3\u67d3\u6027\uff0c\u76f4\u63a5\u63a5\u89f8\u75c5\u4eba\u8840\u6db2\u6216\u8840\u6027\u5206\u6ccc\u7269\u53ef\u5c0e\u81f4\u611f\u67d3\uff0c\u56e0\u6b64\u53ef\u4ee5\u4eba\u50b3\u4eba\u3002\r(4) \u81e8\u5e8a\u8868\u73fe\u5305\u62ec\u767c\u71d2\u3001\u8840\u5c0f\u677f\u6e1b\u5c11\u3001\u8178\u80c3\u9053\u75c7\u72c0\u3001\u591a\u91cd\u5668\u5b98\u529f\u80fd\u5931\u8abf\uff0c\u521d\u671f\u6b7b\u4ea1\u7387\u53ef\u905410-30%\u3002\r(5) \u8a72\u75c5\u6b63\u78ba\u540d\u7a31\u70ba Granulocytic anaplasmosis\u3002\nA. (1)+(4)\nB. (1)+(3)+(4)\nC. (2)+(3)+(4)+(5)\nD. (1)+(2)+(3)+(4)\nE. (1)+(2)+(3)+(4)+(5)\n": "(D)", "103-10.\n\u4e16\u754c\u885b\u751f\u7d44\u7e54\u65bc2012\u5e749\u6708\u9996\u5ea6\u516c\u5e03\u4e2d\u6771\u547c\u5438\u75c7\u5019\u7fa4 (Middle East Respiratory Syndrome)\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7\u6848\u4f8b\u5f8c\uff0c\u73fe\u5728\u5df2\u5728\u6c99\u70cf\u5730\u963f\u62c9\u4f2f\u3001\u7d04\u65e6\u3001\u5361\u9054\u3001\u82f1\u570b\u3001\u5fb7\u570b\u3001\u6cd5\u570b\u7b49\u570b\u5bb6\u9678\u7e8c\u767c\u73fe\u78ba\u8a3a\u75c5\u4f8b\u6578\u767e\u4f8b\uff0c\u5176\u4e2d80%\u4ee5\u4e0a\u96c6\u4e2d\u5728\u6c99\u70cf\u5730\u963f\u62c9\u4f2f\u3002\u4ee5\u4e0b\u4f55\u8005\u6b63\u78ba? (\u61c9\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\r(1)\u53ef\u900f\u904e\u547c\u5438\u9053\u98db\u6cab\u9846\u7c92\uff0c\u76f4\u63a5\u6216\u9593\u63a5\u63a5\u89f8\u611f\u67d3\u8005\u5206\u6ccc\u7269\u50b3\u64ad\uff0c\u800c\u9020\u6210\u7fa4\u805a\u611f\u67d3\u4e8b\u4ef6\uff0c\u91ab\u7642\u5de5\u4f5c\u8005\u5177\u6f5b\u5728\u906d\u53d7\u611f\u67d3\u98a8\u96aa\u3002\r(2) \u81e8\u5e8a\u75c7\u72c0\u5305\u62ec\u767c\u71d2\u3001\u54b3\u55fd\u3001\u547c\u5438\u6025\u4fc3\u8207\u547c\u5438\u56f0\u96e3\u4e4b\u80ba\u708e\u8868\u73fe\uff0c\u90e8\u5206\u75c5\u4eba\u51fa\u73fe\u814e\u8870\u7aed\u3001\u5fc3\u5305\u819c\u708e\u3001\u7030\u6f2b\u6027\u8840\u7ba1\u5167\u51dd\u8840\u3001\u6b7b\u4ea1\u7387\u7d0450%\u3002\r(3) \u6f5b\u4f0f\u671f\u4e00\u822c\u70ba9-12\u5929\u3002\r(4) \u8d74\u4e2d\u6771\u671d\u89c0\u4fe1\u5f92\u53ca\u65c5\u5ba2\u61c9\u7279\u5225\u6ce8\u610f\u624b\u90e8\u885b\u751f\u53ca\u547c\u5438\u9053\u9632\u8b77\u63aa\u65bd\u3002\r(5) \u6211\u570b\u5217\u70ba\u7b2c\u4e94\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u91ab\u8b77\u4eba\u54e1\u5982\u9047\u300c\u91ab\u8b77\u4eba\u54e1\u767c\u751f\u4e0d\u660e\u539f\u56e0\u80ba\u708e\u300d\u3001\u300c\u81e8\u5e8a\u51fa\u73fe\u80ba\u708e\u4e14\u767c\u75c5\u524d14\u65e5\u5167\u5177\u6709\u4e2d\u6771\u65c5\u904a\u53f2\u300d\u3001\u300c\u4e0d\u660e\u539f\u56e0\u80ba\u708e\u7fa4\u805a\u4e8b\u4ef6\u300d\uff0c\u61c9\u63a1\u53d6\u9069\u7576\u611f\u67d3\u8005\u7ba1\u5236\u63aa\u65bd\uff0c\u63a1\u96c6\u547c\u5438\u9053\u53ca\u8840\u6db2\u6aa2\u9ad4\u9001\u75be\u75c5\u7ba1\u5236\u7f72\u4e26\u901a\u5831\u6cd5\u50b3\u3002\nA. (1)+(2)+(4)+(5)\nB. (2)+(3)+(4)+(5)\nC. (1)+(3)+(4)+(5)\nD. (1)+(2)+(3)+(4)\nE. (1)+(2)+(3)+(4)+(5)\n": "(E)", "103-11.\n\u4e00\u4f4d36\u6b72\u7537\u6027\uff0c\u5e73\u65e5\u6709\u5ad6\u5993\u7684\u7fd2\u6163\uff0c\u6b64\u6b21\u56e0\u5168\u8eab\u5026\u6020\uff0c\u8ec0\u5e79\u53ca\u56db\u80a2\u51fa\u73fe\u7d05\u75b9\u800c\u5c31\u91ab\uff0c\u62bd\u8840\u6aa2\u9a57\u7d50\u679c\u8840\u6e05TPHA\uff08Treponema hemagglutination\uff09assay\u70ba1\uff1a5120\uff0cRPR\uff08rapid plasma reagin\uff09assay titer\u70ba128\uff0b\uff0c\u8acb\u554f\u6b64\u6642\u6700\u9069\u7576\u7684\u9996\u9078\u91ab\u7642\u8655\u7f6e\u70ba\u4f55\uff1f\nA. aqueous crystalline penicillin-G\uff0818-24MU/day\uff09\u975c\u8108\u6ce8\u5c0410\u81f314\u5929\u3002\nB. \u808c\u8089\u6ce8\u5c04\u4e00\u5291penicillin-G benzathine 2.4MU\u3002\nC. \u53e3\u670ddoxycycline 100mg bid\u6cbb\u7642\u5169\u9031\u3002\nD. \u6bcf\u9031\u808c\u8089\u6ce8\u5c04\u4e00\u5291penicillin-G benzathine 2.4MU\u9023\u7e8c\u4e09\u9031\u3002\nE. \u808c\u8089\u6ce8\u5c04\u4e00\u5291ceftriaxone 500mg\u3002\n": "(B)", "103-12.\n\u4e00\u4f4d19\u6b72\u7537\u6027\uff0c\u81ea\u8a34\u70ba\u7537\u540c\u6027\u6200\uff0c\u6709\u591a\u6b21\u672a\u4fdd\u8b77\u4e4b\u5371\u96aa\u6027\u884c\u70ba\uff0c\u6700\u8fd110\u5929\u982d\u75db\u3001\u767c\u71d2\u3001\u9838\u90e8\u6dcb\u5df4\u7d50\u816b\u5927\u3001\u56db\u80a2\u95dc\u7bc0\u9178\u75db\u800c\u5c31\u91ab\uff0c\u7406\u5b78\u6aa2\u67e5\u9ad4\u6eab\u70ba39.1\u2103\uff0c\u9838\u90e8\u50f5\u786c\u89f8\u8a3a\u9838\u90e8\u6dcb\u5df4\u7d50\u58d3\u75db\uff0c\u591a\u8655\u8ec0\u5e79\u76ae\u75b9\u53ca\u809d\u813e\u816b\u5927\uff0c\u5be6\u9a57\u5ba4\u6aa2\u67e5\u8840\u6e05\u5b78EBV\u3001Anti-HIV\u3001Mycoplasma IgM\u3001Anti-CMV IgM\u5747\u70ba\u9670\u6027\u53cd\u61c9\u3002\u91ab\u5e2b\u61f7\u7591\u75c5\u60a3\u6709\u521d\u671fHIV\u611f\u67d3\uff0c\u8acb\u554f\u4e0b\u5217\u90a3\u4e00\u9805\u8a66\u9a57\u6700\u80fd\u65e9\u671f\u5075\u6e2c\u662f\u5426\u6709HIV\u611f\u67d3\uff1f\nA. \u8840\u6db2\u9031\u908a\u55ae\u6838\u7403\uff08PBMC\uff09HIV\u57f9\u990a\u3002\nB. \u8840\u6f3f\u75c5\u6bd2\u91cfHIV RNA\uff08RT-PCR\uff09\u3002\nC. \u518d\u505a\u4e00\u6b21\u8840\u6db2Anti-HIV\u6297\u9ad4\u3002\nD. \u8840\u6db2HIV Western-Blot\uff08\u897f\u65b9\u58a8\u9ede\u6e2c\u8a66\uff09\u3002\nE. \u8840\u6db2CD4\u6dcb\u5df4\u7403\u6578\u3002\n": "(B)", "103-13.\n\u4e0b\u5217\u6709\u95dc\u9264\u7aef\u87ba\u65cb\u9ad4\u611f\u67d3\uff08Leptospirosis\uff09\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba\uff1f (\u61c9\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\r(1) Leptospirosis\u5c6c\u65bc\u4eba\u755c\u5171\u901a\u50b3\u67d3\u75c5\uff08zoonosis\uff09\uff0c\u5176\u81f4\u75c5\u539f\u6700\u91cd\u8981\u7684\u8caf\u5b58\u7aa9\uff08reservoir\uff09\u662f\u9f20\u985e\u3002\r(2) Leptospira\u611f\u67d3\u4eba\u9ad4\u53ef\u7d93\u7531\u6709\u50b7\u53e3\u7684\u76ae\u819a\u6216\u5b8c\u6574\u7684\u9ecf\u819c\u9032\u5165\uff0c\u4e26\u4e14\u53ef\u4eba\u50b3\u4eba\uff08human-to-human transmission\uff09\u3002\r(3) Leptospirosis\u611f\u67d3\u8005\u53ef\u4ee5\u50cf\u662f\u6d41\u884c\u6027\u611f\u5192\u7684\u81e8\u5e8a\u8868\u73fe\uff0c\u51fa\u73fe\u767c\u71d2\u3001\u754f\u5bd2\u3001\u982d\u75db\u3001\u808c\u8089\u9178\u75db\u7b49\uff0c\u767c\u71d2\u53ef\u6301\u7e8c3-10\u5929\u3002\r(4) Weil's syndrome\u75c5\u4eba\u6703\u6709\u9ec3\u75b8\u3001\u6025\u6027\u814e\u529f\u80fd\u640d\u50b7\u969c\u7919\u3001\u80ba\u90e8\u51fa\u8840\u53ca\u9ad8\u6b7b\u4ea1\u7387\u3002\r(5) \u9996\u9078\u85e5\u7269\u6cbb\u7642\u70baazithromycin\u3002\nA. (1)+(2)+(4)\nB. (2)+(3)+(4)\nC. (3)+(4)+(5)\nD. (1)+(3)+(5)\nE. (1)+(3)+(4)\n": "(E)", "103-14.\n\u4e00\u4f4d46\u6b72\u5973\u6027\u75c5\u4eba\uff0c\u56e0\u767c\u71d2\u53ca\u754f\u5bd2\u4e00\u9031\u81f3\u672c\u9662\u6025\u8a3a\uff0c\u7406\u5b78\u6aa2\u67e5\u767c\u73fe\u6709\u4e8c\u5c16\u74e3\u6536\u7e2e\u671f\u5fc3\u96dc\u97f3\uff0c\u5169\u5957\u8840\u6db2\u57f9\u990a\u5747\u9577\u51faEnterococcus faecalis\uff0c\u5c0d\u6240\u6e2c\u8a66\u4e4b\u6297\u751f\u7d20\u5747\u5177\u654f\u611f\u6027\uff08susceptible\uff09\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u7a2e\u85e5\u7269\u6cbb\u7642\u65b9\u5f0f\u662f\u6700\u5408\u9069\u4e4b\u9078\u64c7\uff1f\nA. Cefazolin + gentamicin\u3002\nB. Ampicillin + gentamicin\u3002\nC. high dose Penicillin alone\u3002\nD. high dose Ceftriaxone alone\u3002\nE. Vancomycin alone\u3002\n": "(B)", "103-15.\n\u6709\u95dc\u65b0\u578b\u6d41\u611fH5N1\u53caH10N8\u6d41\u611f\u75c5\u6bd2\u611f\u67d3\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u975e\uff1f (\u61c9\u9078\u51fa\u6240\u6709\u6b63\u78ba\u7b54\u6848)\r(1) H5N1\u8207H10N8\u7686\u5177\u6709\u5c0d\u4eba\u985e\u4e0b\u547c\u5438\u9053\u03b12,3-linked sialic acid\u63a5\u53d7\u5668\u7d50\u5408\u4e4b\u80fd\u529b\uff0c\u6613\u9020\u6210\u6025\u6027\u80ba\u640d\u50b7\u3002\r(2) H10N8\u75c5\u6bd2\u516d\u6bb5\u5167\u90e8\u57fa\u56e0\u4f86\u81ea\u65bcH9N2\u79bd\u6d41\u611f\u75c5\u6bd2\u3002\r(3) H5N1\u8207H10N8\u6d41\u611f\u75c5\u6bd2\u66fe\u5728\u4e2d\u570b\u5927\u9678\u767c\u751f\u4eba\u50b3\u4eba\u7fa4\u7a81\u767c\u6d41\u884c\u3002\r(4) H5N1\u8207H10N8\u6d41\u611f\u75c5\u6bd2\u7686\u5c0d\u65bc\u9ce5\u79bd\u985e\u70ba\u9ad8\u81f4\u75c5\u6027\u53ca\u9ad8\u81f4\u6b7b\u7387\u611f\u67d3\u3002\r(5) H10N8\u8207H5N1\u5927\u90e8\u4efd\u75c5\u6bd2\u682a\u5c0d\u73fe\u884c\u85e5\u7269neuraminidase inhibitor\uff08\u5982oseltamivir\uff09\u5747\u5177\u6709\u6297\u85e5\u6027\u3002\nA. (2)+(4)+(5)\nB. (3)+(4)+(5)\nC. (1)+(2)+(3)\nD. (1)+(3)+(5)\nE. (2)+(3)+(4)\n": "(B)", "103-16.\n\u6709\u95dc\u65b0\u578b\u6d41\u611fH7N9\u611f\u67d3\u4e4b\u6d41\u884c\u75c5\u5b78\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u6839\u64da\u4e2d\u570b\u5927\u9678\u516c\u4f48\u4e4bH7N9\u75c5\u4f8b\uff0c\u611f\u67d3\u5f8c\u9020\u6210\u80ba\u708e\u4e4b\u6b7b\u4ea1\u7387\u7d04\u70ba30-40\uff05\u3002\nB. \u53f0\u7063\u5df2\u6709\u5883\u5916\u79fb\u5165\u4e4bH7N9\u611f\u67d3\u500b\u6848\u3002\nC. H7N9\u611f\u67d3\u500b\u6848\u670990\uff05\u500b\u6848\u81e8\u5e8a\u8868\u73fe\u70ba\u80ba\u708e\uff0c\u6709\u63a5\u8fd160\uff05\u70baARDS\u547c\u5438\u8870\u7aed\u3002\nD. H7N9\u611f\u67d3\u500b\u6848\u6709\u8d85\u904e80\uff05\u66fe\u6709\u63a5\u89f8\u6d3b\u79bd\u53f2\u3002\nE. \u7d55\u5927\u90e8\u5206H7N9\u6d41\u611f\u85c9\u7531\u8840\u6e05\u5b78\uff08serology\uff09\u6aa2\u5b9a\u3002\n": "(E)", "103-17.\nAIDS\u75c5\u60a3\u70baT\u6dcb\u5df4\u7d30\u80de\u529f\u80fd\u7f3a\u640d\u4e4b\u6613\u611f\u53d7\u4e3b\uff0c\u4e0b\u5217\u4f55\u7a2e\u75c5\u539f\u4e26\u975e\u70ba\u6b64\u985e\u75c5\u60a3\u5e38\u898b\u4e4b\u611f\u67d3\u75c7\u81f4\u75c5\u539f\uff1f\nA. Pneumocystis jirovecii\u3002\nB. Cytomegalovirus\u3002\nC. Herpes simplex virus\u3002\nD. Candida albicans\u3002\nE. Shigella flexneri\u3002\n": "(E)", "103-18.\n\u4e00\u4f4d40\u6b72\u8840\u6db2\u75be\u75c5\u60a3\u8005\uff0c\u63a5\u53d7\u5168\u813e\u81df\u5207\u9664\u8853\uff08splenectomy\uff09\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u975e\uff1f\nA. \u5927\u90e8\u4efd\u611f\u67d3\u767c\u751f\u65bc\u813e\u81df\u5207\u9664\u5f8c\u7684\u524d2\u5e74\u5167\u3002\nB. \u91cd\u75c7\u611f\u67d3\u4e4b\u6b7b\u4ea1\u7387\u53ef\u9ad850\uff05\u3002\nC. \u4e3b\u8981\u611f\u67d3\u7684\u81f4\u75c5\u83cc\u70ba\u6709\u83a2\u819c\u6027\u7d30\u83cc\uff0c\u4f8b\u5982\uff1aNeisseria meningitidis\u3002\nD. Salmonella\u70ba\u6700\u5e38\u898b\u4e4b\u81f4\u75c5\u539f\uff0c\u7d04\u536050-70\uff05\u3002\nE. \u5152\u7ae5\u63a5\u53d7\u813e\u81df\u5207\u9664\u5f8c\u767c\u751f\u611f\u67d3\u7684\u98a8\u96aa\u9ad8\u65bc\u6210\u4eba\u63a5\u53d7\u813e\u81df\u5207\u9664\u8005\u4e4b\u611f\u67d3\u98a8\u96aa\u3002\n": "(D)", "103-19.\n\u6709\u95dc\u793e\u5340\u7d30\u83cc\u6027\u8166\u819c\u708e\u611f\u67d3\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u70ba\u975e\uff1f\nA. \u6210\u4eba\u6700\u5e38\u898b\u7684\u81f4\u75c5\u83cc\u70baStreptococcus pneumoniae\u3002\nB. 60\u6b72\u4ee5\u4e0a\u60a3\u8005\u6216\u514d\u75ab\u7f3a\u9677\u60a3\u8005\uff0c\u9700\u8003\u616eListeria monocytogenes\u3002\nC. Streptococcus pneumoniae\u8166\u819c\u708e\u5373\u4f7f\u7d66\u4e88\u9069\u7576\u7684\u6297\u751f\u7d20\u6cbb\u7642\uff0c\u6b7b\u4ea1\u7387\u4ecd\u7d04\u70ba20\uff05\u3002\nD. \u7814\u7a76\u986f\u793adexamethasone 10mg q6h \u7d66\u4e884\u5929\u53ef\u6539\u5584\u6210\u4ebaStreptococcus pneumoniae\u8166\u819c\u708e\u9810\u5f8c\u3002\nE. \u56db\u50f9Neisseria meningitidis\u75ab\u82d7\u6ce8\u5c04\u53ef\u9810\u9632serogroup B\u5948\u745f\u6c0f\u8166\u819c\u708e\u96d9\u7403\u83cc\u8166\u819c\u708e\u3002\n": "(E)", "104-1.\n\u53f0\u7063\u5730\u5340\u590f\u5929\u767b\u9769\u71b1\u75ab\u60c5\u589e\u6eab\uff0c\u75c5\u4f8b\u6578\u5feb\u901f\u4e0a\u6607\uff0c\u4e0b\u5217\u95dc\u65bc\u767b\u9769\u71b1\u7684\u63cf\u8ff0\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576?\nA. \u767b\u9769\u75c5\u6bd2\u70ba\u9ec3\u75c5\u6bd2\u79d1(Flaviviridae)\uff0c\u70baRNA\u75c5\u6bd2\uff0c\u76db\u884c\u65bc\u9130\u8fd1\u8d64\u9053\u5340\u57df\uff0c\u5305\u62ec\u4e2d\u5357\u7f8e\u6d32\u3001\u6771\u5357\u4e9e\u53ca\u975e\u6d32\nB. \u5728\u53f0\u7063\uff0c\u767b\u9769\u71b1\u4e3b\u8981\u7684\u50b3\u67d3\u75c5\u5a92\u70ba\u767d\u7dda\u6591\u868a\u53ca\u57c3\u53ca\u6591\u868a\u3002\u57c3\u53ca\u6591\u868a\u591a\u5206\u4f48\u5728\u5357\u90e8\uff0c\u559c\u6b61\u68f2\u606f\u5728\u5ba4\u5167\uff1b\u767d\u7dda\u6591\u868a\u5168\u5cf6\u5206\u4f48\uff0c\u559c\u6b61\u68f2\u606f\u5728\u5ba4\u5916\u3002\nC. \u767b\u9769\u4f11\u514b\u75c7\u5019\u7fa4\u539f\u56e0\u70ba\u75c5\u4eba\u51fa\u73fe\u8840\u6f3f\u6ef2\u6f0f\u5c0e\u81f4\u8840\u58d3\u4e0b\u964d\uff0c\u5373\u4f7f\u65e9\u671f\u7d66\u4e88\u75c5\u60a3\u9069\u7576\u7684\u975c\u8108\u8f38\u6db2\u53ca\u652f\u6301\u6027\u6cbb\u7642\uff0c\u767b\u9769\u4f11\u514b\u75c7\u5019\u7fa4\u4e4b\u6b7b\u4ea1\u7387\u4ecd\u670940%~50%\u3002\nD. \u6aa2\u9a57\u767b\u9769\u71b1\u53ef\u6e2c\u75c5\u4eba\u8840\u6e05\u767b\u9769\u75c5\u6bd2\u7279\u7570\u6027IgM\u967d\u6027\u6216IgG\u6297\u9ad4\u967d\u8f49\u6216\u67094\u500d\u4e0a\u5347\u78ba\u8a3a\u3002\nE. \u767b\u9769\u71b1\u75c5\u6bd2\u5206\u70ba4\u7a2e\u8840\u6e05\u578b\uff0c\u611f\u67d3\u8840\u6e05\u578b\u7b2c\u4e00\u578b\u5f8c\u518d\u611f\u67d3\u7b2c\u4e8c\u578b\u75c5\u75c7\u6700\u70ba\u56b4\u91cd\u3002\n": "(C)", "104-2.\n\u6885\u6bd2\u70ba\u7531\u6885\u6bd2\u87ba\u65cb\u9ad4\u6240\u5f15\u81f4\u4e4b\u4e00\u7a2e\u6027\u50b3\u67d3\u75c5\uff0c\u4ee5\u4e0b\u6558\u8ff0\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576?\nA. \u6cbb\u7642\u9996\u9078\u70baPenicillin\uff0c\u82e5\u75c5\u60a3\u70baPenicillin\u904e\u654f\u6642\uff0c\u53ef\u6539\u7528Doxycycline\u6cbb\u7642\nB. \u80ce\u5152\u5148\u5929\u6027\u6885\u6bd2\u5927\u591a\u6e90\u81ea\u6885\u6bd2\u87ba\u65cb\u9ad4\u5728\u80ce\u5152\u51fa\u751f\u901a\u904e\u7522\u9053\u6642\u50b3\u67d3\nC. \u8461\u8404\u819c\u708e(Uveitis)\u70ba\u6885\u6bd2\u5728\u773c\u775b\u611f\u67d3\u53ef\u898b\u7684\u8868\u73fe\nD. \u96b1\u6027(latent)\u6885\u6bd2\u662f\u6307\u6885\u6bd2\u9032\u5165\u5b8c\u5168\u7121\u81e8\u5e8a\u75c7\u72c0\u7684\u6642\u671f\u3002\u65e9\u671f\u96b1\u6027\u6885\u6bd2\u70ba\u611f\u67d3\u5f8c\u672a\u8d85\u904e1\u5e74\u4e4b\u7121\u75c7\u72c0\u671f\uff0c\u75c5\u60a3\u4ecd\u5177\u8f03\u9ad8\u50b3\u67d3\u6027\uff1b\u665a\u671f\u96b1\u6027\u6885\u6bd2\u5247\u6307\u611f\u67d3\u8d85\u904e1\u5e74\u4e4b\u7121\u75c7\u72c0\u671f\uff0c\u50b3\u67d3\u529b\u8f03\u5f31\nE. \u65e9\u671f\u5148\u5929\u6027\u6885\u6bd2\u81e8\u5e8a\u75c7\u72c0\u4f3c\u5f8c\u5929\u6027\u4e8c\u671f\u6885\u6bd2\uff0c\u800c\u665a\u671f\u5148\u5929\u6027\u6885\u6bd2\u5178\u578b\u75c7\u72c0\u70ba\u6885\u6bd2\u816b\u3001\u9593\u8cea\u6027\u89d2\u819c\u708e\u3001\u8033\u807e\u3001Hutchinson\u6c0f\u9f52\u7b49\n": "(B)", "104-3.\n\u4e00\u4f4d32\u6b72\u7537\u6027\u65bc10\u5929\u524d\u81f3\u967d\u660e\u5c71\u904a\u73a9\uff0c2\u5929\u524d\u958b\u59cb\u51fa\u73fe\u767c\u71d2\u3001\u982d\u75db\u3001\u9f20\u8e4a\u90e8\u6dcb\u5df4\u817a\u816b\uff0c\u76ae\u819a\u51fa\u75b9\uff0c\u4e26\u65bc\u8179\u80a1\u6e9d\u4e0b\u7de3\u767c\u73fe\u6709\u4e00\u7126\u75c2\u75c5\u7076(\u5982\u5716)\uff0c\u6b64\u6642\u4e0b\u5217\u4f55\u7a2e\u8a3a\u65b7\u53ca\u6cbb\u7642\u662f\u6700\u932f\u8aa4\u7684\uff1f\nA. \u6b64\u70baScrub typhus\uff0c\u75c5\u539f\u9ad4\u70baOrientia tsutsugamushi\u3002\nB. \u6b64\u75c5\u539f\u662f\u7531\u6059\u87f2(chigger)\u53ee\u54ac\u6240\u5f15\u8d77\uff1b\u79cb\u5929\u6700\u5e38\u898b\uff0c\u8a3a\u65b7\u53ef\u5229\u7528\u8840\u6e05\u514d\u75ab\u53cd\u61c9(IFA)\u6216PCR\u8a3a\u65b7\u3002\nC. \u6f5b\u4f0f\u671f\u70ba6\u81f321 \u5929\uff0c\u8d85\u904e90%\u60a3\u8005\u81e8\u5e8a\u75c7\u72c0\u6703\u51fa\u73fe\u6b64\u7126\u75c2\u75c5\u7076\u53ca\u76ae\u75b9\u3002\nD. \u6cbb\u7642\u53ef\u7528doxycycline 100mg Bid\u6cbb\u76427-15\u5929\u3002\nE. \u82e5\u75c5\u60a3\u5c0ddoxycycline\u904e\u654f\uff0c\u53ef\u4ee5\u4f7f\u7528azithromycin 500mg QD\u4e09\u5929\u6cbb\u7642\u3002\n": "(C)", "104-4.\n\u4e0b\u5217\u4f55\u8005\u6297\u83cc\u85e5\u7269\u5c6c\u65bc\u61f7\u5b55\u5206\u985eCategory B\u53ef\u4ee5\u9069\u5408\u5b55\u5a66\u4f7f\u7528\uff1f\nA. Aminoglycoside\nB. Fluoroquinolone\nC. Clarithromycin\nD. Erythromycin estolate\nE. Sulfonamide\n": "(D)", "104-5.\n\u4e0b\u5217\u6297\u83cc\u85e5\u7269\u4e4b\u526f\u4f5c\u7528\u914d\u5c0d\uff0c\u4f55\u8005\u70ba\u975e\uff1f\nA. Aminoglycosides - 8th Cranial nerve toxicity\nB. Clindamycin - Clostridium difficile colitis\nC. Levofloxacin - \u5fc3\u96fb\u5716 QTc prolongation\nD. Metronidazole - \u8207Alcohol\u4f75\u7528\u5f15\u8d77Disulfiram reaction\nE. Macrolides - Renal toxicity\n": "(E)", "104-6.\n\u4e0b\u5217\u6709\u95dcListeria monocytogenes\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u517c\u6027\u53ad\u6c27\uff0c\u7fd2\u6163\u65bc\u8f03\u51b7\u74b0\u5883\u5b58\u6d3b\u7684\u683c\u862d\u6c0f\u967d\u6027\u687f\u83cc\u3002\nB. \u61f7\u5b55\u5a66\u5973\u3001\u5668\u5b98\u79fb\u690d\u75c5\u60a3\u548c\u4eba\u985e\u514d\u75ab\u4e0d\u5168\u75c5\u6bd2\u611f\u67d3\u60a3\u8005\u662f\u611f\u67d3\u9ad8\u5371\u96aa\u7fa4\u3002\nC. \u63a5\u89f8\u53ca\u98df\u7528\u6c59\u67d3\u7684\u98df\u7269\u662f\u4e3b\u8981\u611f\u67d3\u9014\u5f91\u3002\nD. \u9996\u9078\u6cbb\u7642\u85e5\u7269\u662fampicillin\uff0c\u5c0d\u65bcampicillin\u904e\u654f\u8005\u53ef\u512a\u5148\u9078\u64c7trimethoprim-sulfomethoxazole(TMP-SMX)\u6cbb\u7642\u3002\nE. \u82e5\u70ba\u8166\u819c\u708e\u500b\u6848\u53ef\u4f7f\u7528IV Ceftriaxone 2g Q12H\u6cbb\u7642\u3002\n": "(E)", "104-7.\n\u4e0b\u5217\u6297\u83cc\u85e5\u7269\u4f55\u8005\u975e\u4e3b\u8981\u7d93\u7531\u814e\u81df\u4ee3\u8b1d\uff0c\u6545\u4e0d\u9700\u4f9d\u814e\u529f\u80fd\u8abf\u6574\u5291\u91cf\uff1f\nA. Cefazolin\nB. Levofloxacin\nC. Penicillin\nD. Metronidazole\nE. Vancomycin\n": "(D)", "104-8.\n\u6709\u95dc\u80ba\u7d50\u6838(Tuberculosis)\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u6b63\u78ba\uff1f\r(1). \u521d\u611f\u67d3\u4e4b\u5f8c\uff0c\u4e00\u822c\u4eba\u7d42\u5176\u4e00\u751f\u9ad4\u5167\u7d50\u6838\u83cc\u518d\u5ea6\u6d3b\u5316\u800c\u767c\u75c5\u7684\u6a5f\u7387\u7d04\u70ba5~10%\uff0c\u5176\u4e2d\u7d04\u6709\u4e00\u534a\u662f\u5728\u611f\u67d3\u5f8c\u7684\u524d\u4e94\u5e74\u767c\u75c5\uff0c\u800c\u4ee5\u7b2c\u4e00\u5e74\u7684\u5371\u96aa\u6027\u6700\u5927\u3002\r(2). \u7d93\u7531\u9a57\u75f0\u767c\u73fe\u7d50\u6838\u83cc\uff0c\u662f\u80ba\u7d50\u6838\u6700\u70ba\u91cd\u8981\u7684\u8a3a\u65b7\u4f9d\u64da\u3002\r(3). \u518d\u6d3b\u5316\u80ba\u90e8\u611f\u67d3\u75be\u75c5(reactivation)\u597d\u767c\u65bc\u80ba\u5c16(apical)\u53ca\u80ba\u4e0a\u8449(upper lobes)  \u4e4b\u524d\u7bc0(anterior segments)\u3002\r(4). \u7576\u75f0\u6db2\u4e2d\u627e\u4e0d\u5230\u7d50\u6838\u83cc\u6642\uff0c\u4ea6\u53ef\u7531\u80f8\u90e8X\u5149\u6aa2\u67e5\u7d50\u679c\u52a0\u4e0a\u75c5\u4eba\u7684\u81e8\u5e8a\u75c7\u72c0\uff0c\u505a\u70ba\u80ba\u7d50\u6838\u7684\u81e8\u5e8a\u8a3a\u65b7\u4f9d\u64da\u3002\r(5). \u767c\u71d2\u3001\u591c\u9593\u76dc\u6c57\u53ca\u9ad4\u91cd\u6e1b\u8f15\u662f\u80ba\u7d50\u6838\u5e38\u898b\u7684\u75c7\u72c0\uff0c\u7d04\u670950%~60%\u7684\u80ba\u7d50\u6838\u500b\u6848\u6703\u51fa\u73fe\u54b3\u8840\u3002\nA. (2)+(3)+(4)\u3002\nB. (1)+(3)+(5)\u3002\nC. (3)+(4)+(5)\u3002\nD. (1)+(2)+(4)\u3002\nE. (1)+(2)+(3)+(4)+(5)\u3002\n": "(D)", "104-9.\n\u4e00\u4f4d40\u6b72\u5973\u6027\uff0c\u98b1\u98a8\u904e\u5f8c\u65bc\u5bb6\u4e2d\u6e05\u7406\u6de4\u6c34\uff0c\u4e00\u9031\u5f8c\u51fa\u73fe\u767c\u71d2\uff0c\u982d\u75db\uff0c\u5168\u8eab\u75e0\u75db\uff0c\u98df\u617e\u4e0d\u632f\uff0c\u9001\u91ab\u9662\u5f8c\uff0c\u767c\u73fe\u773c\u7d50\u819c\u5145\u8840\uff0c\u4e14\u6709\u9ec3\u75b8\u548c\u6025\u6027\u814e\u8870\u7aed\uff0c\u4e0b\u5217\u8a3a\u65b7\u53ca\u8655\u7f6e\uff0c\u4f55\u8005\u6b63\u78ba\uff1f\r(1) \u512a\u5148\u8003\u616e\u9264\u7aef\u87ba\u65cb\u9ad4\u75c5(Leptospirosis)\u3002\r(2) \u8a3a\u65b7\u4e3b\u8981\u4f9d\u64da\u7d30\u83cc\u57f9\u990a\u53caPCR\u3002\r(3) \u9996\u9078\u6cbb\u7642\u85e5\u7269\u53ef\u4f7f\u7528Penicillin\u3002\r(4) \u91cd\u75c7\u8005\u53ef\u4f7f\u7528Ceftriaxone\u6cbb\u7642\u3002\nA. (2)+(3)+(4)\u3002\nB. (1)+(2)+(4)\u3002\nC. (1)+(2)+(3)\u3002\nD. (1)+(3)+(4)\u3002\nE. (1)+(2)+(3)+(4)\u3002\n": "(D)", "104-10.\n\u4ee5\u4e0b\u95dc\u65bc\u72c2\u72ac\u75c5\u7684\u76f8\u95dc\u63cf\u8ff0\u4f55\u8005\u70ba\u6b63\u78ba\uff1a\r(1) \u81f4\u75c5\u539fRabies virus\u662f\u4e00\u7a2eRNA \u75c5\u6bd2\uff0c\u70ba Lyssavirus \u5c6c\u3002\r(2) \u72c2\u72ac\u75c5\u70ba\u7b2c\u4e00\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u61c9\u65bc24\u5c0f\u6642\u5167\u901a\u5831\u3002\r(3) \u4eba\u985e\u611f\u67d3\u4e4b\u6f5b\u4f0f\u671f\u7d04\u70ba 3\u9031\u81f33\u500b\u6708\uff0c\u767c\u75c5\u6642\u6703\u6709\u7126\u616e\u3001\u982d\u75db\u3001\u767c\u71d2\u3001\u54ac\u50b7\u90e8 \u4f4d\u7570\u6a23\u611f\u3001\u6050\u6c34\u3001\u808c\u8089\u9ebb\u75fa\u3001\u62bd\u6410\u7b49\u8166\u708e\u75c7\u72c0,\u6700\u5f8c\u56e0\u5fc3\u80ba\u6216\u591a\u91cd\u5668\u5b98\u8870\u7aed\u800c\u5c0e\u81f4\u6b7b\u4ea1\u3002\r(4) \u7576\u75be\u75c5\u7684\u75c7\u72c0\u4e00\u65e6\u767c\u5c55\u51fa\u4f86\u6642\uff0c\u75ab\u82d7\u548c\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u53ef\u5c07\u81f4\u6b7b\u7387\u964d\u81f360%\u3002\r(5) \u65c5\u904a\u5230\u83f2\u5f8b\u8cd3\u3001\u8d8a\u5357\u3001\u5370\u5ea6\u3001\u6cf0\u570b\u7b49\u570b\u5bb6\uff0c\u5efa\u8b70\u63a5\u53d7\u66b4\u9732\u524d\u9810\u9632\u4e09\u5291\u72c2\u72ac\u75c5\u75ab\u82d7\u3002\nA. (1)+(2)+(4)\nB. (1)+(2)+(3)+(5)\nC. (2)+(3)+(4)\nD. (3)+(4)+(5)\nE. (1)+(2)+(4)+(5)\n": "(B)", "104-11.\n\u5728\u4e0b\u5217\u95dc\u65bc\u8089\u6bd2\u687f\u83cc\u7684\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u9769\u862d\u6c0f\u967d\u6027\uff0c\u6975\u53ad\u6c27\u4e4b\u7522\u5b62\u687f\u83cc\uff0c\u6bd2\u7d20\u662f\u5176\u81f4\u75c5\u56e0\u5b50\u3002\nB. \u4ee5\u98df\u56e0\u578b\u8089\u6bd2\u687f\u83cc\u4e2d\u6bd2\u6700\u70ba\u5e38\u898b\u3002\u901a\u5e38\u5728\u98df\u5165\u53d7\u6bd2\u7d20\u6c61\u67d3\u7684\u98df\u7269\u5f8c\uff0c\u7d0412 \u81f3 36\u5c0f\u6642\u5f8c\u767c\u75c5\u3002\nC. \u982d\u9838\u90e8\u7684\u795e\u7d93\u75c7\u5982\u8996\u529b\u6a21\u7cca\u6216\u8907\u8996\u3001\u773c\u77bc\u4e0b\u5782\u3001\u984f\u9762\u795e\u7d93\u9ebb\u75fa\u3001\u541e\u56a5\u56f0\u96e3\u53ca\u8b1b\u8a71\u56f0\u96e3\u7b49\u3002\nD. \u56b4\u91cd\u75c5\u4eba\u9001\u5230\u6025\u8a3a\u4e3b\u8981\u5448\u73fe\u4ee3\u8b1d\u6027\u9178\u8840\u75c7\uff0c\u6cbb\u7642\u4ee5intensive care\u548c\u6297\u6bd2\u7d20\u70ba\u4e3b\u8ef8\u3002\nE. \u7b2c\u56db\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u767c\u73fe\u500b\u6848\u65bc24\u5c0f\u6642\u5167\u901a\u5831\u75be\u7ba1\u7f72\u3002\n": "(D)", "104-12.\n\u6709\u4e00\u4f4d45\u6b72\u7537\u6027\u75c5\u4eba\uff0c\u56e0\u767c\u71d2\u53ca\u4e0b\u80a2\u8edf\u7d44\u7e54\u611f\u67d3\u800c\u81f3\u6025\u8a3a\u8655\u5c31\u8a3a\u63a5\u53d7\u50b7\u53e3\u6e05\u5275\uff0c\u611f\u67d3\u75c5\u7076\u4e4b\u81bf\u6db2\u57f9\u990a\u9577\u51fa\u793e\u5340\u578bmethicillin-resistant Staphylococcus aureus\uff08MRSA\uff09\uff0c\u4e0b\u5217\u4f55\u7a2e\u53e3\u670d\u85e5\u7269\u6700\u4e0d\u9069\u5408\u7528\u65bc\u6cbb\u7642\u6b64\u75c5\u4eba\uff1f\nA. Ciprofloxacin\nB. Fusidic acid\nC. Linezolid\nD. Sulfamethoxazole/ trimethoprim\nE. Doxycycline\n": "(A)", "104-13.\n\u6709\u95dc\u65b0\u578b\u6d41\u611fH5N1\u53caH7N9 \u6d41\u611f\u75c5\u6bd2\u611f\u67d3\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u975e\uff1f(1) H5N1\u5177\u6709\u5c0d\u4eba\u985e\u4e0b\u547c\u5438\u9053\u7d30\u80de\u03b12,3-linked sialic acid\u63a5\u53d7\u5668\u7d50\u5408\u4e4b\u80fd\u529b\uff0c\u6613\u9020\u6210\u6025\u6027\u80ba\u640d\u50b7 ;  (2) H7N9\u5177\u6709\u5c0d\u4eba\u985e\u547c\u5438\u9053\u4e0a\u76ae\u7d30\u80de\u03b12,6-linked sialic acid\u63a5\u53d7\u5668\u7d50\u5408\u4e4b\u80fd\u529b; (3) H5N1\u8207H7N9\u6d41\u611f\u75c5\u6bd2\u7686\u66fe\u5728\u4e2d\u570b\u5927\u9678\u767c\u751f\u4eba\u50b3\u4eba\u7fa4\u7a81\u767c\u6d41\u884c; (4) H5N1\u8207H7N9\u6d41\u611f\u75c5\u6bd2\u7686\u5c0d\u65bc\u9ce5\u79bd\u985e\u70ba\u9ad8\u81f4\u75c5\u6027\u53ca\u9ad8\u81f4\u6b7b\u7387\u611f\u67d3; (5) H7N9\u8207H5N1\u5927\u90e8\u4efd\u75c5\u6bd2\u682a\u5c0d\u73fe\u884c\u85e5\u7269neuraminidase inhibitor\uff08\u5982oseltamivir\uff09\u5177\u6709\u611f\u53d7\u6027\uff0c\u800c\u5c0damantadine\u5247\u5177\u6709\u6297\u85e5\u6027\u3002\nA. (2)+(4)+(5)\nB. (3)+(4)+(5)\nC. (1)+(2)+(3)\nD. (1)+(3)+(5)\nE. (2)+(3)+(4)\n": "(E)", "104-14.\n\u5728\u53f0\u7063\uff0c\u4e0b\u5217\u75be\u75c5\u8207\u6297\u751f\u7d20\u6cbb\u7642\u9078\u64c7\u4e4b\u7d44\u5408\u4e2d\uff0c\u4f55\u8005\u662f\u6070\u7576\u4e4b\u6cbb\u7642\u9078\u64c7\uff1f(1) Actinomycosis - Cephalexin ;  (2) Nocardiosis - Trimethoprim\uff0fsulfamethoxazole ; (3) Listeria monocytogenes infection - ceftriaxone ; (4) Cat-scratch disease - azithromycin ; (5) Legionellosis - Azithromycin\nA. (1)+(2)+(3)\nB. (1)+(3)+(4)\nC. (2)+(4)+(5)\nD. (3)+(4)+(5)\nE. (1)+(4)+(5)\n": "(C)", "104-15.\n\u4e0b\u5217\u6709\u95dcVaricella-zoster virus (VZV)\u75c5\u6bd2\u611f\u67d3\u6216\u9810\u9632\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u6b63\u78ba?  (1) \u6b64\u75c5\u6bd2\u70ba\u96d9\u80a1DNA\u75c5\u6bd2\uff0c\u521d\u6b21\u611f\u67d3\u9014\u5f91\u4e3b\u8981\u70ba\u547c\u5438\u9053\u50b3\u64ad; (2) \u521d\u6b21\u611f\u67d3\u5f8c\u6f5b\u4f0f\u5728\u810a\u9ad3\u80cc\u6839\u795e\u7d93(dorsal root ganglia)\uff0c\u6613\u5fa9\u767c\u65bc\u80f8\u690e\u81f3\u8170\u690e\u76ae\u7bc0; (3) \u5927\u65bc60\u6b72\u8005\uff0c\u82e5\u63a5\u53d7VZV\u75ab\u82d7\uff0c\u53ef\u6e1b\u5c11\u5e36\u72c0\u76b0\u75b9\u7684\u767c\u751f\u53ca\u6e1b\u8f15\u76b0\u75b9\u5f8c\u7684\u795e\u7d93\u75bc\u75db(post-herpetic neuralgia); (4) \u5c0d\u65bc\u56b4\u91cd\u514d\u75ab\u4e0d\u5168\u60a3\u8005\uff08\u5982\u5668\u5b98\u79fb\u690d\u60a3\u8005\uff09\uff0c\u767c\u751f\u6c34\u75d8\u6216\u5e36\u72c0\u76b0\u75b9\u7686\u61c9\u6cbb\u7642\uff0c\u975c\u6ce8Acyclovir\u53ef\u964d\u4f4e\u5167\u81df\u4fb5\u72af\u4e4b\u5408\u4f75\u75c7; (5) \u5e36\u72c0\u76b0\u75b9\u795e\u7d93\u75db\u5f88\u96e3\u6cbb\u7642\uff0c\u82e5\u8981\u4f7f\u7528\u985e\u56fa\u9187\uff0c\u5247\u61c9\u540c\u6642\u7528\u6297\u75c5\u6bd2\u85e5\u3002\nA. (1)+(2)+(3)\nB. (1)+(2)+(4)\nC. (1)+(2)+(5)\nD. (1)+(2)+(3)+(4)\nE. (1)+(2)+(3)+(4)+(5)\n": "(E)", "104-16.\n\u4e00\u4f4d38\u6b72\u53f0\u5546\u81ea\u5927\u9678\u8fd4\u53f0\u5f8c\uff0c\u767c\u73feHIV\u611f\u67d3\u53ca\u80ba\u90e8\u611f\u67d3M. tuberculosis\uff0c CD4\u6aa2\u67e5\u70ba100 cell/mm3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f(1) \u9664\u7acb\u5373\u6295\u8207\u6297\u7d50\u6838\u85e5\u7269\u5916\uff0c\u4ea6\u61c9\u540c\u6642\u958b\u59cbhighly active anti-retroviral therapy (HAART);  (2) \u60a3\u8005\u6b64\u6642\u5df2\u662fAIDS ; (3) \u7acb\u5373\u6295\u8207\u6297\u7d50\u6838\u85e5\u7269\uff0c\u4e26\u5c07\u60a3\u8005\u8f49\u81f3\u8ca0\u58d3\u9694\u96e2\u75c5\u623f; (4) \u60a3\u8005\u9700\u5118\u5feb\u63a5\u53d7\u6297\u75c5\u6bd2\u85e5\u7269\u6cbb\u7642\uff0c\u6539\u5584\u514d\u75ab\u7cfb\u7d71; (5) \u60a3\u8005\u5148\u63a5\u53d7\u81f3\u5c116\u500b\u6708\u6297\u7d50\u6838\u85e5\u7269\u6cbb\u7642\u5f8c\uff0c\u624d\u80fd\u958b\u59cb\u63a5\u53d7\u6297\u75c5\u6bd2\u85e5\u7269\u6cbb\u7642\u3002\nA. (1)+(2)+(3)+(4)\nB. (1)+(3)+(4)\nC. (2)+(3)+(4)\nD. (2)+(3)\nE. (2)+(3)+(5)\n": "(D)", "104-17.\n\u6709\u95dc\u4f0a\u6ce2\u62c9\u75c5\u6bd2\u611f\u67d3\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u521d\u671f\u75c7\u72c0\u70ba\u7a81\u7136\u51fa\u73fe\u9ad8\u71d2\u3001\u56b4\u91cd\u5026\u6020\u3001\u808c\u8089\u75db\u3001\u982d\u75db\u8207\u54bd\u5589\u75db\u7b49\uff0c\u63a5\u8457\u51fa\u73fe\u5614\u5410\u3001\u8179\u7009\u3001\u76ae\u819a\u6591\u9ede\u72c0\u4e18\u75b9\u8207\u51fa\u8840\u73fe\u8c61\u3002\u91cd\u75c7\u8005\u5e38\u4f34\u6709\u809d\u81df\u53d7\u640d\u3001\u814e\u8870\u7aed\u3001\u4e2d\u6a1e\u795e\u7d93\u640d\u50b7\u3001\u4f11\u514b\u4f75\u767c\u591a\u91cd\u5668\u5b98\u8870\u7aed\u3002\nB. \u50b3\u67d3\u6e90\u4e3b\u8981\u70ba\u679c\u8760\nC. \u4e3b\u8981\u900f\u904e\u63a5\u89f8\u50b3\u67d3\uff0c\u4eba\u8207\u4eba\u4e4b\u50b3\u67d3\u662f\u56e0\u76f4\u63a5\u63a5\u89f8\u5230\u88ab\u611f\u67d3\u8005\u6216\u5176\u5c4d\u9ad4\u4e4b\u8840\u6db2\u3001\u5206\u6ccc\u7269\u3001\u5668\u5b98\u3001\u7cbe\u6db2\uff1b\u6216\u662f\u9593\u63a5\u63a5\u89f8\u88ab\u611f\u67d3\u8005\u9ad4\u6db2\u6c61\u67d3\u7684\u74b0\u5883\u800c\u611f\u67d3\uff0c\u4e14\u5e38\u898b\u6709\u7a7a\u6c23\u5fae\u7c92(aerosols)\u50b3\u64ad\u6848\u4f8b\u3002\nD. \u91ab\u8b77\u4eba\u54e1\u88ab\u611f\u67d3\u4e4b\u60c5\u6cc1\u5728\u975e\u6d32\u9817\u70ba\u5e38\u898b\uff0c\u4e3b\u8981\u662f\u56e0\u70ba\u91ab\u8b77\u4eba\u54e1\u7167\u9867\u75c5\u60a3\u6642\u672a\u9075\u5b88\u9069\u7576\u7684\u9632\u8b77\u63aa\u65bd\uff08\u5982\u6d17\u624b\u3001\u914d\u6234\u6a19\u6e96\u9632\u8b77\u88dd\u5099\u7b49\uff09\u3002\nE. \u4f0a\u6ce2\u62c9\u75c5\u6bd2\u76ee\u524d (up to March 2015) \u5c1a\u7121\u78ba\u5b9a\u6709\u6548\u4eba\u7528\u75ab\u82d7\u53ef\u4f9b\u9810\u9632\u63a5\u7a2e\u3002\n": "(C)", "104-18.\n\u6709\u95dc\u6d41\u611f\u91cd\u75c7\u597d\u767c\u5c0d\u8c61\u548c\u793e\u5340\u611f\u67d3\u80ba\u708e\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba\uff1f(1) \u6d41\u611f\u91cd\u75c7\u597d\u767c\u65bc\u51fa\u751f\u52304\u6b72\u7684\u5152\u7ae5; (2) \u6d41\u611f\u91cd\u75c7\u597d\u767c\u65bc\u5b55\u5a66;  (3) \u6d41\u611f\u91cd\u75c7\u597d\u767c\u65bc65\u6b72\u4ee5\u4e0a\u6709\u6162\u6027\u5fc3\u80ba\u75be\u75c5\u8005; (4) \u793e\u5340\u611f\u67d3\u80ba\u708e\u7531\u80ba\u708e\u93c8\u7403\u83cc\u9020\u6210\u8005\u5e74\u9f61\u6108\u5927\u767c\u751f\u7387\u6108\u9ad8\uff0c\u800c\u975e\u5178\u578b\u80ba\u708e\uff08\u9ef4\u6f3f\u83cc\u3001\u62ab\u8863\u83cc\u548c\u9000\u4f0d\u8ecd\u4eba\u83cc\uff09\u5247\u597d\u767c\u65bc\u5c0f\u5b69; (5)\u9020\u6210\u56b4\u91cd\u793e\u5340\u611f\u67d3\u80ba\u708e\u4e3b\u8981\u81f4\u75c5\u539f\u662f\u80ba\u708e\u93c8\u7403\u83cc\u548c\u9000\u4f0d\u8ecd\u4eba\u83cc\u3002\nA. (1)+(3)+(4)+(5)\nB. (1)+(2)+(3)+(5)\nC. (1)+(2)+(3)+(4)\nD. (2)+(3)+(4)+(5)\nE. (1)+(2)+(3)+(4)+(5)\n": "(B)", "104-19.\n\u4ee5\u4e0b\u6709\u95dc\u6297\u5fae\u751f\u7269\u88fd\u5291\u4e4b\u526f\u4f5c\u7528\uff0c\u4f55\u8005\u932f\u8aa4\uff1f\nA. Vancomycin\u975c\u8108\u6ce8\u5c04\u82e5\u592a\u5feb\u53ef\u80fd\u5c0e\u81f4Red man syndrome\nB. Fluoroquinolones\u82e5\u7528\u65bc\u4f7f\u7528\u6297\u5fc3\u5f8b\u4e0d\u6574\u85e5\u7269\u7684\u60a3\u8005\u6216\u96fb\u89e3\u8cea\u4e0d\u5e73\u8861\u8005\uff0c\u61c9\u7559\u610fQTc\u5ef6\u9577\u4e4b\u4e0d\u826f\u53cd\u61c9\u3002\nC. \u964d\u4f4eaminoglycoside\u814e\u6bd2\u6027\u7684\u65b9\u5f0f\u662f\u63a1\u4e00\u65e5\u591a\u6b21\u5291\u91cf\u7d66\u4e88\u3002\nD. Amphotericin B\u6700\u4e3b\u8981\u7684\u526f\u4f5c\u7528\u662f\u814e\u6bd2\u6027\uff0c\u6bcf\u6b21\u8f38\u6ce8\u524d\u5404\u7d66\u4e88500ml\u751f\u7406\u98df\u9e7d\u6c34\u53ca\u6e1b\u7de9\u8f38\u6ce8\u901f\u5ea6\u53ef\u964d\u4f4e\u526f\u4f5c\u7528\u3002\nE. Terbinafine\u7528\u65bc\u6cbb\u7642\u7532\u766c\uff0c\u6709\u6642\u9020\u6210\u56b4\u91cd\u85e5\u7269\u6027\u809d\u708e\uff0c\u5c0d\u65bc\u809d\u814e\u75be\u75c5\u60a3\u8005\u61c9\u907f\u514d\u4f7f\u7528\u3002\n": "(C)", "105-1.\n\u4e00\u4f4d20\u6b72\u7537\u6027\u65bc\u4e8c\u9031\u524d\u81f3\u91d1\u9580\u65c5\u904a\uff0c4\u5929\u524d\u958b\u59cb\u51fa\u73fe\u767c\u71d2\u3001\u982d\u75db\u3001\u76ae\u819a\u75b9\uff0c\u4e26\u65bc\u8179\u90e8\u767c\u73fe\u6709\u4e00\u75c5\u7076(\u5982\u5716)\uff0c\u6b64\u6642\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u975e\uff1f\nA. \u6b64\u70baScrub typus\uff0c\u75c5\u539f\u9ad4\u70baOrientia tsutsugamushi\u3002\nB. Serology\u662f\u826f\u597d\u7684\u8a3a\u65b7\u5de5\u5177\uff1b\u4e5f\u53ef\u6aa2\u9a57\u4e0a\u8ff0\u75c5\u7076\u505a\u6838\u9178(PCR)\u5206\u6790\u8a3a\u65b7\u3002\nC. \u81e8\u5e8a\u75c7\u72c0\u767c\u751f\u5728\u88abChigger\u53ee\u54ac\u5f8c6\u81f321\u5929(\u6f5b\u4f0f\u671f)\u3002\nD. \u6b64\u75c5\u539f\u611f\u67d3\u7684\u6b7b\u4ea1\u7387\u7d04\u70ba25%\u81f330%\u3002\nE. \u75be\u75c5\u7684\u65e9\u671f\uff0c\u6703\u51fa\u73fe\u76f8\u5c0d\u6027\u7de9\u8108(relative bradycardia)\u3002\n": "(D)", "105-2.\n\u4e0b\u5217\u95dc\u65bcHIV\u611f\u67d3\u8207\u816b\u7624\u7684\u95dc\u4fc2\u4f55\u8005\u932f\u8aa4\uff1f\nA. Kaposi\u2019s sarcoma\u8207Human Herpes virus \u2013 8(HHV-8)\u7684\u611f\u67d3\u6709\u95dc\u3002\nB. Anogenital carcinoma\u8207Human papilloma virus(HPV)\u7684\u611f\u67d3\u6709\u95dc\u3002\nC. Primary CNS lymphoma(\u539f\u767c\u6027\u4e2d\u6a1e\u795e\u7d93\u6dcb\u5df4\u7624)\u8207Epstein-Barr virus ( EBV )\u7684\u611f\u67d3\u6709\u95dc\u3002\nD. Burkitt\u2019s lymphoma\u8207Cytomegalovirus ( CMV )\u7684\u611f\u67d3\u6709\u95dc\u4fc2\u3002\nE. HIV\u611f\u67d3\u76f8\u95dc\u4e4blymphoma\u4e3b\u8981\u662fB cell lymphoma\u3002\n": "(D)", "105-3.\n\u4e00\u4f4d50\u6b72\u7537\u6027\uff0c\u65bc9\u500b\u6708\u524d\u56e0sick sinus sysdrome\u63a5\u53d7\u5fc3\u5f8b\u8abf\u7bc0\u5668(CIED, Cardiovascular implantable electronic device )\u690d\u5165\uff0c\u60c5\u6cc1\u7a69\u5b9a\uff0c\u4f46\u6700\u8fd1\u56e0\u53cd\u8986\u767c\u71d2\u5df2\u56db\u9031\u800c\u4f4f\u9662\u3002\u4f4f\u9662\u8840\u6db2\u57f9\u990a\u5169\u5957\u7686\u6709\u7d30\u83cc\u9577\u51fa\uff0c\u5fc3\u81df\u8d85\u97f3\u6ce2\u767c\u73fe\u5fc3\u5f8b\u8abf\u7bc0\u5668wire\u7684\u524d\u7aef\u6709vegetation\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u8840\u6db2\u57f9\u990a\u83cc\u682a\u7a2e\u985e\uff1f\nA. Staphylococcus aureus\nB. Viridans streptococcus\nC. Staphylococcus epidermidis\nD. Enterococcus faecalis\nE. Escherichia coli\n": "(C)", "105-4.\n\u4e0b\u5217\u6297\u5fae\u751f\u7269\u88fd\u5291\u8207\u526f\u4f5c\u7528\u4e4b\u7d44\u5408\uff0c\u4f55\u8005\u932f\u8aa4\uff1f\nA. Daptomycin \u2013 Myopathy (\u808c\u8089\u75c5\u8b8a)\nB. Chloramphenicol \u2013 Aplastic anemia (\u518d\u751f\u4e0d\u80fd\u6027\u8ca7\u8840 )\nC. Amikacin - Hepatic failure (\u809d\u8870\u7aed)\nD. Tetracycline - Photosensitivity (\u5149\u654f\u611f\u75c7)\nE. Metronidazole \u2013 Peripheral neuropathy (\u5468\u908a\u795e\u7d93\u75c5\u8b8a)\n": "(C)", "105-5.\n\u6709\u95dc\u91ab\u7642\u7167\u8b77\u4eba\u54e1\u9810\u9632\u63a5\u7a2e\u5efa\u8b70\uff0c\u4e0b\u5217\u4f55\u8005\u4e0d\u662f\u73fe\u884c\u5efa\u8b70\u9700\u6ce8\u5c04\u7684\u75ab\u82d7\uff1f\nA. \u75f2\u75b9 - \u816e\u817a\u708e - \u5fb7\u570b\u9ebb\u75b9\u75ab\u82d7 ( Measles-Mumps-Rubella vaccine )\nB. \u6d41\u884c\u6027\u611f\u5192\u75ab\u82d7 ( Influenza vaccine )\nC. \u72c2\u72ac\u75c5\u75ab\u82d7 ( Rabies vaccine )\nD. B\u578b\u809d\u708e\u75ab\u82d7 ( Hepatitis B vaccine )\nE. \u6c34\u75d8\u75ab\u82d7 ( Chickenpox vaccine)\n": "(C)", "105-6.\nClostridium difficile\u611f\u67d3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f\nA. C. difficile\u662f\u4e0d\u6703\u7522\u751f\u5b62\u5b50\u7684\u9769\u862d\u6c0f\u967d\u6027\u687f\u83cc\uff0c\u654570%\u9152\u7cbe\u5177\u6709\u6b64\u83cc\u826f\u597d\u4e4b\u6bba\u83cc\u529b\u3002\nB. \u4ee5\u5927\u8178\u93e1\u6aa2\u67e5\u507d\u819c\u6027\u8178\u708e(Pseudomembranous colitis)\u4e4b\u654f\u611f\u6027\u5f88\u9ad8\uff0c\u56e0\u6b64\u8178\u93e1\u6aa2\u67e5\u82e5\u7121\u51fa\u73fe\u75c5\u7076\u5247\u53ef\u6392\u9664\u6b64\u8a3a\u65b7\u3002\nC. \u81f4\u75c5\u529b\u53ef\u80fd\u548cToxin A\u548cToxin B\u76f8\u95dc\uff0ctoxin A\u662fcytotoxin, toxin B\u662fenterotoxin\u3002\nD. \u5c0d\u65bc\u9996\u6b21\u8f15\u5ea6C. difficile\u8178\u708e\uff0c\u9996\u9078\u6cbb\u7642\u85e5\u7269\u70ba\u53e3\u670dmetronidaozle\u6cbb\u764210\u523014\u5929\u3002\nE. \u5c0d\u65bc\u9996\u6b21C. difficile\u8178\u708e\u91cd\u5ea6\u60a3\u8005\uff0c\u9996\u9078\u6cbb\u7642\u85e5\u7269\u70ba\u91dd\u5291vancomycin\u6cbb\u764210\u523014\u5929\u3002\n": "(D)", "105-7.\n\u4e00\u4f4d40\u6b72\u7537\u6027\u51fa\u570b\u81f3\u4e2d\u6771\u9ea5\u52a0\u53c3\u52a0\u56de\u6559\u671d\u8056\u4e4b\u65c5\uff0c\u65c5\u904a\u4e2d\u4e26\u6709\u751f\u98f2\u99f1\u99dd\u5976\uff0c\u8fd4\u570b\u5f8c\u51fa\u73fe\u767c\u71d2\u53ca\u547c\u5438\u5598\uff0c\u80f8\u90e8X\u5149\u51fa\u73fe\u5169\u5074\u4e0b\u8449\u6d78\u6f64\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u8a62\u554f\u51fa\u570b\u65c5\u904a\u53f2\uff0c\u82e5\u5728\u4e2d\u6771\u5730\u5340\u96e2\u958b\u5f8c14\u5929\u4e4b\u5167\u767c\u71d2\uff0c\u81e8\u5e8a\u53ca\u5f71\u50cf\u6aa2\u67e5\u8a3a\u65b7\u80ba\u708e\uff0c\u61c9\u65bc24\u5c0f\u6642\u5167\u901a\u5831\u4e2d\u6771\u547c\u5438\u75c7\u72c0\u7fa4\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7(MERS - CoV)\u3002\nB. \u4e2d\u6771\u547c\u5438\u75c7\u72c0\u7fa4\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7\u5c6c\u65bc\u7b2c\u4e94\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u5df2\u6709\u51fa\u73fe\u5c40\u9650\u6027\u4eba\u50b3\u4eba\u7684\u7fa4\u805a\u611f\u67d3\u4e8b\u4ef6\u3002\nC. \u4e2d\u6771\u547c\u5438\u75c7\u72c0\u7fa4\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7\u81e8\u5e8a\u8868\u73fe\u5305\u62ec\u767c\u71d2\u3001\u54b3\u55fd\u3001\u547c\u5438\u6025\u4fc3\u8207\u547c\u5438\u56f0\u96e3\u3001\u901a\u5e38\u6703\u6709\u80ba\u708e\uff0c\u90e8\u5206\u75c5\u4eba\u6703\u51fa\u73fe\u814e\u8870\u7aed\u3001\u5fc3\u5305\u819c\u708e\u3001\u8840\u7ba1\u5167\u7030\u6f2b\u6027\u51dd\u8840(DIC)\u6216\u6b7b\u4ea1\u3002\nD. \u4e2d\u6771\u547c\u5438\u75c7\u72c0\u7fa4\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7\u4f4f\u9662\u91cd\u75c7\u6cbb\u7642\u75c5\u60a3\u6b7b\u4ea1\u7387\u7d04\u70ba10%\u81f312%\u3002\nE. \u76ee\u524d\u4e2d\u6771\u547c\u5438\u75c7\u72c0\u7fa4\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7\u4ecd\u7121\u81e8\u5e8a\u8a66\u9a57\u8b49\u5be6\u6709\u6548\u6cbb\u7642\u4e4b\u85e5\u7269\u53ca\u75ab\u82d7\uff0c\u6cbb\u7642\u4e3b\u8981\u4ee5\u652f\u6301\u6027\u7642\u6cd5\u70ba\u4e3b\u3002\n": "(D)", "105-8.\n\u6709\u95dc\u9000\u4f0d\u8ecd\u4eba\u75c7(Legionellosis)\uff0c\u4e0b\u5217\u4f55\u8005\u6558\u8ff0\u70ba\u975e\uff1f\nA. Legionella\u662f\u55dc\u6c27\u9769\u862d\u6c0f\u9670\u6027\u687f\u83cc\uff0c\u4e3b\u8981\u662fLegionella pneumophila\u8207\u4eba\u985e\u611f\u67d3\u6709\u95dc\u3002\nB. \u50b3\u67d3\u65b9\u5f0f\u662f\u98db\u6cab\u50b3\u67d3\uff0c\u901a\u5e38\u7d93\u7531\u5438\u5165\u53d7\u6c59\u67d3\u6c34\u6e90\u800c\u81f4\u75c5\uff0c\u6f5b\u4f0f\u671f\u70ba2\u81f310\u5929\u3002\nC. \u514d\u75ab\u529b\u4f4e\u4e0b\u611f\u67d3\u75c5\u4eba\u5bb9\u6613\u611f\u67d3\uff0c\u4f7f\u752810\u81f314\u5929\u7b2c\u4e09\u4ee3\u982d\u5b62\u5b50\u7d20(\u5982Ceftriaxone)\u53ef\u6709\u6548\u6cbb\u7642\u3002\nD. \u91ab\u9662\u4f9b\u6c34\u7cfb\u7d71\u4e2d\u767c\u73fe\u8a72\u75c5\u83cc\u6642\uff0c\u53ef\u85c9\u4e8c\u6c27\u5316\u6c2f(chlorine dioxide)\u6d88\u6bd2\uff0c\u6216\u9285-\u9280\u96e2\u5b50\u4ea4\u63db(copper-silver ionization)\u9032\u884c\u6d88\u6bd2\u3002\nE. Legionella\u53ef\u9020\u6210\u80ba\u5916\u611f\u67d3\uff0c\u5982\u8179\u819c\u708e\u6216\u814e\u76c2\u814e\u708e\u3002\n": "(C)", "105-9.\n\u6709\u95dc\u61f7\u5b55\u6642\u671f\u4f7f\u7528\u6297\u751f\u7d20\uff0c\u4e0b\u5217\u4f55\u8005\u5c6c\u65bcPregnancy category D\uff0c\u4e0d\u5efa\u8b70\u4f7f\u7528\uff1f\nA. Azithromycin\nB. Clindamycin\nC. Metronidazole\nD. Vancomycin\nE. Sulfonamide\n": "(E)", "105-10.\n\u6709\u95dc\u8332\u5361\u75c5\u6bd2(Zika virus)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u975e\uff1f\nA. \u8332\u5361\u75c5\u6bd2\u8207\u767b\u9769\u71b1\u75c5\u6bd2\u540c\u5c6c\u65bc\u9ec3\u75c5\u6bd2\u79d1(Flaviviridae)\uff0c\u6f5b\u4f0f\u671f\u7d043\u81f37\u5929(\u6700\u9577\u7d0412\u65e5)\u3002\nB. \u53f0\u7063\u75be\u75c5\u7ba1\u5236\u7f72\u516c\u5e03\u8332\u5361\u75c5\u6bd2\u5c6c\u65bc\u7b2c\u4e94\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u970024\u5c0f\u6642\u5167\u901a\u5831\u3002\nC. \u8332\u5361\u75c5\u6bd2\u4ea6\u53ef\u85c9\u7531\u6027\u884c\u70ba\u6216\u8f38\u8840\u611f\u67d3\u3002\nD. \u75c5\u5a92\u868a\u4e3b\u8981\u70ba\u71b1\u5e36\u5bb6\u868a\u8207\u74b0\u7d0b\u5bb6\u868a\u50b3\u64ad\u3002\nE. \u5b55\u5a66\u611f\u67d3\u6b64\u75c5\u6bd2\u53ef\u80fd\u7531\u6bcd\u5b50\u5782\u76f4\u611f\u67d3\u9020\u6210\u80ce\u5152\u51fa\u751f\u5c0f\u982d\u7578\u578b\u75c7\u3002\n": "(D)", "105-11.\n\u6709\u95dc\u6297\u751f\u7d20 - \u6709\u6548\u6cbb\u7642(\u75be\u75c5/\u81f4\u75c5\u539f)-\u6291\u83cc/\u6bba\u83cc\u6a5f\u8f49\u4e4b\u914d\u5c0d\uff0c\u4e0b\u5217\u5404\u7d44\u5408\u4f55\u8005\u70ba\u975e\uff1f\nA. Penicillin \u2013 Syphilis \u2013 \u7d30\u80de\u58c1\u5408\u6210\u6291\u5236\u3002\nB. Clarithromycin \u2013 Legionella \u2013 50S ribosome\u86cb\u767d\u8cea\u5408\u6210\u6291\u5236\u3002\nC. Levofloxacin \u2013 Pseudomonas aeruginosa \u2013 30S ribosome\u86cb\u767d\u8cea\u5408\u6210\u6291\u5236\u3002\nD. Dapomycin \u2013 Staphylococcus aureus \u2013 \u7d30\u80de\u819c\u6291\u5236\u3002\nE. Polymyxin \u2013 Acinetobacter baumannii \u2013 \u7d30\u80de\u819c\u6291\u5236\u3002\n": "(C)", "105-12.\n\u6aa2\u6e2c\u6f5b\u96b1\u6027(latent)\u7d50\u6838\u75c5\u5e38\u7528\u7684\u65b9\u6cd5\u6709\u7d50\u6838\u83cc\u7d20\u76ae\u819a\u8a66\u9a57(Mantoux tuberculin skin test, TST)\u548c\u4e19\u578b\u5e72\u64fe\u7d20\u91cb\u51fa\u5206\u6790(interferon-\u03b3 release assays, IGRAs)\uff0c\u4ee5\u4e0b\u4f55\u8005\u6b63\u78ba?\r1. IGRAs\u53ef\u9451\u5225\u6d3b\u52d5\u6027\u611f\u67d3\u548c\u6f5b\u96b1\u6027\u611f\u67d3\uff0c\u800cTST\u5247\u53ea\u53ef\u5075\u6e2c\u6f5b\u96b1\u6027\u611f\u67d3\u3002\r2. TST\u5047\u967d\u6027\u53ef\u767c\u751f\u65bc\u975e\u7d50\u6838\u5206\u679d\u687f\u83cc\u611f\u67d3\u6216\u66fe\u63a5\u7a2e\u5361\u4ecb\u82d7\u8005\u3002\r3. IGRAs\u5728\u8a3a\u65b7\u7d50\u6838\u611f\u67d3\u7684\u5c08\u4e00\u6027\u548c\u654f\u611f\u6027\u7686\u9ad8\u65bcTST\u3002\r4. IGRAs\u6bd4TST\u66f4\u9069\u5408\u7528\u65bc\u66fe\u63a5\u7a2e\u5361\u4ecb\u82d7\u8005\u3002\r5. \u5728\u5075\u6e2c\u6f5b\u96b1\u6027\u7d50\u6838\uff0c\u7576TST\u6216IGRAs\u967d\u6027\u6642\uff0c\u5fc5\u9808\u8a55\u4f30\u662f\u5426\u6709\u6d3b\u52d5\u6027\u7d50\u6838\u611f\u67d3\u3002\nA. 1+2+3\nB. 2+3+4\nC. 2+4+5\nD. 3+4+5\nE. 1+4+5\n": "(C)", "105-13.\n\u9810\u9632\u6d41\u884c\u6027\u611f\u5192\u75c5\u6bd2\u611f\u67d3\u53ca\u5176\u5408\u4f75\u75c7\u6700\u6709\u6548\u7684\u65b9\u6cd5\u662f\u75ab\u82d7\u63a5\u7a2e\uff0c\u4e00\u822c\u5efa\u8b70\u6240\u67096\u500b\u6708\u4ee5\u4e0a\u7684\u4eba\u7686\u53ef\u63a5\u7a2e\uff0c\u4ee5\u4e0b\u6709\u95dc\u6211\u570b\u5b63\u7bc0\u6027\u6d41\u611f\u75ab\u82d7\u572865\u6b72\u4ee5\u4e0a\u8001\u4eba\u53ca\u5168\u4eba\u53e3\u4e4b\u6bcf\u5e74\u65bd\u6253\u7387\u4e4b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?\nA. 65\u6b72\u4ee5\u4e0a\u8001\u4eba\u65bd\u6253\u7387\u7d0480%\uff0c\u5168\u4eba\u53e3\u65bd\u6253\u7387\u7d0450%\nB. 65\u6b72\u4ee5\u4e0a\u8001\u4eba\u65bd\u6253\u7387\u7d0460%\uff0c\u5168\u4eba\u53e3\u65bd\u6253\u7387\u7d0440%\nC. 65\u6b72\u4ee5\u4e0a\u8001\u4eba\u65bd\u6253\u7387\u7d0440%\uff0c\u5168\u4eba\u53e3\u65bd\u6253\u7387\u7d0415-20%\nD. 65\u6b72\u4ee5\u4e0a\u8001\u4eba\u65bd\u6253\u7387\u7d0430%\uff0c\u5168\u4eba\u53e3\u65bd\u6253\u7387<10%\nE. \u4ee5\u4e0a\u7686\u4e0d\u6b63\u78ba\n": "(C)", "105-14.\n\u4e00\u4f4d80\u6b72\u5973\u6027\u4f4f\u5728\u5b89\u990a\u9662\uff0c\u5979\u534a\u5e74\u524d\u56e0\u4e2d\u98a8\u800c\u958b\u59cb\u88ab\u7f6e\u653e\u5c0e\u5c3f\u7ba1\uff0c\u6700\u8fd1\u56e0\u6d41\u9f3b\u6c34\u3001\u54b3\u55fd\u53ca\u8f15\u5fae\u767c\u71d2\u88ab\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u7d66\u4e88\u75c7\u72c0\u6027\u6cbb\u7642\u5f8c\u9001\u56de\u5b89\u990a\u9662\uff0c\u75c5\u4eba\u57284\u5929\u5f8c\u88ab\u5e36\u56de\u9580\u8a3a\u8ffd\u8e64\uff0c\u6b64\u6642\u75c5\u4eba\u53ea\u6709\u8f15\u5fae\u54b3\u55fd\uff0c\u6c92\u767c\u71d2\uff0c\u9935\u98df\u60c5\u6cc1\u826f\u597d\uff0c\u800c\u5728\u6025\u8a3a\u5ba4\u6240\u505a\u5c3f\u57f9\u990a\u6709Vancomycin\u6297\u85e5\u6027\u8178\u7403\u83cc\uff0c\u8acb\u554f\u6b64\u6642\u5982\u4f55\u6cbb\u7642?\nA. \u7d66\u4e88Linezolid\nB. \u7d66\u4e88Ciprofloxacin\nC. \u7d66\u4e88Daptomycin\nD. \u7d66\u4e88Amoxicillin\nE. \u4ee5\u4e0a\u7686\u975e\n": "(E)", "105-15.\n\u4e00\u4f4d49\u6b72\u7537\u6027\u56e0\u767c\u71d2\u7531A\u91ab\u9662\u8f49\u4f86\uff0c\u4ed6\u66fe\u5728A\u91ab\u9662\u63a5\u53d7\u6aa2\u67e5\u4e26\u63a5\u53d7Ceftriaxone\u53caDoxycycline\u6cbb\u7642\u4e00\u9031\uff0c\u56e0\u672a\u9000\u71d2\u4e14\u8840\u6db2\u57f9\u990a\u5831\u544a\u9670\u6027\uff0c\u5728A\u91ab\u9662\u7cde\u4fbf\u57f9\u990a\u6709MRSA\u3002\u75c5\u4eba\u8f49\u4f86\u6642\u8840\u58d3140/80mmHg\uff0c\u5fc3\u8df378/min\uff0c\u547c\u543818/min\uff0c\u9ad4\u6eab38\u2103\uff0c\u521d\u6b65\u6aa2\u67e5\u4e26\u672a\u767c\u73fe\u611f\u67d3\u90e8\u4f4d\uff0c\u8acb\u554f\u9019\u6642\u8a72\u4ec0\u9ebc\u6297\u751f\u7d20?\nA. Fusidic acid\nB. Sulfamethoxazole-Trimethoprim\nC. Vancomycin\nD. Linezolid\nE. \u4e0d\u4f7f\u7528\u6297\u751f\u7d20\n": "(E)", "105-16.\n\u4ee5\u4e0b\u4f55\u8005\u4e0d\u662f\u4eba\u985e\u514d\u75ab\u7f3a\u4e4f\u75c5\u6bd2(HIV)\u611f\u67d3\u4e4b\u9ad8\u5371\u96aa\u8005?\nA. \u975c\u8108\u85e5\u766e\u8005\nB. \u6709\u6885\u6bd2\u6216\u5176\u4ed6\u6027\u50b3\u67d3\u75c5\u8005\nC. \u591a\u91cd\u6027\u4f34\u4fb6\u8005\nD. \u5e74\u8f15\u7d50\u6838\u75c5\u60a3\u8005\nE. \u4ee5\u4e0a\u7686\u662f\u9ad8\u5371\u96aa\u8005\n": "(E)", "105-17.\nWHO 2009\u5e74\u7248\u7684\u767b\u9769\u71b1\u5206\u985e\u53ca\u6cbb\u7642\u6307\u5f15\u4e3b\u8981\u5728\u63d0\u4f9b\u75ab\u5340\u91ab\u7642\u4eba\u54e1\u5c0d\u75c5\u60a3\u7684\u8a55\u4f30\u53ca\u6309\u81e8\u5e8a\u75c5\u60c5\u8f15\u91cd\u5206\u7d1a\u5206\u6d41\uff0c\u4ee5\u6709\u6548\u6cbb\u7642\u53ca\u8655\u7406\u75c5\u4eba\u3002\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u70ba\u932f?\nA. \u5c07\u75c5\u4eba\u5206\u985e\u70baGroup A\u3001B\u548cC\uff0c\u800c\u4e0d\u518d\u5340\u5206\u767b\u9769\u71b1\u8207\u767b\u9769\u51fa\u8840\u71b1\u3002\nB. Group B\u75c5\u4eba\u70ba\u6709\u300c\u8b66\u793a\u5fb5\u8c61\u300d(\u5982\u8179\u90e8\u75bc\u75db\u3001\u9ad4\u6db2\u84c4\u7a4d\u3001\u9ecf\u819c\u51fa\u8840\u3001\u55dc\u7761\u3001\u8e81\u52d5\u4e0d\u5b89\u3001\u809d\u816b\u5927\u53ca\u8840\u6bd4\u5bb9\u503c\u589e\u52a0\u4f34\u96a8\u8840\u5c0f\u677f\u6025\u901f\u4e0b\u964d)\u6216\u6709\u6f5b\u5728\u75be\u75c5\u6216\u9867\u53ca\u7279\u5b9a\u793e\u7d93\u72c0\u6cc1\uff0c\u9700\u4f4f\u9662\u6cbb\u7642\u3002\nC. Group C\u75c5\u4eba\u70ba\u6709\u56b4\u91cd\u8840\u6f3f\u6ef2\u6f0f\u5c0e\u81f4\u767b\u9769\u4f11\u514b\u75c7\u5019\u7fa4\u6216\u9ad4\u6db2\u84c4\u7a4d\u4f34\u96a8\u547c\u5438\u7a98\u8feb\u3001\u56b4\u91cd\u51fa\u8840\u3001\u56b4\u91cd\u5668\u5b98\u640d\u50b7\uff0c\u9700\u7dca\u6025\u8f49\u9001\u5230\u8a2d\u5099\u5b8c\u5584\u4e4b\u91ab\u9662\u6216\u5165\u4f4f\u52a0\u8b77\u75c5\u623f\u3002\nD. Group A\u53caGroup B\u9ad4\u6db2\u88dc\u5145\u9f13\u52f5\u53e3\u670d\uff0c\u82e5\u9700\u975c\u8108\u8f38\u6db2\u5247\u4ee5\u751f\u7406\u9e7d\u6c34\u6216Ringer's lactate\u8f38\u6db224\u81f348\u5c0f\u6642\uff0c\u5728Group C\u75c5\u4eba\u6709\u4f4e\u8840\u58d3\u4f11\u514b\u6642\uff0c\u7528\u7b49\u5f35Crystalloid\u6216Colloid\u6eb6\u6db2\uff0c\u4ee520 ml/kg\u572815\u5206\u9418\u5167\u7d66\u4e88\uff0c\u884c\u7dca\u6025\u8f38\u6db2\u3002\nE. \u75c5\u4eba\u61c9\u907f\u514d\u4f7f\u7528aspirin\uff0c\u800c\u6539\u7528NSAID\u4f86\u6e1b\u8f15\u75c7\u72c0\uff0c\u7576\u8840\u5c0f\u677f\u4f4e\u65bc30000/cumm\uff0c\u5c31\u5fc5\u9808\u7acb\u5373\u8f38\u6ce8\u8840\u5c0f\u677f\u3002\n": "(E)", "105-18.\n\u4e0b\u5217\u6709\u95dcClostridium difficile\u611f\u67d3\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u932f\u8aa4?\nA. \u9810\u9632Clostridium difficile\u5b62\u5b50\u50b3\u64ad\u7684\u9662\u611f\u63aa\u65bd\u5305\u62ec\u6234\u624b\u5957\u3001\u7a7f\u9694\u96e2\u8863\u53ca\u4ee5\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u6d17\u624b\u3002\nB. \u78ba\u5b9a\u8a3a\u65b7Clostridium difficile-associated disease (CDAD)\u6240\u9020\u6210\u7684\u8179\u7009\u9700\u6aa2\u6e2c\u7cde\u4fbftoxin A\u548cB\uff0c\u6216\u8005\u7522\u751ftoxin\u7684\u57fa\u56e0\u3002\nC. CDAD\u75c5\u4eba\u7684\u8868\u73fe\u9664\u4e86\u8179\u7009\u5916\uff0c\u9084\u5305\u62ec\u767c\u71d2\u3001\u8179\u75db\u3001\u767d\u8840\u7403\u5347\u9ad8(leukocytosis)\u3002\nD. \u6cbb\u7642\u8f15\u5fae\u5230\u4e2d\u7b49\u56b4\u91cd\u5ea6CDAD\u7684\u85e5\u7269\u512a\u5148\u9078\u64c7\u70ba\u53e3\u670dmetronidazole 500 mg Q8h\uff0c\u4f7f\u752810\u81f314\u5929\u3002\nE. \u5927\u7d0420%\u7684CDAD\u75c5\u4eba\u6703\u767c\u751frecurrence\n": "(A)", "105-19.\n\u70ba\u964d\u4f4e\u91ab\u7642\u6a5f\u69cb\u5167\u591a\u91cd\u6297\u85e5\u6027\u75c5\u539f\u4e4b\u4ea4\u53c9\u611f\u67d3\uff0c\u97ff\u61c9\u4e16\u754c\u885b\u751f\u7d44\u7e54(WHO)\u4e4b\u5021\u5c0e\u91ab\u8b77\u4eba\u54e1\u624b\u90e8\u885b\u751f\u904b\u52d5\u3002\u6709\u95dc\u624b\u90e8\u885b\u751f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?\r1. \u4f7f\u7528\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u9032\u884c\u624b\u90e8\u885b\u751f\uff0c\u5728\u6e05\u6f54\u6548\u679c\u3001\u4f7f\u7528\u6642\u6a5f\u3001\u82b1\u8cbb\u6642\u9593\u3001\u5c0d\u76ae\u819a\u7684\u5f71\u97ff\u3001\u5b89\u5168\u8003\u91cf\u53ca\u6d17\u624b\u9075\u5f9e\u6027\u7b49\u65b9\u9762\uff0c\u5747\u6bd4\u4f7f\u7528\u80a5\u7682\u6216\u6db2\u614b\u7682\u9032\u884c\u6fd5\u6d17\u624b\u7684\u6548\u679c\u70ba\u4f73\u3002\r2. WHO\u63a8\u52d5\u7684\u91ab\u8b77\u4eba\u54e1\u624b\u90e8\u885b\u751f\u904b\u52d5\uff0c\u5f37\u8abf\u91ab\u8b77\u4eba\u54e1\u5728\u624b\u90e8\u7121\u660e\u986f\u9ad2\u6c59\u6642\uff0c\u512a\u5148\u4f7f\u7528\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u6e05\u6f54\u624b\u90e8\u3002\r3. \u624b\u90e8\u6709\u660e\u986f\u9ad2\u6c59\u6216\u6cbe\u6709\u8840\u6db2/\u9ad4\u6db2\u6642\uff0c\u5efa\u8b70\u4f7f\u7528\u80a5\u7682\u548c\u6e05\u6c34\u4e4b\u6fd5\u6d17\u624b\u6280\u8853\u6d17\u624b20\u79d2\u3002\r4. \u70ba\u63d0\u9ad8\u624b\u90e8\u885b\u751f\u8a2d\u5099\u7684\u53ef\u8fd1\u6027\uff0cWHO\u5ba3\u5c0e\u5728\u7167\u8b77\u9ede\u666e\u904d\u8a2d\u7f6e\u6216\u96a8\u8eab\u651c\u5e36\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u3002\r5. \u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u5c0d\u8afe\u7f85\u75c5\u6bd2(norovirus)\u3001\u8178\u75c5\u6bd2\u7686\u6709\u5f88\u597d\u4e4b\u6d88\u6bd2\u6548\u679c\u3002\nA. 1+2+3+4+5\nB. 1+2+4\nC. 2+4+5\nD. 2+3+4\nE. 1+3+4\n": "(B)", "106-1.\n\u6709\u95dcClostridium difficile\u611f\u67d3\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f\nA. \u9664\u4e86\u57f7\u884c\u63a5\u89f8\u9694\u96e2\u9632\u8b77\uff0c\u7167\u8b77C. difficile\u611f\u67d3\u60a3\u8005\u4ee570%\u9152\u7cbe\u9032\u884c\u624b\u90e8\u885b\u751f\uff0c\u53ef\u5177\u6709\u826f\u597d\u4e4b\u6bba\u83cc\u529b\u3002\nB. \u4ee5\u5927\u8178\u93e1\u6aa2\u67e5\u507d\u819c\u6027\u8178\u708e(Pseudomembranous colitis)\u4e4b\u654f\u611f\u6027\u9ad8\u905490%\u4ee5\u4e0a\uff0c\u82e5\u8178\u93e1\u6aa2\u67e5\u7121\u51fa\u73fe\u75c5\u7076\u5247\u5e7e\u4e4e\u53ef\u4ee5\u6392\u9664\u6b64\u8a3a\u65b7\u3002\nC. \u4e3b\u8981\u81f4\u75c5\u529b\u548ctoxin A\u548ctoxin B\u76f8\u95dc\uff0ctoxin A\u662fcytotoxin, toxin B\u662fenterotoxin\uff0c\u5169\u8005\u555f\u52d5\u9020\u6210\u507d\u819c\u6027\u8178\u708e\u3002\nD. \u5c0d\u65bc\u8f15\u5ea6C. difficile\u611f\u67d3\u521d\u6b21\u767c\u4f5c\u8178\u708e\u60a3\u8005\uff0c\u9996\u9078\u6cbb\u7642\u975c\u8108\u6ce8\u5c04\u6216\u53e3\u670dmetronidazole 500 mg TID\u6cbb\u764210\u523014\u5929\u3002\nE. \u5c0d\u65bcC. difficile\u611f\u67d3\u53cd\u8986\u591a\u6b21\u767c\u4f5c\u8178\u708e\u60a3\u8005\uff0c\u9996\u9078\u6cbb\u7642\u70ba\u975c\u8108\u6ce8\u5c04vancomycin 500 mg Q6H\u6cbb\u764210\u523014\u5929\u3002\n": "(D)", "106-2.\n\u4e00\u540d\u7537\u5b50\u5728\u5927\u9678\u5de5\u4f5c\u6642\u56e0\u5916\u51fa\u906d\u91ce\u72ac\u54ac\u50b7\u8173\u8dbe\uff0c\u7576\u6642\u672a\u5c31\u91ab\uff0c\u4e00\u500b\u591a\u6708\u5f8c\u51fa\u73fe\u4e0b\u534a\u8eab\u7570\u5e38\u7662\u3001\u9ebb\u75db\u3001\u5614\u5410\u3001\u541e\u56a5\u56f0\u96e3\u53ca\u5589\u56a8\u816b\u75db\u7b49\u75c7\u72c0\uff0c\u4e26\u6709\u6050\u6c34\u4e4b\u73fe\u8c61\uff0c\u5c31\u91ab\u5f8c\u56e0\u7591\u4f3c\u72c2\u72ac\u75c5(rabies) \u800c\u5165\u9662\uff0c\u95dc\u65bc\u6b64\u75c5\uff0c\u8acb\u554f\u4ee5\u4e0b\u63cf\u8ff0\u4f55\u8005\u932f\u8aa4\uff1f\nA. \u75c5\u60a3\u6050\u6c34\u4e4b\u73fe\u8c61\u662f\u56e0\u54bd\u5589\u90e8\u808c\u8089\u4e4b\u75d9\u6523\u6240\u5f15\u8d77\u3002\nB. \u53f0\u7063\u81ea\u6c11\u570b\u56db\u5341\u516b\u5e74\u8d77\u53f0\u7063\u5730\u5340\u5373\u4e0d\u518d\u6709\u4eba\u7684\u672c\u571f\u75c5\u4f8b\uff0c\u6c11\u570b\u4e94\u5341\u5e74\u4e00\u6708\u5f8c\u5373\u672a\u518d\u51fa\u73fe\u52d5\u7269\u7684\u75c5\u4f8b\u3002\u76ee\u524d\u5728\u53f0\u7063\u88ab\u672c\u5730\u7684\u72d7\u3001\u8c93\u54ac\u50b7\uff0c\u539f\u5247\u4e0a\u4e0d\u5fc5\u65bd\u6253\u4eba\u7528\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u6216\u75ab\u82d7\u3002\nC. \u5982\u9700\u524d\u5f80\u72c2\u72ac\u75c5\u75ab\u5340\uff0c\u5efa\u8b70\u884c\u524d\u81f3\u5c11\u4e00\u500b\u6708\uff0c\u63a5\u7a2e\u4e09\u5291\u75ab\u82d7\u4ee5\u7522\u751f\u514d\u75ab\u4fdd\u8b77\u3002\nD. \u5728\u75ab\u5340\u88ab\u52d5\u7269\u54ac\u50b7\u5f8c\uff0c\u5b9c\u5fb9\u5e95\u5730\u6e05\u6d17\u3001\u6d88\u6bd2\u50b7\u53e3\uff0c\u8fc5\u901f\u63a5\u53d7\u4eba\u7528\u72c2\u72ac\u75c5\u514d\u75ab\u7403\u86cb\u767d\u53ca\u63a5\u7a2e4\u5291\u75ab\u82d7\u3002\nE. \u82e5\u672a\u6cbb\u7642\uff0c\u6b64\u75c5\u81f4\u6b7b\u7387\u7d04\u70ba45%\u3002\n": "(E)", "106-3.\n\u6709\u95dc\u9000\u4f0d\u8ecd\u4eba\u75c7(Legionellosis)\uff0c\u4e0b\u5217\u4f55\u8005\u6558\u8ff0\u70ba\u975e\uff1f\nA. \u5178\u578b\u8840\u6db2\u6aa2\u9a57\u7d50\u679c\u70ba\u767d\u8840\u7403\u589e\u52a0\u3001\u809d\u529f\u80fdAST/ALT\u4e0a\u5347\u3001\u4f4e\u8840\u9209\u3001\u4f4e\u8840\u78f7\u3001Cold agglutinin\u9670\u6027\u3002\nB. \u6b64\u83cc\u6700\u9069\u5408\u65bc\u651d\u6c0f25\u81f342\u5ea6\u6c34\u74b0\u5883\u751f\u9577\uff0c\u50b3\u67d3\u65b9\u5f0f\u662f\u98db\u6cab\u50b3\u67d3\uff0c\u60a3\u8005\u901a\u5e38\u7d93\u7531\u5438\u5165\u53d7\u6c59\u67d3\u6c34\u6e90\u800c\u81f4\u75c5\uff0c\u6f5b\u4f0f\u671f\u70ba2\u81f310\u5929\u3002\nC. \u514d\u75ab\u529b\u4f4e\u4e0b\u611f\u67d3\u75c5\u4eba\u53ca\u6709\u6162\u6027\u80ba\u75c5\u8001\u5e74\u4eba\u5bb9\u6613\u611f\u67d3\uff0c 14\u5929\u81f321\u5929\u7b2c\u4e09\u4ee3\u982d\u5b62\u5b50\u7d20(cephalosporin)\u53ef\u6709\u6548\u6cbb\u7642\u3002\nD. \u79fb\u690d\u5668\u5b98\u60a3\u8005\u5728\u79fb\u690d\u5f8c3\u500b\u6708\u5167\u662f\u5f97\u5230Legionella\u611f\u67d3\u7684\u9ad8\u5371\u96aa\u671f\uff0c\u4e14\u80f8\u90e8X\u5149\u5728\u79fb\u690d\u60a3\u8005\u6613\u898b\u958b\u6d1e\u75c5\u7076(cavitation)\u3002\nE. Legionella\u53ef\u9020\u6210\u80ba\u5916\u611f\u67d3\uff0c\u5982\u8179\u819c\u708e\u6216\u76ae\u819a\u8edf\u7d44\u7e54\u611f\u67d3\u3002\n": "(C)", "106-4.\n\u9000\u4f0d\u8ecd\u4eba\u83cc(Legionella)\u5728\u91ab\u9662\u7684\u51b7\u537b\u6c34\u5854\u53ef\u80fd\u9020\u6210\u6c59\u67d3\uff0c\u6709\u95dc\u9000\u4f0d\u8ecd\u4eba\u83cc\u6d88\u6bd2\u65b9\u5f0f\u4e0b\u5217\u4f55\u8005\u70ba\u975e?\nA. \u52a0\u71b1\u6cd5\uff0c\u63d0\u9ad8\u6c34\u7ba1\u6c34\u6eab\uff0c\u7dad\u6301\u51fa\u6c34\u7ba1\u8def\u6c34\u6eab\u81f3\u651d\u6c0f45~50\u5ea6\u3002\nB. \u6c2f\u5316\u6d88\u6bd2(chlorination)\uff0c\u5982\u52a0\u5165\u4e8c\u6c27\u5316\u6c2f\u3002\nC. \u7d2b\u5916\u7dda\u6d88\u6bd2(UV light)\u3002\nD. \u9285\u9280\u96e2\u5b50\u4ea4\u63db\u6cd5(copper-silver ion exchange)\u3002\nE. \u5fae\u7c73\u5b54\u5f91\u4e4b\u6ffe\u6c34\u5668(microfiltration)\u3002\n": "(A)", "106-5.\n\u4e0b\u5217\u90a3\u4e9b\u6297\u751f\u7d20\u7684\u6291\u83cc\u6a5f\u8f49\u70ba\u7834\u58de\u7d30\u80de\u819c?(1)penicillins\uff1b(2)aminoglycosides\uff1b (3)macrolides\uff1b(4)quinolones \uff1b(5)polymyxins \uff1b(6)daptomycin\nA. (1)+(4)\nB. (2)+(3)\nC. (4)+(5)\nD. (5)+(6)\nE. (3)+(4)\n": "(D)", "106-6.\n\u4e0b\u5217\u6297\u5fae\u751f\u7269\u85e5\u5291\u8207\u526f\u4f5c\u7528\u4e4b\u7d44\u5408\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f\nA. Macrolides ---- QTc prolongation(\u5fc3\u96fb\u5716QTc\u5ef6\u9577)\nB. Clindamycin ---- Pseudomembranous colitis(\u507d\u819c\u6027\u8178\u708e)\nC. Metronidazole ----Lipodystrophy(\u8102\u80aa\u75c5\u8b8a)\nD. Sulfonamide ---- Hypersensitivity(\u904e\u654f\u53cd\u61c9)\nE. Fluoroquinolones ---- Dysglycemia(\u8840\u7cd6\u7570\u5e38)\n": "(C)", "106-7.\n\u6709\u95dc\u767b\u9769\u71b1(Dengue fever)\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u9805\u6700\u4e0d\u9069\u7576\uff1f\r(1)\u767b\u9769\u75c5\u6bd2\u5c6c\u65bc\u9ec3\u75c5\u6bd2\u79d1(Flavivirdae)\u6240\u5f15\u8d77\uff0c\u70ba\u55ae\u80a1DNA\u75c5\u6bd2\uff1b (2)\u67094\u7a2e\u578b\u5225\uff0c\u611f\u67d3\u67d0\u4e00\u578b\u767b\u9769\u75c5\u6bd2\u8005\uff0c\u53ef\u5c0d\u5176\u4ed6\u578b\u5225\u4e4b\u75c5\u6bd2\u5177\u6709\u7d42\u8eab\u514d\u75ab\uff1b(3)\u5c48\u516c\u71b1(Chikungunya)\u75c5\u6bd2\u4e5f\u662f\u5c6c\u65bcFlaviviridae(\u9ec3\u75c5\u6bd2\u79d1)\uff0c\u50b3\u64ad\u5a92\u4ecb\u8207\u767b\u9769\u71b1\u76f8\u540c\uff1b(4)\u767b\u9769\u51fa\u8840\u71b1\u82e5\u7121\u9069\u7576\u6cbb\u7642\uff0c\u6b7b\u4ea1\u7387\u53ef\u905420%\uff0c\u65e9\u671f\u8a3a\u65b7\u4e26\u52a0\u4ee5\u9069\u7576\u652f\u6301\u6027\u6cbb\u7642\uff0c\u6b7b\u4ea1\u7387\u53ef\u4f4e\u81f31%\u3002\nA. (1)+(4)\nB. (3)+(4)\nC. (2)+(3)\nD. (2)+(4)\nE. (1)+(2)+(3)\n": "(E)", "106-8.\n\u4ee5\u4e0b\u95dc\u65bc\u767b\u9769\u71b1(Dengue fever)\u7684\u63cf\u8ff0\uff0c\u4f55\u8005\u70ba\u6700\u4e0d\u9069\u7576\uff1f\nA. \u5728\u53f0\u7063\u4e3b\u8981\u7684\u75c5\u5a92\u868a\u70ba\u57c3\u53ca\u6591\u868a(Andes aegypti)\u53ca\u767d\u7dda\u6591\u868a(Aedes albopictus)\u3002\nB. \u5e38\u898b\u75c7\u72c0\u70ba\u982d\u75db\u3001\u5f8c\u773c\u7aa9\u75db\u3001\u808c\u8089\u75db\u3001\u51fa\u75b9\u3001\u767d\u8840\u7403\u6e1b\u5c11\u3002\nC. \u88ab\u611f\u67d3\u767b\u9769\u75c5\u6bd2\u7684\u6591\u868a\u53ee\u54ac\u5f8c\uff0c\u5927\u7d04\u7d93\u904e10\u81f314\u5929\uff0c\u6b64\u611f\u67d3\u5bbf\u4e3b\u6703\u958b\u59cb\u51fa\u73fe\u81e8\u5e8a\u767b\u9769\u71b1\u75c5\u75c7\u3002\nD. \u56db\u7a2e\u4e0d\u540c\u8840\u6e05\u578b\u75c5\u6bd2\u7686\u53ef\u81f4\u75c5\uff0c\u5c6c\u7b2c\u4e8c\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u970024\u5c0f\u6642\u5167\u901a\u5831\u3002\nE. \u5728\u75c5\u4eba\u767c\u75c5\u524d1\u5929\u81f3\u767c\u75c5\u5f8c5\u5929\u7a31\u70ba\u300c\u75c5\u6bd2\u8840\u75c7\u671f\u300d\uff0c\u6b64\u6642\u671f\u611f\u67d3\u8005\u82e5\u88ab\u6591\u868a\u53ee\u54ac\uff0c\u5247\u6b64\u6591\u868a\u5c07\u611f\u67d3\u767b\u9769\u75c5\u6bd2\u3002\n": "(C)", "106-9.\n\u6709\u95dc\u4e0b\u5217\u91dd\u5c0d\u6d41\u884c\u6027\u611f\u5192(\u6d41\u611f)\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u70ba\u975e?\nA. \u6d41\u611f\u75c5\u6bd2\u53ef\u5206\u70baA\u3001B\u3001C\u4e09\u7a2e\u578b\u5225\uff0c\u5176\u4e2dC\u578b\u6d41\u611f\u75c5\u6bd2\u751a\u5c11\u5f15\u8d77\u4eba\u985e\u75be\u75c5\u3002\nB. \u53f0\u7063\u4e3b\u8981\u7684\u5b63\u7bc0\u6027\u6d41\u611f\u75c5\u6bd2\u70baA\u578b\u6d41\u611f\u75c5\u6bd2H3N2\u8207H1N1\u4e9e\u578b\uff0c\u4ee5\u53caB\u578b\u6d41\u611f\u75c5\u6bd2\u7b493\u985e\u3002\nC. \u6d41\u611f\u4e4b\u53ef\u50b3\u67d3\u671f\uff0c\u6210\u4eba\u5927\u7d04\u5728\u75c7\u72c0\u51fa\u73fe\u5f8c3\u81f37\u5929\uff0c\u5e7c\u7ae5\u53ef\u9577\u9054\u6578\u5341\u5929\u3002\nD. \u9810\u9632\u6d41\u611f\u6700\u597d\u7684\u65b9\u6cd5\u5c31\u662f\u65bd\u6253\u75ab\u82d7\uff0c\u7d0470%\u81f380%\u5065\u5eb7\u6210\u5e74\u4eba\u65bd\u6253\u6d41\u611f\u75ab\u82d7\u53ef\u9054\u5177\u6709\u4fdd\u8b77\u529b\u4e4b\u6297\u9ad4\u3002\nE. \u9810\u9632\u6d41\u611f\u4e4b\u6297\u75c5\u6bd2\u85e5\u5291\uff0c\u5982Oseltamivir\u53caZanamivir\u7b49\uff0c\u662f\u51dd\u8840\u539f(Hemagglutinin)\u6291\u5236\u5291\uff0c\u53ef\u540c\u6642\u6cbb\u7642A\u53caB\u578b\u6d41\u611f\u75c5\u6bd2\u3002\n": "(E)", "106-10.\n\u6709\u95dc\u4e0b\u5217\u91dd\u5c0d\u65b0\u578bA\u578b\u6d41\u611f(Novel Influenze A)\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u70ba\u975e?\nA. \u9ad8\u75c5\u539f\u6027\u79bd\u6d41\u611f\u5305\u62ecH5N1\u3001H5N6\u3001H7N7\u3001H7N9\u75c5\u6bd2\u7b49\u3002\nB. H5N1\u53caH7N9\u66fe\u51fa\u73fe\u5bb6\u5ead\u7fa4\u805a\u6848\u4f8b\uff0c\u6545\u4e0d\u6392\u9664\u6709\u4fb7\u9650\u6027\u4eba\u50b3\u4eba\u7684\u53ef\u80fd\uff0c\u60df\u76ee\u524d\u4ecd\u7121\u8b49\u64da\u986f\u793a\u6709\u6301\u7e8c\u6027\u4eba\u50b3\u4eba\u7684\u73fe\u8c61\u3002\nC. \u65b0\u578bA\u578b\u6d41\u611f\u7684\u6f5b\u4f0f\u671f\u57281\u81f310\u65e5\u4e4b\u9593\uff0c\u76ee\u524d\u63a1\u752810\u65e5\u4f5c\u70ba\u4f30\u8a08\u6f5b\u4f0f\u671f\u4e4b\u4e0a\u9650\u3002\nD. \u4eba\u985e\u611f\u67d3H5N6\u6d41\u611f\u7684\u75c5\u4f8b\u591a\u70ba\u8f15\u75c7\uff0c\u5c11\u6578\u60a3\u8005(\u7d0410%)\u5728\u611f\u67d33\u81f38\u5929\u5f8c\u51fa\u73fe\u80ba\u708e\uff0c\u4e26\u5feb\u901f\u9032\u5c55\u70ba\u6025\u6027\u547c\u5438\u7a98\u8feb\u75c7\u5019\u7fa4(ARDS)\u3002\nE. \u8fd1\u4e94\u6210\u7684H7N9\u6d41\u611f\u75c5\u4f8b\u70ba65\u6b72(\u542b)\u4ee5\u4e0a\u60a3\u8005\uff0c\u81f3\u5c11\u516d\u6210\u4ee5\u4e0a\u75c5\u4f8b\u6709\u6f5b\u5728\u6027\u75be\u75c5\u3002\n": "(D)", "106-11.\n\u6709\u95dc\u8332\u5361\u75c5\u6bd2(Zika virus)\u7684\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f\nA. \u8332\u5361\u75c5\u6bd2\u8207\u767b\u9769\u71b1\u75c5\u6bd2\u540c\u5c6c\u65bc\u9ec3\u75c5\u6bd2\u79d1(Flaviviridae)\uff0c\u6f5b\u4f0f\u671f\u7d043\u81f37\u5929(\u6700\u9577\u7d0412\u65e5)\u3002\nB. \u8332\u5361\u75c5\u6bd2\u611f\u67d3\u75c7\u4e4b\u75c7\u72c0\u8207\u767b\u9769\u71b1\u76f8\u4f3c\u4f46\u8f03\u8f15\u5fae\uff0c\u7d04\u670925%\u7684\u611f\u67d3\u75c5\u4f8b\u6703\u51fa\u73fe\u81e8\u5e8a\u75c7\u72c0\uff0c\u75c7\u72c0\u6301\u7e8c\u7d042\u81f37\u5929\u3002\nC. \u5178\u578b\u7684\u75c7\u72c0\u662f\u767c\u71d2\u3001\u7d05\u75b9\u3001\u95dc\u7bc0\u75db\u3001\u975e\u5316\u81bf\u6027\u7d50\u819c\u708e\uff0c\u75c5\u4f8b\u53ef\u80fd\u51fa\u73fe\u795e\u7d93\u7cfb\u7d71 (\u5982Guillain-Barre Syndrome)\u6216\u514d\u75ab\u7cfb\u7d71 (\u5982Idiopathic Thrombocytopenic Purpura) \u4f75\u767c\u75c7\u3002\nD. \u8332\u5361\u75c5\u6bd2\u75c5\u5a92\u50b3\u64ad\u4e3b\u8981\u70ba\u4e09\u6591\u5bb6\u868a\u8207\u77ee\u5c0f\u5bb6\u868a\uff0c\u4ea6\u53ef\u85c9\u7531\u6027\u884c\u70ba\u6216\u8f38\u8840\u611f\u67d3\u3002\nE. \u5b55\u5a66\u611f\u67d3\u6b64\u75c5\u6bd2\u53ef\u80fd\u7531\u6bcd\u5b50\u5782\u76f4\u611f\u67d3\u9020\u6210\u80ce\u5152\u51fa\u751f\u5c0f\u982d\u7578\u578b\u75c7\uff0c\u5b9a\u7fa9\u70ba\u51fa\u751f24\u5c0f\u6642\u5f8c\u6e2c\u91cf\u5b30\u5152\u982d\u570d\uff0c\u982d\u570d\u5c0f\u65bc\u7b2c3\u500b\u767e\u5206\u4f4d\u3002\n": "(D)", "106-12.\n\u95dc\u8332\u5361\u75c5\u6bd2(Zika virus)\u7684\u611f\u67d3\u7ba1\u5236\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f\nA. \u53f0\u7063\u75be\u75c5\u7ba1\u5236\u7f72\u516c\u5e03\u8332\u5361\u75c5\u6bd2\u5c6c\u65bc\u7b2c\u4e94\u985e\u6cd5\u5b9a\u50b3\u67d3\u75c5\uff0c\u9700\u65bc24\u5c0f\u6642\u5167\u901a\u5831\u3002\nB. \u8332\u5361\u75c5\u6bd2\u611f\u67d3\u75c7\u76ee\u524d\u7121\u75ab\u82d7\u53ef\u9810\u9632\uff0c\u5f97\u75c5\u5f8c\u50c5\u80fd\u75c7\u72c0\u652f\u6301\u6027\u6cbb\u7642\uff0c\u907f\u514d\u75c5\u5a92\u868a\u53ee\u54ac\u662f\u6700\u91cd\u8981\u7684\u9810\u9632\u65b9\u6cd5\u3002\nC. \u500b\u6848\u7d93\u6aa2\u9a57\u78ba\u5b9a\u611f\u67d3\u8332\u5361\u75c5\u6bd2\u5f8c\uff0c\u5247\u5f8c\u7e8c\u63a1\u6aa2\u4ee5\u9593\u96947\u65e5\u70ba\u539f\u5247\uff0c\u8840\u6db2\u53ca\u5c3f\u6db2\u6aa2\u9a57\u7d50\u679c\u5206\u5b50\u751f\u7269\u5b78\u6838\u9178\u6aa2\u6e2c\u5747\u70ba\u9670\u6027\uff0c\u624d\u80fd\u505c\u6b62\u8ffd\u8e64\u63a1\u6aa2\u3002\nD. \u7121\u8ad6\u7537\u6027\u6216\u5973\u6027\u4e4b\u611f\u67d3\u8005\uff0c\u5747\u61c9\u63a1\u53d6\u5b89\u5168\u6027\u884c\u70ba\u81f3\u5c116\u500b\u6708\uff0c\u82e5\u7537\u6027\u7684\u6027\u4f34\u4fb6\u70ba\u5b55\u5a66\uff0c\u5247\u6027\u884c\u70ba\u6642\u61c9\u6234\u4fdd\u96aa\u5957\u81f3\u6027\u4f34\u4fb6\u5206\u5a29\u3002\nE. \u63a5\u89f8\u8005\u53ca\u611f\u67d3\u6e90\u7684\u8abf\u67e5\uff0c\u9700\u8abf\u67e5\u6307\u6a19\u500b\u6848\u767c\u75c5\u524d3\u5929\u81f3\u767c\u75c5\u5f8c7\u5929\u7684\u505c\u7559\u5730\u9ede\u53ca\u63a5\u89f8\u8005\u3002\n": "(E)", "106-13.\n\u4e0b\u5217\u6709\u95dc\u5fc3\u5167\u819c\u708e\u4f55\u8005\u6558\u8ff0\u6b63\u78ba\uff1f(1)\u975c\u8108\u85e5\u766e\u8005\u4e4b\u5fc3\u5167\u819c\u708e\u6700\u5e38\u898b\u81f4\u75c5\u83cc\u70baStaphylococcus aureus\uff1b(2)\u8840\u6db2\u57f9\u990a\u9670\u6027\u4e4b\u5fc3\u5167\u819c\u708e\uff0c\u5176\u6700\u91cd\u8981\u6cbb\u7642\u85e5\u7269\u70baDoxycycline\uff1b(3)\u4e00\u5e74\u5167\u5f97\u904e\u5fc3\u5167\u819c\u708e\u8005\uff0c\u5728\u9032\u884c\u547c\u5438\u9053\u6216\u8178\u80c3\u9053\u93e1\u6aa2\u67e5\u4e4b\u524d\uff0c\u5fc5\u9808\u7d66\u4e88\u9810\u9632\u6027\u6297\u751f\u7d20\uff1b(4)\u6709\u534a\u6578\u75c5\u4eba\u53ef\u4ee5\u770b\u5230Osler nodes\uff0cJaneway lesion\u6216subungual hemorrhages\uff1b(5)\u8840\u6db2\u57f9\u990a\u9577\u9ef4\u83cc\u8005\u4e4b\u5167\u819c\u708e\u60a3\u8005\u901a\u5e38\u9810\u5f8c\u5dee\u3002\nA. (1)+(4)\nB. (1)+(3)\nC. (1)+(2)+(3)\nD. (1)+(2)+(4)\nE. (1)+(2)+(5)\n": "(E)", "106-14.\n\u70ba\u964d\u4f4e\u547c\u5438\u5668\u76f8\u95dc\u80ba\u708e\uff0c\u76ee\u524d\u885b\u751f\u798f\u5229\u90e8\u75be\u75c5\u7ba1\u5236\u7f72\u6b63\u5728\u63a8\u52d5\u4e00\u7cfb\u5217\u7d44\u5408\u5f0f\u7167\u8b77\u4ee5\u9810\u9632\u547c\u5438\u5668\u76f8\u95dc\u80ba\u708e\u611f\u67d3\u3002\u8acb\u554f\u4e0b\u5217\u54ea\u4e9b\u9805\u76ee\u5305\u62ec\u5728\u300c\u9810\u9632\u547c\u5438\u5668\u76f8\u95dc\u80ba\u708e\u611f\u67d3\u7684\u7d44\u5408\u5f0f\u7167\u8b77\u300d\u4e4b\u4e2d? (\u8acb\u9078\u51fa\u6240\u6709\u6b63\u78ba\u9078\u9805) (1) \u6bcf\u65e5\u62d4\u7ba1\u8a55\u4f30\uff1b(2) \u5e8a\u982d\u62ac\u9ad830-45\u5ea6\uff1b(3)\u6bcf\u65e5\u57f7\u884c\u53e3\u8154\u6297\u83cc\u7167\u8b77\uff1b(4)\u6bcf\u65e5\u4e2d\u6b62\u93ae\u975c\u5291\uff1b(5)\u88dc\u5145\u547c\u5438\u5668\u7ba1\u8def\u6c34\u5206\u3002\nA. (1)+(2)+(3)+(4)+(5)\nB. (1)+(2)+(3)+(4)\nC. (1)+(2)+(3)+(5)\nD. (1)+(2)+(4)+(5)\nE. (1)+(3)+(4)+(5)\n": "(B)", "106-15.\n\u6709\u95dc2016\u5e74\u7248Surviving Sepsis Campaign guidelines\uff0c\u95dc\u65bc\u6557\u8840\u75c7\u53ca\u6557\u8840\u6027\u4f11\u514b\u7684\u81e8\u5e8a\u8655\u7406\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4? (\u8acb\u9078\u51fa\u6240\u6709\u9078\u9805)(1)\u61c9\u5728\u6700\u521d3\u5c0f\u6642\u5167\u81f3\u5c11\u7d66\u4e88\u6bcf\u516c\u65a4\u9ad4\u91cd30 mL\u7684\u8f38\u6db2\u88dc\u5145\uff1b(2)\u5373\u4f7f\u81e8\u5e8a\u72c0\u6cc1\u5df2\u6539\u5584\uff0c\u6297\u751f\u7d20\u7642\u7a0b\u4e00\u5b9a\u898110-14\u5929\u624d\u8db3\u5920\uff1b(3)\u5efa\u8b70\u5e38\u898f\u4f7f\u7528Hydroxyethyl starches\u4f86\u8655\u7f6e\u6557\u8840\u6027\u4f11\u514b\uff1b(4)\u6557\u8840\u6027\u4f11\u514b\u7684\u7b2c\u4e00\u7dda\u5347\u58d3\u5291\u9078\u64c7\u70ba\u53bb\u7532\u57fa\u814e\u4e0a\u817a\u7d20\uff08Norepinephrine\uff09\uff1b(5)\u5efa\u8b70\u5e38\u898f\u4f7f\u7528\u76ae\u8cea\u9187(hydrocortisone)\u4f86\u6cbb\u7642\u6557\u8840\u6027\u4f11\u514b\u3002\nA. (1)+(2)+(4)\nB. (1)+(2)+(5)\nC. (1)+(3)+(4)\nD. (2)+(3)+(5)\nE. (2)+(4)+(5)\n": "(D)", "106-16.\n\u4e0b\u5217\u95dc\u65bc\u975e\u7d50\u6838\u5206\u679d\u687f\u83cc(Non-Tuberculous Mycobacteria, NTM)\u7684\u6558\u8ff0\u4f55\u8005\u6b63\u78ba?(1)\u8fd1\u5e74\u4f86\u88ab\u9451\u5b9a\u51fa\u4f86\u7684\u83cc\u682a\u6578\u6709\u6108\u4f86\u6108\u591a\u7684\u8da8\u52e2\uff0c\u4e3b\u8981\u662f\u56e0\u70ba\u5bb9\u6613\u5728\u4eba\u7fa4\u4e2d\u50b3\u64ad\uff1b(2)\u5e38\u767c\u751f\u5728\u80ba\u90e8\u7d50\u69cb\u7570\u5e38\u6216\u514d\u75ab\u7f3a\u9677\u75c5\u4eba\u8eab\u4e0a\uff1b(3)\u5404\u7a2e\u4e0d\u540cNTM\u83cc\u7a2e\u5c0d\u85e5\u7269\u7684\u611f\u53d7\u6027\u4e0d\u540c\uff0c\u6574\u9ad4\u800c\u8a00NTM\u5c0dClarithromycin\u5177\u611f\u53d7\u6027\uff0c\u800c\u5c0dPyrazinamide\u4e0d\u5177\u611f\u53d7\u6027\uff1b(4)\u6839\u64da\u7f8e\u570b\u80f8\u8154\u79d1\u5b78\u6703\u91dd\u5c0d\u80ba\u90e8NTM\u7684\u8a3a\u65b7\u6a19\u6e96\uff0c\u81e8\u5e8a\u8a3a\u65b7(\u80ba\u90e8\u75c7\u72c0\u53ca\u5f71\u50cf\u5b78\u7570\u5e38)\u4ee5\u53ca\u5fae\u751f\u7269\u5b78\u8a3a\u65b7(\u57f9\u990a\u7d50\u679c\u967d\u6027)\uff0c\u4efb\u4e00\u689d\u4ef6\u5373\u53ef\u8a3a\u65b7\uff1b(5) NTM\u611f\u67d3\u8207\u7d50\u6838\u75c5(tuberculosis)\u7684\u9451\u5225\u8a3a\u65b7\uff0c\u53ef\u63a1\u7528\u7d50\u6838\u83cc\u7d20PPD\u76ae\u5167\u8a66\u9a57\u3002\nA. (1)+(2)\nB. (1)+(3)\nC. (2)+(3)\nD. (2)+(4)\nE. (3)+(5)\n": "(C)", "106-17.\n19\u6b72\u7537\u6027\u5728\u53f0\u7063\u767b\u5c71\u65c5\u904a\u5f8c\u958b\u59cb\u51fa\u73fe\u767c\u71d2\u3001\u982d\u75db\u3001\u5168\u8eab\u808c\u8089\u9178\u75db\uff0c\u65bc\u9580\u8a3a\u6642\u767c\u73fe\u75c5\u4eba\u53f3\u817f\u5167\u5074\u6709\u4e00\u7126\u75c2(eschar)\uff0c\u4e14\u9f20\u8e4a\u6dcb\u5df4\u817a\u816b\u5927\uff0c\u8840\u6db2\u6aa2\u67e5\u767d\u8840\u7403\u6578\u70ba3150/\u03bcL\u3001GOT 112 IU/L\u3001GPT 184 IU/L\uff0c\u5c0d\u65bc\u6b64\u75c5\u4f8b\u4e4b\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u932f\u8aa4?\nA. \u6b64\u75be\u75c5\u70ba\u6059\u87f2\u75c5(scrub typhus)\uff0c\u81f4\u75c5\u83cc\u70baOrientia tsutsugamushi\nB. \u6b64\u81f4\u75c5\u83cc\u662f\u7531\u8768(louse)\u6240\u50b3\u64ad\nC. \u53f0\u7063\u6d41\u884c\u6b64\u611f\u67d3\u7684\u5730\u5340\u5728\u6771\u90e8\u5730\u5340\u53ca\u96e2\u5cf6\nD. \u6cbb\u7642\u7684\u9996\u9078\u85e5\u7269\u662fdoxycycline\nE. \u6b64\u75c5\u4e4b\u6f5b\u4f0f\u671f(incubation period)\u7d04\u70ba9\u81f318\u5929\n": "(B)", "106-18.\n\u7576\u4f60\u8981\u5e6b\u4e00\u4f4d\u547c\u5438\u56f0\u96e3\u7684\u75c5\u4eba\u9032\u884c\u6c23\u7ba1\u5167\u63d2\u7ba1\u6642\uff0c\u8acb\u554f\u6a19\u6e96\u9632\u8b77\u63aa\u65bd\u662f\u4ec0\u9ebc\uff1f(1)\u6d17\u624b\u3001\u6234\u624b\u5957\uff1b(2)\u6234N95\u53e3\u7f69\uff1b(3)\u7a7f\u9694\u96e2\u8863\uff1b(4)\u6234\u773c\u7f69\uff1b(5)\u6234\u5916\u79d1\u624b\u8853\u53e3\u7f69\nA. (1)+(2)+(3)\nB. (1)+(2)+(3)+(4)\nC. (1)+(3)+(5)\nD. (1)+(3)+(4)+(5)\nE. (1)+(2)+(4)\n": "(B)", "106-19.\n\u6709\u95dc\u6297\u7d50\u6838\u85e5\u7269\u6cbb\u7642\u4e4b\u63cf\u8ff0\uff0c\u4ee5\u4e0b\u4f55\u8005\u932f\u8aa4\uff1f\nA. Pyrazinamide (PZA) \u53ef\u5f15\u8d77\u9ad8\u5c3f\u9178\u8840\u75c7\uff0c\u4f46\u5f88\u5c11\u9020\u6210\u75db\u98a8\u767c\u4f5c\nB. Ethambutol\u53ef\u9020\u6210\u8996\u795e\u7d93\u708e\nC. Rifampicin\u6703\u4f7f\u5c3f\u6db2\u8b8a\u6a58\u7d05\u8272\nD. \u7576\u4f7f\u7528\u6297\u7d50\u6838\u85e5\u5f8c\uff0c\u809d\u529f\u80fd\u8d85\u904e\u6b63\u5e385\u500d\u6642\uff0c\u61c9\u8003\u616e\u505cIsoniazid\u3001PZA\u53carifampicin\nE. \u901a\u5e38\u6297\u7d50\u6838\u6cbb\u7642\u524d\u4e8c\u500b\u6708\u8981\u4f7f\u7528\u56db\u7a2e\u85e5\uff0c\u7a31\u70baIntensive Phase\uff0c\u5982\u82e5\u7121\u6297\u85e5\u554f\u984c\uff0c\u5247PZA\u672a\u5b8c\u6574\u4f7f\u7528\u4e8c\u500b\u6708\u6642\uff0c\u6cbb\u7642\u5168\u7a0b\u53ef\u516d\u500b\u6708\u7d50\u675f\n": "(E)", "107-1.\n\u4e00\u4f4d53\u6b72\u5973\u6027, 8\u670815\u65e5\u56e0\u70ba\u9ad8\u71d2\u3001\u754f\u5bd2\u3001\u982d\u75db\u3001\u808c\u8089\u75e0\u75db\u800c\u5230\u6025\u8a3a\u5ba4\u6c42\u6cbb,\u62bd\u8840\u6aa2\u9a57\u767d\u8840\u740313500/cumm\u3001\u4e2d\u6027\u767d\u8840\u740386%\u3001\u8840\u5c0f\u677f56000/cumm\u3001AST 176 U/L\u3001ALT 152 U/L\u3001Cr 1.4 mg/dL\u3001CRP 10mg/dL\u3001\u8840\u6db2\u57f9\u990a\u9670\u6027, \u5979\u548c\u4e00\u7fa4\u540c\u4f34\u559c\u597d\u6cb3\u5ddd\u6e38\u6cf3\u3002\u8acb\u554f\u4e0b\u5217\u54ea\u9805\u8077\u696d\u6700\u4e0d\u5bb9\u6613\u5f97\u5230\u9019\u500b\u75be\u75c5?\nA. \u7378\u91ab\nB. \u8fb2\u592b\nC. \u5c60\u5bb0\u5834\u5de5\u4eba\nD. \u516c\u8eca\u53f8\u6a5f\nE. \u6c59\u6c34\u9053\u5de5\u4eba\n": "(D)", "107-2.\n\u6709\u95dc\u6885\u6bd2\u7684\u6aa2\u9a57, \u4ee5\u4e0b\u4f55\u8005\u6b63\u78ba?(1). \u7576\u75c5\u4eba\u662fHIV(+)\u6642, \u82e5RPR (\u6216VDRL)\u22671:32\u6216CD4<=350/cumm, \u5247\u61c9\u505aCSF\u6aa2\u67e5RPR (2). primary/secondary\u6885\u6bd2, \u539fRPR\u70ba1:32, \u65bc\u6cbb\u7642\u5f8c6\u81f312\u500b\u6708\u8ffd\u8e64, \u518d\u9a57RPR\u70ba1:8, \u4e43\u8868\u793a\u6cbb\u7642\u53cd\u61c9\u826f\u597d (3). Latent/late syphilis \u65bc\u6cbb\u7642\u5f8c6\u300112\u300124\u500b\u6708\u7686\u61c9\u518d\u9032\u884c\u8ffd\u8e64\u6aa2\u67e5 (4). \u540c\u6642\u6709HIV(+)\u8005, \u6cbb\u7642\u5f8c3\u30016\u30019\u300112\u53ca24\u500b\u6708\u7686\u8981\u8ffd\u8e64\u6aa2\u9a57\nA. (1)+(2)+(3)\nB. (2)+(3)+(4)\nC. (1)+(2)+(4)\nD. (1)+(3)+(4)\nE. (1)+(2)+(3)+(4)\n": "(E)", "107-3.\n\u6c99\u9580\u6c0f\u83cc\u5e38\u6e90\u81ea\u86cb\u3001\u751f\u8089\u3001\u725b\u5976\u7522\u54c1\u3001\u82b1\u751f\u91ac\u3001\u65b0\u9bae\u852c\u83dc\u6216\u63a5\u89f8\u722c\u87f2\u985e\u52d5\u7269,\u53ef\u4ee5\u9020\u6210\u8178\u9053\u611f\u67d3\u75c7\u72c0\u6216\u83cc\u8840\u75c7, \u4ee5\u4e0b\u6709\u95dc\u6cbb\u7642\u4e4b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f (1). \u5e74\u7d00\u5c0f\u65bc50\u6b72\u4e4b\u5065\u5eb7\u6210\u4eba\u82e5\u6709\u8f15\u5fae\u81f3\u4e2d\u7b49\u5ea6\u8178\u80c3\u75c7\u72c0,\u53ef\u4e0d\u9700\u7528\u6297\u751f\u7d20 (2). \u6210\u4eba\u5e74\u7d00\u5927\u65bc50\u6b72, \u75c7\u72c0\u8f15\u5fae\u5247\u4e0d\u9700\u4f7f\u7528\u6297\u751f\u7d20 (3). \u6709\u4eba\u5de5\u8840\u7ba1\u690d\u5165\u7269\u3001\u4eba\u5de5\u95dc\u7bc0\u8005, \u75c7\u72c0\u8f15\u5fae\u4ea6\u61c9\u4f7f\u7528\u6297\u751f\u7d20 (4). \u63a5\u53d7\u5316\u5b78\u6cbb\u7642\u85e5\u6cbb\u7642\u764c\u75c5\u6216\u514d\u75ab\u6291\u5236\u5291\u8005, \u75c7\u72c0\u8f15\u5fae\u4ea6\u61c9\u4f7f\u7528\u6297\u751f\u7d20\nA. (1)+(2)+(3)+(4)\nB. (1)+(3)+(4)\nC. (2)+(3)+(4)\nD. (3)+(4)\nE. (4)\n": "(B)", "107-4.\n\u6709\u95dcA\u65cf\u93c8\u7403\u83cc\u9020\u6210\u7684\u6025\u6027\u54bd\u5589\u708e(pharyngitis)\u4e4b\u6558\u8ff0\uff0c\u4ee5\u4e0b\u6709\u95dc\u6cbb\u7642\u4e4b\u6558\u8ff0\u4f55\u8005\u4e0d\u6b63\u78ba\uff1f\nA. \u6cbb\u7642\u53ef\u964d\u4f4e\u98a8\u6fd5\u71b1\u4e4b\u98a8\u96aa\nB. \u6cbb\u7642\u53ef\u7e2e\u77ed\u75be\u75c5\u75c7\u72c0\nC. \u53ef\u964d\u4f4e\u5c0d\u5bc6\u5207\u63a5\u89f8\u8005\u6216\u5728\u64c1\u64e0\u74b0\u5883\u4e2d\u4e4b\u50b3\u64ad\nD. \u6cbb\u7642\u53ef\u63a110\u5929\u4e4b\u53e3\u670dAmoxicillin\nE. \u6cbb\u7642\u63a1moxifloxacin 7\u5929\n": "(E)", "107-5.\n\u4e00\u822c\u5c0d\u7da0\u81bf\u687f\u83cc\u611f\u67d3\u7684\u6cbb\u7642\u53ef\u9078\u4e0b\u5217\u54ea\u4e9b\u6297\u751f\u7d20? (1). Moxifloxacin (2). Cefepime (3). Cefoxitin (4). Ertapenem (5). Ceftazidime\nA. (1)+(2)+(4)\nB. (1)+(4)+(5)\nC. (2)+(4)+(5)\nD. (1)+(4)\nE. (2)+(5)\n": "(E)", "107-6.\n\u4ee5\u4e0b\u54ea\u4e9b\u6297\u85e5\u6027\u7d30\u83cc\u611f\u67d3\u53ef\u88ab\u914d\u5c0d\u6297\u751f\u7d20\u6240\u6cbb\u7642? (1). Extended spectrum beta-lactamase (ESBL)-producing E. coli: Ertapenem (2). KPC carbapenemase-producing K. pneumoniae: Meropenem (3). VRE: Linezolid (4). MRSA: Daptomycin (5). Carbapenem-resistant Pseudomonas aeruginosa: Tigecycline\nA. (1)+(2)+(3)\nB. (1)+(3)+(4)\nC. (3)+(4)+(5)\nD. (1)+(3)+(4)+(5)\nE. (1)+(3)\n": "(B)", "107-7.\n\u8702\u7aa9\u7d44\u7e54\u708e\u5728\u4ee5\u4e0b\u4f55\u7a2e\u60c5\u6cc1\u5b9c\u4f7f\u7528amoxicillin/clavulanic acid\u6cbb\u7642? (1). \u7576\u6709\u6162\u6027\u6dcb\u5df4\u816b\u4f75\u767c\u6025\u6027\u8702\u7aa9\u7d44\u7e54\u708e (2). \u7576\u6709\u52d5\u7269(\u8c93\u3001\u72d7)\u6216\u4eba\u54ac\u50b7 (3). \u7576\u5728\u6cb3\u5ddd\u5de5\u4f5c\u6709\u53d7\u50b7\u4e14\u6d78\u6ce1\u904e\u6cb3\u5ddd\u6c34\u6642 (4). \u7576\u6709\u91d8\u5b50\u523a\u50b7\u6df1\u90e8\u7d44\u7e54\u6642 (5). \u7576\u6709\u88ab\u9b5a\u523a\u50b7\u6642\nA. (2)+(4)\nB. (3)+(5)\nC. (1)+(2)\nD. (2)+(5)\nE. (1)+(2)+(3)+(4)\n": "(C)", "107-8.\n\u4e00\u4f4d75\u6b72\u7537\u6027\u56e0\u767c\u71d2\u4e8c\u5929\uff0c\u547c\u5438\u6025\u4fc3\u53ca\u54b3\u55fd\u52a0\u5287\u800c\u4f4f\u9662\u3002\u4ed6\u66fe\u65bc\u4e09\u5468\u524d\u7f79\u60a3\u6d41\u611f\u80ba\u708e\uff0c\u4f46\u547c\u5438\u9053\u75c7\u72c0\u5df2\u7d93\u5728\u4e94\u5929\u524d\u6062\u5fa9\u4e86\u3002\u7136\u800c\u9019\u4e8c\u5929\u54b3\u55fd\u53ca\u547c\u5438\u6025\u4fc3\u53c8\u7522\u751f\uff0c\u6709\u7070\u9ec3\u8272\u7684\u75f0\u6db2\u3002\u4ed6\u5e73\u6642\u6709\u9ad8\u8840\u58d3\uff0c\u4f4f\u9662\u9ad4\u6eab38.3\u00b0C\uff0c\u8840\u58d3140/86mmHg,\u5fc3\u8df390/min\uff0c\u547c\u543826/min, \u8840\u6c27\u6fc3\u5ea690% (\u5728room air)\uff0c\u80f8\u90e8\u547c\u5438\u97f3\u4e8c\u5074\u7686\u6709\u56c9\u97f3\uff0c \u800c\u80f8\u90e8X\u5149\u5169\u5074\u7686\u6709\u7a7a\u6d1e\u6027\u6d78\u6f64\u73fe\u8c61\uff0c\u8acb\u554f\u9019\u4f4d\u75c5\u4eba\u6700\u53ef\u80fd\u7684\u81f4\u75c5\u539f\u662f\u751a\u9ebc\uff1f\nA. Legionella species\nB. Staphylococcus aureus\nC. Pseudomonas aeruginosa\nD. Pneumocystis jirovecii\nE. Streptococcus pneumoniae\n": "(B)", "107-9.\nKlebsiella pneumoniae \u6f38\u6f38\u6210\u70ba\u6700\u91cd\u8981\u7684\u8178\u539f\u6027\u81f4\u75c5\u83cc, \u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba? (1). \u6240\u6709\u7684\u81e8\u5e8a Klebsiella pneumoniae\u83cc\u682a\u7686\u5c0d Ampicillin\u548c Ticarcillin\u5177\u6297\u85e5\u6027 (2). Extended spectrum beta-lactamase (ESBL)-producing K. pneumoniae\u5c0dceftriaxone\u548c ceftazidime\u5177\u6709\u6297\u85e5\u6027\uff0c\u4f46\u5c0d Ertapenem\u548c Fluoroquinolones \u5247\u7686\u5177\u6709\u611f\u53d7\u6027 (3). \u53ef\u7522\u751fNDM-1 carbapenemase \u7684 K. pneumoniae \u83cc\u53ef\u7528Tigecycline\u548cPolymycins\u6cbb\u7642 (4). \u53f0\u7063\u53ef\u7522\u751fKPC carbapenemase \u7684 K. pneumoniae \u83cc\u682a\u662f\u900f\u904e\u8cea\u9ad4\u7522\u751f\u6297\u85e5\u6027\uff0c\u4e26\u900f\u904e\u91ab\u7642\u7167\u8b77\u6a5f\u69cb\u50b3\u64ad (5).\r\u5728\u53f0\u7063\u9020\u6210\u809d\u81bf\u760d\u6216\u773c\u5167\u708e\u4e3b\u8981\u662f ESBL-producing K. pneumoniae\nA. (1)+(2)+(3)\nB. (1)+(2)+(4)\nC. (1)+(3)+(4)\nD. (1)+(3)+(5)\nE. (1)+(2)+(3)+(4)\n": "(C)", "107-10.\n\u70ba\u964d\u4f4e\u91ab\u7642\u6a5f\u69cb\u5167\u591a\u91cd\u6297\u85e5\u6027\u75c5\u539f\u4e4b\u4ea4\u53c9\u611f\u67d3\uff0c\u5021\u5c0e\u91ab\u8b77\u4eba\u54e1\u624b\u90e8\u885b\u751f\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6b63\u78ba? (1). \u4f7f\u7528\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u9032\u884c\u624b\u90e8\u885b\u751f\uff0c\u5728\u6e05\u6f54\u6548\u679c\u3001\u4f7f\u7528\u6642\u6a5f\u3001\u82b1\u8cbb\u6642\u9593\u3001\u5c0d\u76ae\u819a\u7684\u5f71\u97ff\u3001 \u5b89\u5168\u8003\u91cf\u53ca\u6d17\u624b\u9075\u5f9e\u6027\u7b49\u65b9\u9762\uff0c\u5747\u6bd4\u4f7f\u7528\u80a5\u7682\u6216\u6db2\u614b\u7682\u9032\u884c\u6fd5\u6d17\u624b\u7684\u6548\u679c\u70ba\u4f73 (2). \u91ab\u8b77\u4eba\u54e1\u5728\u624b\u90e8\u7121\u660e\u986f\u9ad2\u6c59\u6642\uff0c\u512a\u5148\u4f7f\u7528\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u6e05\u6f54\u624b\u90e8 (3). \u624b\u90e8\u6709\u660e\u986f\u9ad2\u6c59\u6216\u6cbe\u6709\u8840\u6db2/\u9ad4\u6db2\u6642\uff0c\u4f7f\u7528\u80a5\u7682\u548c\u6e05\u6c34\u4e4b\u6fd5\u6d17\u624b15\u79d2 (4).  \u5728\u7167\u8b77\u9ede\u666e\u904d\u8a2d\u7f6e\u6216\u96a8\u8eab\u651c\u5e36\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2 (5). \u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u6db2\u5c0d\u8afe\u7f85\u75c5\u6bd2(norovirus)\u3001\u8178\u75c5\u6bd2\u548cClostridium difficile\u7686\u6709\u5f88\u597d\u4e4b\u6d88\u6bd2\u6548\u679c\nA. (1)+(2)+(3)+(4)+(5)\nB. (1)+(2)+(4)\nC. (2)+(4)+(5)\nD. (2)+(3)+(4)\nE. (1)+(3)+(4)\n": "(B)", "107-11.\n\u4e00\u4f4d20 \u6b72\u7537\u6027\u75c5\u60a3\uff0c\u767c\u71d2\u6578\u5929\u4f4f\u9662\u6cbb\u7642\uff0c\u672a\u4f7f\u7528beta-blocker\uff0c\u4f4f\u9662\u751f\u547d\u5fb5\u8c61\u70ba\u9ad4\u6eab38.5\u81f339.5\u5ea6C\u3001\u5fc3\u8df3\u6bcf\u5206\u941870\u81f380\u4e0b\uff0c\u8acb\u554f\u4e0a\u8ff0\u7d00\u9304\u70ba\u4e0b\u5217\u54ea\u4e9b\u75be\u75c5\u4e4b\u81e8\u5e8a\u8868\u5fb5? (1). \u6c99\u9580\u6c0f\u83cc(Salmonella typhi) (2). \u9000\u4f0d\u8ecd\u4eba\u83cc(Legionella) (3). \u7acb\u514b\u6b21\u9ad4(Rickettsia) (4). \u6d41\u611f\u75c5\u6bd2(Influenza)\nA. (1)+(3)\nB. (2)+(3)\nC. (3)+(4)\nD. (1)+(2)+(3)\nE. (1)+(2)+(3)+(4)\n": "(D)", "107-12.\n\u6709\u95dc\u6557\u8840\u75c7\u81f4\u75c5\u539f\u8207\u6297\u751f\u7d20\u6cbb\u7642\u7684\u914d\u5c0d,\u4e0b\u5217\u54ea\u4e9b\u7d44\u5408\u662f\u6b63\u78ba\u7684? (1). Neisseria meningitidis - ceftriaxone (2). Group A Streptococcus - penicillin (3). Rickettsia - clindamycin (4). Enterococcus - cefazolin\nA. (1)+(2)\nB. (2)+(3)\nC. (1)+(3)\nD. (2)+(4)\nE. (1)+(4)\n": "(A)", "107-13.\n\u4e0b\u5217\u54ea\u4e9b\u75ab\u82d7\u662f\u6b63\u5728\u61f7\u5b55\u7684\u5a66\u5973\u4e0d\u5efa\u8b70\u6ce8\u5c04\u7684(\u5373\u75ab\u82d7\u7981\u5fcc\u75c7)? (1). Influenza (Flu\u75ab\u82d7) (2). MMR (measles-mumps-rubella)\u75ab\u82d7 (3). Varicella (Chickenpox)\u75ab\u82d7 (4). Pneumococcal (PPSV 23)\u75ab\u82d7\nA. (1)+(3)\nB. (2)+(3)\nC. (1)+(4)\nD. (1)+(2)+(3)\nE. (2)+(3)+(4)\n": "(B)", "107-14.\n\u4e00\u4f4d50\u6b72\u4e4b\u5973\u6027\u75c5\u60a3\uff0c10\u5929\u524d\u5230\u6771\u5357\u4e9e\u65c5\u904a\u66fe\u751f\u98df\u6d77\u9bae\uff0c\u8fd4\u570b\u5f8c\u767c\u751f\u8179\u7009\u8179\u75db\uff0c\u62bd\u8840\u6aa2\u67e5\u767c\u73fe\u8840\u6db2\u55dc\u4f0a\u7d05\u6027\u767d\u7403\u7570\u5e38\u589e\u52a0(WBC 7800/mm3\u3001eosinophil 38%)\uff0c\u8acb\u554f\u6700\u53ef\u80fd\u662f\u4e0b\u5217\u4f55\u7a2e\u75c5\u539f?\nA. Capillaria (\u97ad\u6bdb\u87f2)\nB. Ascaris (\u86d4\u87f2)\nC. Strongyloides (\u7cde\u5c0f\u687f\u7dda\u87f2)\nD. Hookworm (\u9264\u87f2)\nE. Cryptosporidium (\u96b1\u5b62\u5b50\u87f2)\n": "(A)", "107-15.\n\u6709\u95dc\u58de\u6b7b\u6027\u7b4b\u819c\u708e(necrotizing fasciitis)\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u975e?\nA. \u53ef\u80fd\u6e90\u81ea\u65bc\u5275\u50b7\u3001\u6c34\u75d8\u611f\u67d3\u76ae\u75c2\u3001\u624b\u8853\u6216\u751f\u7522\u5f8c\u50b7\u53e3\nB. \u7cd6\u5c3f\u75c5\u3001\u975c\u8108\u85e5\u766e\u3001\u6162\u6027\u809d\u814e\u75be\u75c5\u662f\u76f8\u95dc\u7684\u5bbf\u4e3b\u56e0\u7d20\nC. \u767c\u75c5\u5f8c\u7d043\u81f35\u5929\u8868\u76ae\u51fa\u73fe\u6c34\u6ce1(bullae)\u53ca\u76ae\u819a\u58de\u6b7b(necrosis)\nD. \u82e5\u5408\u4f75\u6709\u6bd2\u6027\u4f11\u514b\u75c7\u5019\u7fa4(toxic shock syndrome)\uff0c\u6b7b\u4ea1\u7387\u53ef\u9ad8\u905470%\nE. Clostridium peringens \u5f15\u8d77\u4e4b\u58de\u6b7b\u6027\u7b4b\u819c\u708e\u75c5\u7a0b\u6162\uff0c\u81e8\u5e8a\u75c7\u72c0\u7de9\u548c\uff0c\u6b7b\u4ea1\u7387\u4f4e\n": "(E)", "107-16.\n\u4e0b\u5217\u6709\u95dc\u793e\u5340\u6027\u80ba\u708e\u81f4\u75c5\u539f\u8207\u76f8\u95dc\u5bbf\u4e3b\u56e0\u7d20\u7684\u914d\u5c0d\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576?\nA. Acinetobacter - \u9152\u766e (alcoholism)\nB. Klebsiella pneumoniae - \u7cd6\u5c3f\u75c5 (diabetes)\nC. Haemophilus influenza - \u6162\u6027\u963b\u585e\u6027\u80ba\u75c5 (COPD)\nD. Pseudomonas aeruginosa - \u652f\u6c23\u7ba1\u64f4\u5f35(bronchiectasis)\nE. Legionella - \u6d41\u611f\u611f\u67d3\u5f8c (post - flu)\n": "(E)", "107-17.\n\u4e00\u4f4d30\u6b72\u5973\u6027\uff0c\u5728\u5403\u5b8c\u86cb\u6c99\u62c93\u5c0f\u6642\u5f8c\u51fa\u73fe\u6025\u6027\u8179\u75db\u3001\u5641\u5fc3\u5614\u5410\u53ca\u8179\u7009\uff0c \u8acb\u554f\u6700\u53ef\u80fd\u662f\u4e0b\u5217\u54ea\u4e00\u81f4\u75c5\u83cc\u6240\u5f15\u8d77?\nA. Staphylococcus aureus\nB. Enterotoxigenic E.coli\nC. Campylobacter jejuni\nD. Vibrio parahaemolyticus\nE. Ameoba histolytica\n": "(A)", "107-18.\n\u6709\u95dc\u56f0\u96e3\u68ad\u72c0\u687f\u83cc NAPI/BI/027\u83cc\u682a\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u975e?\nA. NAPI/BI/027\u83cc\u682a\u662f\u8fd1\u5e74\u4f86\u9020\u6210\u5168\u7403\u6d41\u884c\uff0c\u6b50\u7f8e\u5730\u5340\u91ab\u9662\u7fa4\u7a81\u767c\u7684\u4e3b\u8981\u83cc\u682a\nB. \u6b64\u83cc\u682a\u5c0d\u65bcfluoroquinolones\u985e\u6297\u751f\u7d20\u5177\u6709\u9ad8\u5ea6\u611f\u53d7\u6027(susceptible)\nC. \u8207\u4e00\u822c\u83cc\u682a\u76f8\u6bd4\uff0cNAPI/BI/027\u83cc\u682a\u53ef\u7522\u751f16\u81f323\u500d\u7684toxin A\u8207toxin B\nD. \u6b64\u83cc\u4ea6\u5df2\u88ab\u767c\u73fe\u9664toxin A\u53catoxin B\u5916\uff0c\u53e6\u53ef\u7522\u751f\u7b2c3\u7a2e\u6bd2\u7d20(binary toxin CDT)\nE. \u6b64\u83cc\u682a\u53ef\u4f7f\u7528metronidazole\u6216vancomycin\u4f86\u4f5c\u7b2c\u4e00\u7dda\u53e3\u670d\u6cbb\u7642\n": "(B)", "107-19.\n\u4e00\u4f4d20\u6b72\u5e74\u8f15\u5973\u6027\uff0c\u982d\u75db\u767c\u71d2\u53ca\u9838\u90e8\u50f5\u786c\u81f3\u6025\u8a3a\u5c31\u91ab\uff0c\u6025\u8a3a\u91ab\u5e2b\u57f7\u884c\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\uff0c\u8a3a\u65b7\u70ba\u7d30\u83cc\u6027\u8166\u819c\u708e\uff0c\u8acb\u554f\u4e0b\u5217\u6709\u95dc\u8166\u810a\u9ad3\u6db2\u6aa2\u67e5\u7d50\u679c\u6558\u8ff0\uff0c\u4f55\u8005\u70ba\u975e?\nA. \u591a\u578b\u6838\u767d\u8840\u7403(PMN)\u6578 >100 cells/uL\nB. \u8461\u8404\u7cd6\u6fc3\u5ea6 < 40 mg/dL\nC. \u86cb\u767d\u8cea(protein) > 45 mg/dL\nD. \u8166\u810a\u9ad3\u6db2\u7d30\u83cc\u57f9\u990a\u967d\u6027\u7387\u9ad8\uff0c\u7d04\u70ba80%\nE. \u8166\u810a\u9ad3\u6db2\u9769\u862d\u6c0f\u67d3\u8272\u967d\u6027\u7387\u4f4e\uff0c\u7d04\u70ba40%\n": "(E)", "108-1.\n\u4e00\u4f4d76\u6b72\u5a66\u5973\u56e0\u793e\u5340\u611f\u67d3\u80ba\u708e\u4f4f\u9662\uff0c\u63a5\u53d7\u6c27\u6c23\u88dc\u5145\uff0c\u6ce8\u5c04ceftriaxone\u548cazithromycin\u51713\u5929\uff0c\u8840\u6db2\u53ca\u75f0\u6db2\u57f9\u990a\u5747\u7121\u7d30\u83cc\u9577\u51fa\u3002\u5979\u611f\u89ba\u6bd4\u8f03\u8212\u670d\uff0c\u98df\u617e\u826f\u597d\uff0c\u54b3\u55fd\u53ca\u547c\u5438\u6025\u4fc3\u90fd\u6539\u5584\u4e86\uff0c\u5728\u4f4f\u9662\u7b2c2\u5929\u5c31\u9000\u71d2\u4e86\u3002\u5979\u6c92\u6709\u5176\u4ed6\u5171\u75c5\u3002\u8eab\u9ad4\u8a3a\u5bdf\u9ad4\u6eab37.8\u00b0C\uff0c\u8840\u58d3120/74 mmHg\uff0c\u5fc3\u8df390/min\uff0c\u547c\u543818/min\uff0c\u672a\u984d\u5916\u7d66\u6c27\u6c23\u6642\u6c27\u98fd\u548c\u5ea6\u70ba94%\u3002\u5979\u547c\u5438\u5e73\u7a69\uff0c\u807d\u8a3a\u5169\u5074\u80ba\u57fa\u5e95\u547c\u5438\u8072\u964d\u4f4e\uff0c\u53e9\u8a3a\u7121\u6fc1\u97f3(dullness)\uff0c\u5fc3\u81df\u8a3a\u5bdf\u7121\u7279\u6b8a\u767c\u73fe\uff0c\u96d9\u4e0b\u80a2\u7121\u6c34\u816b\uff0c\u5be6\u9a57\u5ba4\u6aa2\u67e5\u5468\u908a\u8840\u767d\u8840\u740313000/cumm(\u5165\u9662\u664218000/cumm)\uff0c\u751f\u5316\u503c\u6b63\u5e38\u3002\r\u8acb\u554f\u4e0b\u5217\u6700\u5408\u9069\u4e4b\u6297\u751f\u7d20\u6cbb\u7642\u70ba\u4f55\u8005?\nA. \u6301\u7e8cceftriaxone\u6ce8\u5c04\u6cbb\u7642\u3002\nB. \u6539\u6210\u53e3\u670d\u6297\u751f\u7d20\u4e26\u51fa\u9662\u3002\nC. \u6539\u6210\u53e3\u670d\u6297\u751f\u7d20\u4e26\u89c0\u5bdf24\u5c0f\u6642\u3002\nD. \u6539\u6210\u53e3\u670d\u6297\u751f\u7d20\u4e26\u8207\u6ce8\u5c04\u6297\u751f\u7d20\u91cd\u758a24\u5c0f\u6642\u3002\nE. \u505c\u7528\u6297\u751f\u7d20\u4e26\u51fa\u9662\u3002\n": "(B)", "108-2.\n\u4e00\u4f4d83\u6b72\u7537\u6027\uff0c\u56e0\u70ba\u5c3f\u8def\u611f\u67d3\u4f75\u83cc\u8840\u75c7\u800c\u4f4f\u9032\u52a0\u8b77\u75c5\u623f\u3002\u4e09\u5929\u524d\u4ed6\u56e0\u70ba\u9593\u65b7\u6027\u795e\u667a\u6df7\u4e82\u3001\u865b\u5f31\uff0c\u89e3\u5c3f\u75bc\u75db\u548c\u8840\u5c3f\u88ab\u9001\u5230\u6025\u8a3a\uff0c\u56e0\u70ba\u8840\u6d41\u52d5\u529b\u60c5\u6cc1\u4e0d\u7a69\u800c\u5165\u4f4f\u52a0\u8b77\u75c5\u623f\uff0c\u525b\u958b\u59cb\u63a5\u53d7\u975c\u8108\u8f38\u6db2\uff0c\u7d93\u9a57\u6027meropenem\u3002\u4e09\u5929\u5f8c\u4f4e\u8840\u58d3\u548c\u767c\u71d2\u90fd\u7de9\u89e3\uff0c\u8eab\u9ad4\u8a3a\u5bdf\u9ad4\u6eab37.6\u00b0C\uff0c\u8840\u58d3120/80 mmHg\uff0c\u5fc3\u8df394/min\uff0c\u547c\u543818/min\uff0c\u5fc3\u81df\u8a3a\u5bdf\u6b63\u5e38\uff0c\u8170\u5074\u548c\u8179\u90e8\u7121\u58d3\u75db\uff0c\u5c3f\u6db2\u57f9\u990aEnterococcus faecalis\u5927\u65bc100000\u83cc\u843d\uff0c\u800c\u8840\u6db2\u57f9\u990a\u4e5f\u662fE. faecalis\uff0c\u6297\u751f\u7d20\u611f\u67d3\u6027\u8a66\u9a57\u5c0dampicillin\uff0cvancomycin\u548cgentamicin\u5177\u654f\u611f\u6027\u3002\r\u8acb\u554f\u6b64\u6642\u4e0b\u5217\u54ea\u4e00\u9805\u6297\u751f\u7d20\u6cbb\u7642\u662f\u9069\u7576\u7684?\nA. \u6539\u6210ampicillin\nB. \u6539\u6210ampicillin\u548cgentamicin\nC. \u6539\u6210vancomycin\nD. \u6539\u6210vancomycin\u548cgentamicin\nE. \u7e7c\u7e8c\u4f7f\u7528meropenem\n": "(A)", "108-3.\n\u4e00\u4f4d60\u6b72\u7537\u6027\u56e0\u8179\u7009\u548c\u767c\u71d23\u5929\u800c\u4f86\u5c31\u8a3a\uff0c\u4ed6\u6c92\u6709\u8179\u75db\u6216\u5614\u5410\uff0c\u7cde\u4fbf\u6df7\u6709\u9ecf\u6db2\uff0c\u4f46\u6c92\u6709\u770b\u5230\u8840\u4fbf\uff0c\u4ed6\u611f\u89ba\u75b2\u52de\u548c\u98df\u617e\u8b8a\u5dee\uff0c\u4ed6\u5f9e\u4e8b\u5e02\u5834\u5de5\u4f5c\u3002\u8eab\u9ad4\u8a3a\u5bdf\u9ad4\u6eab38\u00b0C\uff0c\u8840\u58d3146/68 mmHg\uff0c\u5fc3\u8df382/min\uff0c\u547c\u543822/min\uff0c\u8179\u90e8\u8a3a\u5bdf\u8178\u97f3\u589e\u5f37\uff0c\u6574\u500b\u8179\u90e8\u6709\u8f15\u5fae\u58d3\u75db\u3002\u5be6\u9a57\u5ba4\u6aa2\u67e5\u5468\u908a\u8840\u767d\u8840\u740311400/mm^3\uff0c\u7cde\u4fbf\u6709\u6f5b\u8840\u53cd\u61c9\u3002\u4ed6\u63a5\u53d7\u7cde\u4fbf\u57f9\u990a\u53ca\u7d93\u9a57\u6027\u6297\u751f\u7d20levofloxacin 3\u5929\u5f8c\uff0c\u7cde\u4fbf\u57f9\u990a\u5448\u73feCampylobacter jejuni\uff0c\u5c0dlevofloxacin\u6709\u6297\u85e5\u6027\u3002\u4ed6\u4f86\u9580\u8a3a\u8907\u67e5\u6642\uff0c\u611f\u89ba\u75c5\u5df2\u597d\uff0c\u8179\u7009\u53ca\u767c\u71d2\u90fd\u5df2\u7de9\u89e3\u3002\r\u8acb\u554f\u9019\u6642\u6700\u9069\u7576\u7684\u8655\u7406\u662f?\nA. \u505clevofloxacin\nB. \u63a1\u8840\u6db2\u57f9\u990a\nC. \u518d\u63a1\u96c6\u7cde\u4fbf\u57f9\u990a\nD. \u6539\u6210azithromycin\nE. \u6539\u6210ciprofloxacin\n": "(A)", "108-4.\n\u4e00\u4f4d60\u6b72\u5973\u6027\u56e0\u70ba\u547c\u5438\u6025\u4fc3\u548c\u8173\u816b\u65bc1\u5929\u524d\u88ab\u9001\u5230\u6025\u8a3a\u5ba4\uff0c\u81e8\u5e8a\u5224\u65b7\u70ba\u5931\u511f\u6027(decompensated)\u5fc3\u8870\u7aed\uff0c\u5979\u63a5\u53d7\u5c0e\u5c3f\u7ba1\u7f6e\u653e\uff0c\u975c\u8108\u6ce8\u5c04\u7d66\u4e88\u5229\u5c3f\u5291\u5e76\u4f4f\u9662\u3002\u5979\u6709\u9ad8\u8840\u58d3\u3001\u7cd6\u5c3f\u75c5\u548c\u6162\u6027\u814e\u75c5\u7b49\u6f5b\u5728\u75be\u75c5\u3002\u5979\u6240\u4f7f\u7528\u7684\u85e5\u7269\u5305\u62ecaspirin\uff0ccarvedilol\uff0cinsulin\uff0clisinopril\uff0crosuvastatin\uff0cspironolactone\u548c\u8996\u9700\u8981\u7528furosemide\u3002\u8eab\u9ad4\u8a3a\u5bdf\u9ad4\u6eab36.5\u00b0C\uff0c\u8840\u58d3128/72 mmHg\uff0c\u5fc3\u8df396/min\uff0c\u547c\u543818/min\uff0c\u807d\u8a3a\u80ba\u90e8\u96d9\u5074\u57fa\u5e95\u6709\u56c9\u97f3\uff0c\u5fc3\u97f3\u6709S3\uff0c\u4e8c\u5074\u4e0b\u80a2\u6709\u7b2c\u4e8c\u5ea6\u6c34\u816b\uff0c\u7531\u5c3f\u7ba1\u6d41\u51fa\u7684\u5c3f\u6db2\u662f\u6e05\u6f88\u7684\uff0c\u5be6\u9a57\u5ba4\u6aa2\u67e5\u8840\u6e05Creatinine 2.8 mg/dL\u3002\r\u8acb\u554f\u6b64\u6642\u5c0d\u75c5\u4eba\u5c0e\u5c3f\u7ba1\u6700\u6070\u7576\u7684\u8655\u7406\u70ba\u4f55?\nA. \u4e09\u5929\u5f8c\u62d4\u5c0e\u5c3f\u7ba1\nB. \u63db\u4e00\u652f\u5c0e\u5c3f\u7ba1\nC. \u62d4\u6389\u5c0e\u5c3f\u7ba1\nD. \u7576\u814e\u529f\u80fd\u56de\u5fa9\u5230\u75c5\u4eba\u57fa\u790e\u503c\u6642\u62d4\u5c0e\u5c3f\u7ba1\nE. \u7b49\u51fa\u9662\u518d\u62d4\u5c0e\u5c3f\u7ba1\n": "(C)", "108-5.\n\u8fd1\u5e74\u53c8\u8208\u8d77\u9ebb\u75b9\u7fa4\u805a\u75ab\u60c5\uff0c\u76f8\u95dc\u6558\u8ff0\u8acb\u9078\u51fa\u6700\u6b63\u78ba\u4e4b\u7d44\u5408\u3002\r(1)\u50b3\u7d71\u521d\u6b21\u611f\u67d3\u9ebb\u75b9\u7684\u81e8\u5e8a\u8868\u73fe\u5305\u62ec\u5168\u8eab\u6027\u76ae\u819a\u6591\u4e18\u75b9\uff0c\u767c\u71d238.3\u00b0C\u4ee5\u4e0a\uff0c\u4ee5\u53cacoryza\uff0ccough\u6216conjunctivitis\uff0c\u800c\u66fe\u65bd\u6253\u904e\u75ab\u82d7\u8005\u5f97\u5230\u9ebb\u75b9\u5247\u75c7\u72c0\u5e38\u5448\u73fe\u4e0d\u5178\u578b (2)\u9ebb\u75b9\u8fc4\u4eca\u4e26\u7121\u6297\u75c5\u6bd2\u85e5\u7269\u53ef\u6cbb\u7642\uff0c\u81e8\u5e8a\u8655\u7406\u63a1\u652f\u6301\u6027\u6cbb\u7642\u5982\u6c34\u4efd\u548c\u9000\u71d2\u85e5\u3002\u800cvitamin A\u6cbb\u7642\u53ef\u964d\u4f4e\u9ebb\u75b9morbidity\u548cmortality (3)\u9ebb\u75b9\u56b4\u91cd\u5408\u4f75\u75c7\u5305\u62ec\u75c5\u6bd2\u76f4\u63a5\u4fb5\u72af\u547c\u5438\u9053\u53ca\u7e8c\u767c\u6027\u7d30\u83cc\u611f\u67d3\u9020\u6210\u80ba\u708e\u6216\u4e2d\u8033\u708e\u3002\u6975\u56b4\u91cd\u7684\u8166\u810a\u9ad3\u708e\u767c\u751f\u7387\u7d04\u70ba\u5343\u5206\u4e4b\u4e00 (4)\u91ab\u8b77\u4eba\u54e1\u82e510\u81f315\u5e74\u5167\u6709\u6253\u904eMMR\u75ab\u82d7\uff0c\u5728\u672a\u9632\u8b77\u60c5\u6cc1\u66b4\u9732\u5230\u5e36\u75c5\u6bd2\u91cf\u8f03\u9ad8\u7684\u514d\u75ab\u6291\u5236\u60a3\u8005\uff0c\u4e0d\u5fc5\u64d4\u5fc3\u906d\u53d7\u611f\u67d3\r(5)\u6025\u6027IgM\u82e5\u5448\u9670\u6027\uff0c\u4e5f\u4e0d\u53ef\u6392\u9664\u611f\u67d3\uff0c\u800c\u9f3b\u54bd\u62ed\u5b50PCR\u6aa2\u6e2c\u4e4b\u967d\u6027\u7387\u6703\u66f4\u9ad8\u3002\nA. (1)+(3)+(5)\nB. (1)+(2)+(3)\nC. (1)+(2)+(3)+(4)\nD. (1)+(2)+(3)+(5)\nE. (1)+(2)+(3)+(4)+(5)\n": "(D)", "108-6.\n\u6709\u95dc\u767b\u9769\u71b1\u7684\u63cf\u8ff0\uff0c\u6700\u6b63\u78ba\u7684\u7d44\u5408\u70ba\u4e0b\u5217\u4f55\u8005?\t\r(1)\u767c\u75b9\u7d04\u5728\u982d\u75db\u3001\u767c\u71d2\u7b2c4\u81f3\u7b2c7\u65e5\uff0c\u5f9e\u8ec0\u5e79\u6563\u81f3\u982d\u90e8\u53ca\u56db\u80a2\u3002\r(2)\u767c\u75b9\u6b21\u5e8f\u548c\u9ebb\u75b9\u985e\u4f3c\u3002\r(3)\u76ae\u75b9\u51fa\u73fe\u6642\uff0c\u8840\u5c0f\u677f\u3001\u767d\u8840\u7403\u6578\u76ee\u7d04\u964d\u81f3\u6700\u4f4e\u9ede\uff0c\u800c\u5f8c\u518d\u9010\u6f38\u56de\u5347\u3002\r(4)\u76ae\u75b9\u521d\u767c\u984f\u8272\u8f03\u6f6e\u7d05\uff0c\u800c\u5f8c\u6f38\u6697\u6d88\u9000\uff0c\u7d044-7\u5929\u624d\u6d88\u5931\u3002\r(5)\u7d04\u670950%\u81f390%\u7684\u75c5\u4eba\u611f\u67d3\u75c7\u72c0\u4e0d\u660e\u986f\u3002\nA. (1)+(2)+(3)+(4)\nB. (1)+(3)+(4)+(5)\nC. (1)+(2)+(3)+(4)+(5)\nD. (3)+(4)+(5)\nE. (1)+(2)+(3)\n": "(B)", "108-7.\n\u6709\u6548\u964d\u4f4e\u4e2d\u5fc3\u975c\u8108\u5c0e\u7ba1\u611f\u67d3\u7684\u7d44\u5408\u5f0f\u65b9\u6cd5\u5df2\u7d93\u5728\u5148\u9032\u570b\u5bb6\u5f97\u5230\u9a57\u8b49\uff0c\u5176\u4e2d\u5305\u62ec: (1)\u624b\u90e8\u885b\u751f\uff0c\u9078\u64c7\u9069\u7576\u7f6e\u5165\u90e8\u4f4d (2)\u4f7f\u75282% chlorhexidine\u6d88\u6bd2\u5291\u6d88\u6bd2\u76ae\u819a (3)\u6700\u5927\u7121\u83cc\u9762\u9632\u8b77 (4)\u6bcf\u65e5\u8a55\u4f30\u5118\u65e9\u62d4\u9664\u4e0d\u9700\u8981\u4e4b\u5c0e\u7ba1 (5)\u7d44\u5957\u5f0f\u7684\u4f9b\u61c9\u5305\u6216\u7f6e\u653e\u8eca\uff0c\u63a1checklist\u4ee5\u78ba\u5b9a\u6bcf\u4e00\u6b65\u9a5f\u4e4b\u9075\u5f9e\u3002\nA. (1)+(2)+(4)\nB. (1)+(3)+(4)\nC. (1)+(3)+(4)+(5)\nD. (1)+(2)+(3)+(4)+(5)\nE. (1)+(2)+(3)+(4)\n": "(D)", "108-8.\n\u624b\u90e8\u885b\u751f\u662f\u9810\u9632\u9662\u5167\u4ea4\u53c9\u611f\u67d3\u6700\u6709\u6548\u4e4b\u65b9\u6cd5\uff0c\u6709\u95dc\u9152\u7cbe\u6027\u4e7e\u6d17\u624b\u4e4b\u63cf\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba? (1)\u624b\u90e8\u6709\u660e\u986f\u5f04\u9ad2\u6216\u8840\u6db2\u6c59\u67d3\u4e0d\u53ef\u4f7f\u7528\uff0c\u61c9\u63a1\u6d17\u624b\u4e73\u6fd5\u6d17\u624b (2)\u5728\u63a5\u89f8\u75c5\u4eba\u6216\u65c1\u908a\u74b0\u5883\u524d\u5f8c\u4f7f\u7528 (3)\u75c5\u623f\u6709Clostridium difficile\u7fa4\u805a\u611f\u67d3\u6642\u4f7f\u7528 (4)\u8178\u75c5\u6bd2\u6d41\u884c\u6642\u4f7f\u7528 (5)\u5927\u90e8\u5206\u7684\u60c5\u6cc1\u7686\u53ef\u4f7f\u7528\u3002\nA. (1)+(2)+(5)\nB. (1)+(2)+(3)+(5)\nC. (1)+(2)+(4)+(5)\nD. (1)+(2)+(3)+(4)+(5)\nE. (2)+(3)+(4)+(5)\n": "(A)", "108-9.\n\u53f0\u7063\u5730\u534065\u6b72\u4ee5\u4e0a\u8001\u4eba\uff0c\u5efa\u8b70\u63a5\u7a2e\u75ab\u82d7\u70ba\u4f55? (1)\u80ba\u708e\u7403\u83cc\u75ab\u82d7 (2)\u65e5\u672c\u8166\u708e\u75ab\u82d7 (3)\u6d41\u611f\u75ab\u82d7 (4)B\u578b\u55dc\u8840\u687f\u83cc\u75ab\u82d7(Hib vaccine) (5)\u7834\u50b7\u98a8\u53ca\u6e1b\u6bd2\u767d\u5589\u6df7\u5408\u75ab\u82d7(Td)\nA. (2)+(3)+(4)\nB. (2)+(3)+(5)\nC. (1)+(2)+(3)\nD. (1)+(3)+(5)\nE. (1)+(3)\n": "(D)", "108-10.\n\u6709\u95dc\u6297\u751f\u7d20\u4e4b\u63cf\u8ff0\uff0c\u4e0b\u5217\u54ea\u4e00\u9805\u4e0d\u6b63\u78ba?\nA. Fluoroquinolone\u985e\u6297\u751f\u7d20\u5728QTc prolongation\u7684\u75c5\u4eba\u7522\u751f\u5fc3\u5f8b\u4e0d\u6574\u7684\u98a8\u96aa\u589e\u52a0\nB. \u8001\u5e74\u4eba\u548c\u540c\u6642\u7528steroid\u7684\u4eba\u4f7f\u7528fluoroquinolone\u6703\u589e\u52a0tendinitis\u526f\u4f5c\u7528\u4e4b\u98a8\u96aa\nC. \u61f7\u5b55\u5a66\u4eba\u4e0d\u5efa\u8b70\u4f7f\u7528streptomycin\uff0ctetracycline\u6216tigecycline (category D)\nD. \u4f7f\u7528ceftriaxone\u4e0d\u53ef\u52a0\u5165\u542b\u9223\u4e4b\u9ede\u6ef4\u6ce8\u5c04\u6db2\nE. Fluoroquinolone\u5c0dMRSA\u53caVRE\u6cbb\u7642\u6548\u679c\u826f\u597d\n": "(E)", "108-11.\n\u793e\u5340\u6027\u6297\u85e5\u6027\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc(Community-acquired MRSA)\u80ba\u708e\u611f\u67d3\uff0c\u8fd1\u5e74\u4f86\u6709\u6d41\u884c\u7387\u4e0a\u5347\u7684\u8da8\u52e2\uff0c\u4e0b\u5217\u76f8\u95dc\u7684\u6558\u8ff0\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576?\nA. \u80ba\u90e8\u611f\u67d3\u8f03\u6613\u51fa\u73fe\u958b\u6d1e\u6027\u75c5\u7076(Cavitation)\u6216\u58de\u6b7b\nB. \u75c5\u4eba\u5927\u591a\u70ba\u6162\u6027\u814e\u529f\u80fd\u4e0d\u5168\u63a5\u53d7\u8840\u6db2\u900f\u6790\u60a3\u8005(Chronic dialysis)\nC. \u60a3\u8005\u8f03\u70ba\u5e74\u8f15\uff0c\u4e14\u591a\u534a\u4e4b\u524d\u5065\u5eb7\u72c0\u6cc1\u826f\u597d\nD. \u5408\u4f75\u54b3\u8840\u3001\u808c\u8089\u75e0\u75db\u53ca\u76ae\u75b9\nE. \u9664oxacillin\u6297\u85e5\u4e4b\u5916\uff0c\u5176\u4ed6\u591a\u6578\u6297\u751f\u7d20\u5177\u6709\u611f\u53d7\u6027(susceptible)\n": "(B)", "108-12.\n\u4e0b\u5217\u793e\u5340\u6027\u80ba\u708e\u81f4\u75c5\u539f\u8207\u5bbf\u4e3b\u56e0\u5b50\u4e4b\u914d\u5c0d\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576?\nA. Alcoholism - Streptococcus pneumoniae\nB. Bronchiectasis - Pseudomonas aeruginosa\nC. Post-Influenza illness - Stapylococcus aureus\nD. Exposure to bird - Chlamydia trochomatis\nE. Exposure to sheep - Coxiella burnetii\n": "(D)", "108-13.\n\u4e00\u4f4d30\u6b72\u5973\u6027\uff0c\u958b\u5fc3\u642d\u4e58\u90f5\u8f2a\u51fa\u904a\uff0c\u4f46\u5728\u8239\u4e0a\u9032\u98df\u5f8c24\u5c0f\u6642\u5de6\u53f3\u958b\u59cb\u51fa\u73fe\u767c\u71d2\u3001\u8179\u75db\u3001\u8179\u7009\u4e4b\u75c7\u72c0\uff0c\u5176\u4ed6\u540c\u884c\u8005\u4e5f\u6709\u591a\u4eba\u51fa\u73fe\u8178\u80c3\u4e0d\u9069\uff0c\u8acb\u554f\u4e0b\u5217\u4f55\u8005\u662f\u6700\u53ef\u80fd\u7684\u81f4\u75c5\u539f?\nA. Norovirus\nB. Giardia lamblia\nC. Cryptosporidium\nD. Entameoba histolytica\nE. Escherichia coli\n": "(A)", "108-14.\n\u6709\u95dc\u5178\u578b\u9000\u4f0d\u8ecd\u4eba\u75c7(Legionnaires' disease)\u4e4b\u75c5\u53f2\uff0c\u81e8\u5e8a\u8868\u5fb5\u8207\u6aa2\u9a57\u7d50\u679c\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u9069\u7576?\nA. \u4f75\u6709\u767c\u9ad8\u71d2(>40\u2103)\u3001\u8179\u7009(Diarrhea)\u7b49\nB. \u5c3f\u6db2\u6297\u539f\u53cd\u61c9\u4e4b\u654f\u611f\u5ea6(Sensitivity)\u7d04\u70ba70%\nC. \u4f75\u6709\u9ad8\u8840\u9209\u75c7(hypernatremia)\u53ca\u4f4e\u8840\u9240\u75c7(hypokalemia)\nD. \u5178\u578b\u75f0\u6db2\u53ef\u898b\u4e2d\u6027\u7403(neutrophils)\u6d78\u6f64\u589e\u52a0\u4f46\u9769\u862d\u6c0f\u67d3\u8272\u627e\u4e0d\u5230\u7d30\u83cc\nE. \u8207\u6709\u6c59\u67d3\u7684\u6c34\u6e90\u74b0\u5883\u63a5\u89f8\u6709\u95dc\n": "(C)", "108-15.\n\u4e00\u4f4d30\u6b72\u7684\u5973\u6027\uff0c\u5403\u4e86\u751f\u8c6c\u8089\u4e4b\u5f8c\u767c\u751f\u660e\u986f\u7684\u8178\u80c3\u708e\u75c7\u72c0\uff0c\u4e14\u6709\u767c\u71d2\u3001\u53f3\u4e0b\u8179\u75db\u53ca\u8179\u7009\uff0c\u6025\u8a3a\u5ba4\u8a3a\u67e5\u767c\u73feterminal ileum\u90e8\u4f4d\u767c\u708e(ileitis)\uff0c\u4e26\u6709\u53f3\u4e0b\u8179\u90e8\u53cd\u5f48\u75db\u7591\u4f3c\u76f2\u8178\u708e\uff0c\u8acb\u554f\u6700\u6709\u53ef\u80fd\u662f\u4e0b\u5217\u54ea\u4e00\u7a2e\u8178\u9053\u81f4\u75c5\u539f?\nA. Vibrio cholera\nB. Salmonella typhi\nC. Yersinia enterocolitica\nD. E. coli O157\nE. Enterovirus 71 (EV71)\n": "(C)", "108-16.\n\u6709\u95dc\u4e2d\u6771\u547c\u5438\u75c7\u72c0\u7fa4\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7(MERS-CoV)\uff0c\u4e0b\u5217\u4f55\u8005\u6558\u8ff0\u70ba\u975e\uff1f\nA. \u50b3\u67d3\u9014\u5f91\u70ba\u98db\u6cab\u53ca\u63a5\u89f8\u50b3\u67d3\uff0c\u6f5b\u4f0f\u671f\u7d04\u70ba7\u81f314\u5929\uff0c\u5df2\u6709\u51fa\u73fe\u5c40\u9650\u6027\u4eba\u50b3\u4eba\u7684\u7fa4\u805a\u611f\u67d3\u4e8b\u4ef6\nB. \u4e2d\u6771\u547c\u5438\u75c7\u72c0\u7fa4\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7\u81e8\u5e8a\u8868\u73fe\u5305\u62ec\u767c\u71d2\u3001\u54b3\u55fd\u3001\u547c\u5438\u6025\u4fc3\u8207\u547c\u5438\u56f0\u96e3\u3001\u901a\u5e38\u6703\u6709\u80ba\u708e\uff0c\u90e8\u5206\u75c5\u4eba\u6703\u51fa\u73fe\u814e\u8870\u7aed\u3001\u5fc3\u5305\u819c\u708e\u3001\u8840\u7ba1\u5167\u7030\u6f2b\u6027\u51dd\u8840(DIC)\u6216\u6b7b\u4ea1\nC. \u75c5\u60a3\u5c31\u91ab\u6216\u9032\u884c\u6aa2\u67e5\u6642\uff0c\u75c5\u60a3\u9700\u5f37\u5236\u914d\u6234N95\u53e3\u7f69\uff0c\u4f4f\u9662\u91cd\u75c7\u63d2\u7ba1\u75c5\u60a3\u6b7b\u4ea1\u7387\u7d04\u70ba10%\u81f312%\nD. \u75c5\u60a3\u61c9\u5165\u4f4f\u8ca0\u58d3\u9694\u96e2\u75c5\u5ba4\uff0c\u82e5\u7121\u8ca0\u58d3\u9694\u96e2\u75c5\u5ba4\u53ef\u66ab\u6642\u5b89\u7f6e\u6709\u885b\u6d74\u8a2d\u5099\u7684\u55ae\u4eba\u75c5\u5ba4\uff0c\u4e14\u75c5\u5ba4\u623f\u9580\u61c9\u7dad\u6301\u95dc\u9589\nE. \u76ee\u524d\u4ecd\u7121\u6709\u6548\u6cbb\u7642\u85e5\u7269\uff0c\u4e3b\u8981\u4ee5\u652f\u6301\u6027\u7642\u6cd5\u70ba\u4e3b\n": "(C)", "108-17.\n\u6709\u95dc\u81f4\u75c5\u539f\u611f\u67d3\u8207\u6297\u751f\u7d20\u6cbb\u7642\u7684\u914d\u5c0d,\u4e0b\u5217\u54ea\u4e9b\u7d44\u5408\u662f\u6b63\u78ba\u7684?\r(1) Bacteroides - metronidazole\r(2) Meningococcus - ceftriaxone\r(3) Staphylococcus - vancomycin or oxacillin\r(4) Enterococcus - cefazolin\nA. (1)+(2)+(3)\nB. (2)+(3)+(4)\nC. (1)+(3)+(4)\nD. (1)+(2)+(4)\nE. (1)+(2)+(3)+(4)\n": "(A)", "108-18.\n\u6709\u4e00\u4f4d30\u6b72\u5b55\u5a66\uff0c\u60f3\u4f86\u9580\u8a3a\u65bd\u6253\u75ab\u82d7\u9810\u9632\u611f\u67d3\uff0c\u4e0b\u5217\u54ea\u4e9b\u75ab\u82d7\u5c6c\u65bc\u6d3b\u6027\u75ab\u82d7\u662f\u5b55\u5a66\u4e0d\u5efa\u8b70\u6ce8\u5c04\u7684?\r(1) Influenza vaccine \u6d41\u611f\u75ab\u82d7\r(2) MMR vaccine (Measles - Mump - Rubella vaccine) \u9ebb\u75b9-\u816e\u817a\u708e-\u5fb7\u570b\u9ebb\u75b9\u75ab\u82d7\r(3) Varicella vaccine \u6c34\u75d8\u75ab\u82d7\r(4) Pneumococcal vaccine \u80ba\u708e\u93c8\u7403\u83cc\u75ab\u82d7\nA. (1)+(3)\nB. (2)+(3)\nC. (1)+(4)\nD. (1)+(2)+(3)\nE. (2)+(3)+(4)\n": "(B)", "108-19.\n\u6709\u95dc\u9000\u4f0d\u8ecd\u4eba\u75c7(Legionella Infection)\u4e4b\u6cbb\u7642\u85e5\u7269\uff0c\u4e0b\u5217\u4f55\u8005\u662f\u6700\u5b8c\u6574\u7684\u53ef\u9078\u64c7\u85e5\u7269\u7d44\u5408?\r(1)Macrolides\r(2)Quinolones\r(3)Tetracyclines\r(4)Cephalosporins\r(5)Trimethoprim/ Sulfamethoxazle\nA. (1)+(2)\nB. (1)+(2)+(3)\nC. (2)+(3)+(4)\nD. (1)+(2)+(3)+(5)\nE. (3)+(4)+(5)\n": "(D)", "109-101.\u9580\u8a3a\u4f86\u4e86\u4e00\u4f4d70\u6b72\u5973\u6027 \uff0c\u5979\u5148\u751f3\u500b\u6708\u524d\u78ba\u8a3a\u958b\u653e\u6027\u80ba\u7d50\u6838 \uff0c\u5979\u65bc2\u500b\u6708\u524d\u7167\u4e00\u5f35\u80f8\u90e8 X\u5149\u7121\u7570\u5e38\u72c0\u6cc1 \uff0c\u5979\n\u73fe\u5728\u6c92\u4efb\u4f55\u75c7\u72c0 \u3002\u4ee5\u4e0b\u4f55\u8005\u6b63\u78ba \uff1f   \nA.\u5e6b\u5979\u5b89\u6392\u80f8\u90e8 X\u5149\u6aa2\u67e5\uff0c\u82e5\u6b63\u5e38\uff0c\u5247\u7e7c\u7e8c\u5b9a\u671f\u8ffd\u8e64\nB.\u5e6b\u5979\u5b89\u6392\u80f8\u90e8 X\u5149\u6aa2\u67e5\uff0c\u767c\u73fe\u53f3\u4e0b\u80ba\u6709\u6d78\u6f64\u73fe\u8c61\uff0c\u7d66\u4e88\u8655\u65b9levofloxacin\u6cbb\u76427-10\u5929\nC.\u5e6b\u5979\u5b89\u6392\u80f8\u90e8 X\u5149\u6aa2\u67e5\uff0c\u7121\u7570\u5e38\u767c\u73fe \uff0c\u53ef\u518d\u5b89\u6392\u4e19\u578b\u5e72\u64fe\u7d20\u91cb\u51fa\u5206\u6790 (inferferon -\u03b3 release assay )\u6aa2\n\u6e2c\uff0c\u4ee5\u505a\u70ba\u6f5b\u4f0f\u7d50\u6838\u6cbb\u7642\u6c7a\u7b56\u4e4b\u53c3\u8003\nD.\u76f4\u63a5\u5b89\u6392\u4e19\u578b\u5e72\u64fe\u7d20\u91cb\u51fa\u5206\u6790\u6aa2\u6e2c\uff0c\u82e5\u70ba\u967d\u6027\u7d50\u679c\uff0c\u7d93\u75c5\u4eba\u540c\u610f\u53ef\u76f4\u63a5\u7d66\u4e88\u6f5b\u4f0f\u7d50\u6838\u6cbb\u7642\u8655\u65b9   \nE.\u5e6b\u5979\u5b89\u6392\u80f8\u90e8 X\u5149\u6aa2\u67e5\uff0c\u767c\u73fe\u53f3\u4e0b\u80ba\u6709\u6d78\u6f64\u73fe\u8c61\uff0c\u8490\u96c6\u75f0\u6db2acid fast stain\u9670\u6027\uff0c\u7e7c\u7e8c\u5b9a\u671f\u8ffd\u8e64\u5373\u53ef\n": "[C]", "109-102.\u4f60\u6536\u7642\u7684\u767b\u9769\u71b1\u60a3\u8005\u5373\u5c07\u51fa\u9662\uff0c\u95dc\u65bc\u51fa\u9662\u885b\u6559\uff0c\u4ee5\u4e0b\u4f55\u8005\u6b63\u78ba\uff1f    \nA.\u767b\u9769\u71b1\u5e38\u767c\u751f\u5728\u71b1\u5e36\u53ca\u4e9e\u71b1\u5e36\u5730\u5340\uff0c\u5728\u53f0\u7063\u4e3b\u8981\u75c5\u5a92\u868a\u70ba\u7627\u868a\u548c\u767d\u7dda\u6591\u868a\nB.\u5f97\u904e\u767b\u9769\u71b1\u4e4b\u5f8c\u5373\u6703\u51fa\u73fe\u4fdd\u8b77\u6027\u6297\u9ad4\uff0c\u5c0d\u767b\u9769\u71b1\u7d42\u751f\u514d\u75ab\nC.\u767b\u9769\u71b1\u4e00\u5171\u6709 4\u578b\uff0c\u76ee\u524d\u8a8d\u70ba\u7b2c\u4e00\u6b21\u611f\u67d3\u767b\u9769\u71b1\u75c5\u6bd2\u5f8c\u9ad4\u5167\u81ea\u7136\u7522\u751f\u7684\u6297\u9ad4 \uff0c\u53ef\u80fd\u6703\u5728\u611f\u67d3\u5176\u4ed6\u578b\u5225\n\u767b\u9769\u71b1\u6642\u9020\u6210 \u300c\u6297\u9ad4\u4f9d\u8cf4\u6027\u514d\u75ab\u52a0\u5f37\u53cd\u61c9 \u300d(antibody dependent enhancement; ADE )\uff0c\u9020\u6210\u56b4\u91cd\u7684\n\u4f75\u767c\u75c7\nD.\u767b\u9769\u51fa\u8840\u71b1 (dengue hemorrhagic fever) \u8207\u767b\u9769\u71b1\u4f11\u514b\u75c7\u5019\u7fa4 (dengue shock syndrome) \u50c5\u6703\u51fa\u73fe\u5728\n\u7b2c\u4e00\u578b\u767b\u9769\u71b1 \uff0c\u6240\u4ee5\u82e5\u66fe\u5f97\u904e\u767b\u9769\u51fa\u8840\u71b1 \uff0c\u5c31\u6703\u7d42\u751f\u514d\u75ab\u4e86\nE.\u767b\u9769\u71b14\u6548\u50f9\u6e1b\u6bd2\u6d3b\u75ab\u82d7 (Sanofi) \u5efa\u8b70\u4f7f\u7528\u65bc\u672a\u66fe\u611f\u67d3\u904e\u767b\u9769\u71b1\u7684\u4eba\n": "[C]", "109-103.\u6709\u95dc\u8178\u7403\u83cc\u8207\u6297\u751f\u7d20\u4e4b\u6558\u8ff0 \uff0c\u8acb\u9078\u51fa\u6700\u6b63\u78ba\u7684\u7b54\u6848\n(1) Vancomycin\u6297\u85e5\u6027\u8178\u7403\u83cc (VRE) \u6700\u5e38\u898b\u7684\u83cc\u7a2e\u662fEnterococcus faecium\n(2) Enterococcus faecalis\u83cc\u8840\u75c7\u901a\u5e38\u4ee5 vancomycin\u6cbb\u7642\n(3) Enterococcus faecails\u611f\u67d3\u7684\u9996\u9078\u6cbb\u7642\u901a\u5e38\u662f ampicillin\n(4) VRE\u7684\u56b4\u91cd\u611f\u67d3\u5e38\u9700\u4f7f\u7528linezolid \u6216daptomycin\u6cbb\u7642\n(5) \u5c3f\u6db2\u57f9\u990a\u6216\u75f0\u6db2\u57f9\u990a\u6709VRE \uff0c\u9700\u4f7f\u7528linezolid\u6cbb\u7642   \nA.(1)+(2)\nB.(1)+(3)\nC.(2)+(4)\nD.(1)+(3)+(4)\nE.(1)+(2)+(3)+(4)+(5)\n": "[D]", "109-104.\u52a0\u8b77\u75c5\u623f\u6d17\u6c34\u69fd\u540c\u6642\u4f7f\u7528\u65bc\u6c59\u67d3\u7269\u6e05\u6d17\u548c\u6d17\u624b\u7b49\u884c\u70ba \uff0c\u5bb9\u6613\u9020\u6210\u9662\u5167\u611f\u67d3 \uff0c\u56e0\u6b64\u5efa\u8b70\u6c59\u6c34\u8207\u6e05\u6f54\u6c34\u69fd\u9700\u5340\n\u5206\u6e05\u695a\uff0c\u751a\u81f3\u5c07\u6c59\u6c34\u69fd\u79fb\u51fa\u52a0\u8b77\u75c5\u623f \uff0c\u5e38\u898b\u4e4b\u75c5\u539f\u83cc\u4e0b\u5217\u4f55\u8005\u70ba\u975e \uff1f   \nA.Pseudomonas aeruginosa\nB.Nontuberculous Mycobacterium\nC.Chryseobacterium\nD.Stenotrophomonas maltophilia\nE.Aspergillus fumigatus\n": "[E]", "109-105.\u98df\u5a92\u6027\u75be\u75c5\uff0c\u4ee5\u4e0b\u54ea\u4e9b\u914d\u5c0d\u6700\u4e0d\u6b63\u78ba\uff1f    \nA.Listeriosis\u8207\u4e73\u916a\nB.Campylobacter jejuni\u8207\u672a\u716e\u719f\u96de\u8089\nC.Salmonella\u8207\u751f\u96de\u86cb\nD.Norovirus\u8207\u751f\u8814\u6216\u6c61\u67d3\u7684\u6c34\nE.Q fever\u8207\u751f\u725b\u8089\n": "[E]", "109-106.\u66b4\u9732\u5f8c\u9810\u9632\u5efa\u8b70\u4f7f\u7528\u6297\u5fae\u751f\u7269\u88fd\u5291\u8005 \uff0c\u8acb\u9078\u51fa\u6700\u9069\u7576\u7684\u7b54\u6848 \uff1f\n(1) HIV\n(2) \u9ebb\u75b9\n(3) COVID-19\n(4) Influenza\n(5) Meningococcus      \nA.(1)+(2)+(4)\nB.(1)+(3)+(4)\nC.(1)+(4)+(5)\nD.(1)+(3)+(4)+(5)\nE.(1)+(2)+(3)+(4)+(5)\n": "[C]", "109-107.\u4e0b\uf99c\u7528\u65bc\u6cbb\u7642methicillin-resistant Staphylococcus aureus (MRSA)\u4e4b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f    \nA.MRSA\u8207 methicillin-susceptible Staphylococcus aureus (MSSA) \u5fc3\u5167\u819c\u708e\u6b7b\u4ea1\u7387\u76f8\u8fd1\nB.\u53ea\u6709\u9662\u5167\u611f\u67d3\u624d\u6709MRSA\u7684\u98a8\u96aa\uff0c\u4e00\u822c\u793e\u5340\u578b\u80ba\u708e\u4e0d\u61c9\u5c07MRSA\u5217\u5165\u8003\u91cf\nC.Tigecycline\u5c6c\u65bc\u6bba\u83cc\u578b\u85e5\u7269\uff0c\u53ef\u7528\u65bc\u5fc3\u5167\u819c\u708e\u53ca\u83cc\u8840\u75c7\u4e4b\u6cbb\u7642\uff0c\u9ad8\u5291\u91cf\u4f7f\u7528\u9808\u6ce8\u610f\u8178\u80c3\u9053\u75c7\u72c0\nD.Linezolid\u9577\u6642\u9593\u4f7f\u7528\u53ef\u80fd\u6703\u9020\u6210\u8840\u5c0f\u677f\u6578\u91cf\u964d\u4f4e\uff0c\u4e5f\u53ef\u80fd\u5f15\u767c\u8996\u795e\u7d93\u75c5\u8b8a\uff0c\u9808\u6ce8\u610f\u773c\u5e95\u6aa2\u67e5\nE.Vancomycin\u4f7f\u7528\u6642\u53ea\u9808\u76e3\u6e2c\u8840\u4e2d trough \u6fc3\u5ea6\uff0c\u4ee5\u8a55\u4f30\u5176\u7642\u6548\u53ca\u526f\u4f5c\u7528\n": "[D]", "109-108.\u6709\u95dc\u51a0\u72c0\u75c5\u6bd2 \uff0c\u8acb\u9078\u51fa\u6700\u9069\u7576\u7684\u7b54\u6848\u3002 \n(1) SARS-CoV\u3001MERS-CoV\u3001SARS-CoV-2\u7686\u5c6c\u65bcRNA\u75c5\u6bd2 \uff0c\u6b64\u4e09\u8005\u7686\u5c6c\u65bcBetacoronavirus\n(2) \u51a0\u72c0\u75c5\u6bd2\u4e2d \uff0cE gene\u8ca0\u8cac\u88fd\u9020Envelope protein \uff0c\u5e6b\u52a9\u75c5\u6bd2\u7d50\u5408\u53d7\u9ad4 \uff0c\u9032\u800c\u5165\u4fb5\u4eba\u9ad4\u7d30\u80de\n(3) \u6b64\u4e09\u682a\u75c5\u6bd2\u4ee5SARS -CoV\u611f\u67d3\u8005\u4e4b\u6b7b\u4ea1\u7387\u6700\u9ad8\n(4) SARS-CoV-2\u611f\u67d3\u8005\u53ef\u80fd\u5f15\u767c\u7d30\u80de\u7d20\u98a8\u66b4\u75c7\u5019\u7fa4 (cytokine storm syndrome )\uff0c\u76ee\u524d\u5df2\u767c\u73fe\u91cd\u75c7\u60a3\u8005\u9ad4\n\u5167IL-6\u6fc3\u5ea6\u6703\u504f\u9ad8\n(5) \u5efa\u8b70\u5e38\u898f\u4f7f\u7528hydroxychloroquine\u4ee5\u6709\u6548\u6cbb\u7642SARS -CoV-2\u611f\u67d3\u8005   \nA.(1)+(2)+(3)\nB.(1)+(3)+(4)\nC.(1)+(3)\nD.(1)+(4)\nE.(2)+(3)+(5)\n": "[D]", "109-109.\u8acb\u554f\u7d30\u83cc\u6027\u8166\u819c\u708e\u7684\u8a3a\u65b7\u3001\u6cbb\u7642\u4ee5\u4e0b\u4f55\u8005\u932f\u8aa4\uff1f    \nA.\u9808\u76e1\u5feb\u4f7f\u7528\u6297\u751f\u7d20\nB.\u75c5\u4eba\u53ef\u80fd\u6703\u982d\u75db\u3001\u754f\u5149\nC.\u78ba\u5b9a\u8a3a\u65b7\u9700\u8170\u690e\u7a7f\u523a\uff0c\u5c07\u8166\u810a\u9ad3\u6db2\u9001\u57f9\u990a\nD.\u8170\u690e\u7a7f\u523a\u524d\u9808\u8003\u616e\u505a\u96fb\u8166\u65b7\u5c64\u907f\u514d\u52a0\u91cd\u53ef\u80fd\u5df2\u5347\u9ad8\u4e4b\u8166\u58d3\nE.\u4f7f\u7528\u8f03\u5f8c\u7dda\u4e4bcarbapenem\u985e\u6297\u751f\u7d20\u53ef\u907f\u514d\u6cbb\u7642\u5931\u6557\n": "[E]", "109-110.\u6709\u95dc\u767c\u71d2\u3001\u76ae\u75b9(skin rashes)\u4e4b\u75be\u75c5\u8207\u81f4\u75c5\u539f\u4e4b\u914d\u5c0d\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u975e\uff1f    \nA.Measles (\u9ebb\u75b9) - Paramyxovirus\nB.Rubella (\u5fb7\u570b\u9ebb\u75b9) - Togavirus\nC.Erythema infectiosum (\u7b2c\u4e94\u75c5)- Coxsackievirues A9\nD.Roseola (\u73ab\u7470\u71b1\u3001\u7b2c\u516d\u75c5) - Human herpesvirus 6\nE.Dengue fever (\u767b\u9769\u71b1) \u2013Flaviviruses\n": "[C]", "109-111.\u4e00\u4f4d\u5eda\u5e2b \uff0c\u5728\u6e05\u7406\u5eda\u9918\u6642\u4e0d\u614e\u88ab\u8001\u9f20 (Rodent)\u54ac\u50b7\u8173\u8dbe \uff0c\u5e7e\u5929\u5f8c\u958b\u59cb\u51fa\u73fe\u9ad8\u71d2 \u3001\u754f\u5bd2\u3001\u982d\u75db\u3001\u56db\u80a2\u75bc\n\u75db\u3001\u6dcb\u5df4\u816b\u8139 \u3001\u8840\u6db2\u7d30\u83cc\u57f9\u990a\u6709\u5831\u544a\u9577\u83cc \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u975e \uff1f   \nA.\u81f4\u75c5\u539f\u70baStreptobacillus moniliformis \u6216Pasteurella multocida   \nB.\u6b64\u611f\u67d3\u81f4\u75c5\u83cc\u5c6c\u65bc\u9769\u862d\u6c0f\u967d\u6027\u687f\u83cc(Gram positive bacilli)\nC.\u6b64\u83cc\u751f\u9577\u7de9\u6162\uff0c\u53ef\u80fd\u9700\u89813\u81f37\u5929\u57f9\u990a\u624d\u6703\u990a\u51fa\nD.\u82e5\u5c0d\u65bcPenicillin\u6709\u904e\u654f\uff0c\u53ef\u4ee5\u4f7f\u7528doxycycline\nE.\u81f4\u75c5\u539f\u4ea6\u53ef\u70baLeptospira\uff0c\u53ef\u5229\u7528\u8840\u6e05\u6297\u9ad4\u529b\u50f9\u8a3a\u65b7\n": "[B]", "109-112.\u6709\u95dc\u9810\u9632\u4e2d\u5fc3\u975c\u8108\u5c0e\u7ba1\u76f8\u95dc\u8840\u6d41\u611f\u67d3\u4e4b\u5be6\u8b49 \uff0c\u4e0b\u5217\u4f55\u8005\u7d44\u5408\u70ba\u6b63\u78ba \uff1f\n(1) \u4f7f\u7528\u6700\u5927\u7121\u83cc\u9762 (maximal barrier precautions )\u505a\u9632\u8b77\n(2) \u76ae\u819a\u6d88\u6bd2\u6548\u679c\u4f7f\u7528 \u03b2-iodine\u512a\u65bcchlorhexidine \n(3) \u7f6e\u653e\u5c0e\u7ba1\u524d\u5f8c\u9700\u57f7\u884c\u624b\u90e8\u885b\u751f (hand hygiene )\n(4) \u4e2d\u5fc3\u975c\u8108\u5c0e\u7ba1\u7f6e\u653e\u6642\u9593\u4ee514\u5929\u70ba\u539f\u5247 \uff0c\u6bcf14\u5929\u9700\u5e38\u898f\u66f4\u63db\u4e00\u6b21 \uff0c\u4ee5\u907f\u514d\u611f\u67d3   \nA.(1)+(2)+(3)+(4)\nB.(1)+(2)+(3)\nC.(2)+(4)\nD.(1)+(3)\nE.(1)+(3)+(4)\n": "[D]", "109-113.\u6709\u95dc\u6297\u751f\u7d20\u6cbb\u7642\u8207\u6557\u8840\u75c7\u81f4\u75c5\u539f\u7684\u914d\u5c0d ,\u4e0b\u5217\u54ea\u4e9b\u7d44\u5408\u662f\u6b63\u78ba\u7684 \uff1f\n(1) Ceftriaxone - Neisseria meningitidis \n(2) Penicillin - Group A Streptococcus \n(3) Clindamycin - Rickettsia \n(4) Ceftazidime- Enterococcus   \nA.(1)+(2)\nB.(2)+(3)\nC.(1)+(3)\nD.(2)+(4)\nE.(1)+(4)\n": "[A]", "109-114.\u6709\u4e00\u4f4d30\u6b72\u5b55\u5a66 \uff0c\u60f3\u4f86\u9580\u8a3a\u65bd\u6253\u75ab\u82d7\u9810\u9632\u611f\u67d3 \uff0c\u4e0b\u5217\u90a3\u4e9b\u75ab\u82d7\u662f\u5b55\u5a66\u4e0d\u5efa\u8b70\u6ce8\u5c04\u7684 \uff1f\n(1) Influenza vaccine \u6d41\u611f\u75ab\u82d7\n(2) MMR vaccine (Measles \u2013 Mump \u2013 Rubella vaccine) \u9ebb\u75b9 -\u816e\u817a\u708e-\u5fb7\u570b\u9ebb\u75b9\u75ab\u82d7\n(3) Varicella vaccine \u6c34\u75d8\u75ab\u82d7\n(4) Pneumococcal vaccine \u80ba\u708e\u93c8\u7403\u83cc\u75ab\u82d7   \nA.(1)+(3)\nB.(2)+(3)\nC.(1)+(4)\nD.(1)+(2)+(3)\nE.(2)+(3)+(4)\n": "[B]", "109-115.\u4e0b\u5217\u6709\u95dc\u793e\u5340\u6027\u80ba\u708e\u81f4\u75c5\u539f\u8207\u76f8\u95dc\u5bbf\u4e3b\u56e0\u7d20\u7684\u914d\u5c0d\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f    \nA.Streptococcus pneumoniae -\u9152\u766e (alcoholism)\nB.Klebsiella pneumoniae \u2013\u7cd6\u5c3f\u75c5 (diabetes)\nC.Haemophilus influenzae \u2013\u6162\u6027\u963b\u585e\u6027\u80ba\u75c5 (COPD)\nD.Pseudomonas aeruginosa \u2013\u652f\u6c23\u7ba1\u64f4\u5f35(bronchiectasis)\nE.Coxiella burnetii \u2013\u8207\u9ce5\u985e\u63a5\u89f8   \n": "[E]", "109-116.\u6709\u95dc2019\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u75c7(COVID-19)\u4e4b\u6558\u8ff0\uff0c\u4f55\u8005\u70ba\u975e\uff1f    \nA.COVID-19\u50b3\u67d3\u9014\u5f91\u4e3b\u8981\u70ba\u8fd1\u8ddd\u96e2\u98db\u6cab\u50b3\u67d3\u6216\u63a5\u89f8\u50b3\u67d3\nB.\u5178\u578b\u75c7\u72c0\u70ba\u767c\u71d2\u3001\u4e7e\u54b3\u3001\u5026\u6020\uff0c\u7d04\u6709\u4e09\u5206\u4e4b\u4e00\u6703\u547c\u5438\u6025\u4fc3\nC.\u76ee\u524d\u8a3a\u65b7COVID-19\u4ee5\u5206\u5b50\u6838\u9178RT-PCR\u70ba\u6025\u6027\u671f\u6aa2\u9a57\u9996\u9078\nD.70%\u9152\u7cbe\u4e7e\u6d17\u624b\u6db2\u53ef\u4ee5\u6709\u6548\u6bba\u6b7b\u51a0\u72c0\u75c5\u6bd2\nE.\u5168\u7403COVID-19 \u611f\u67d3\u7684\u6b7b\u4ea1\u7387\u7d04\u70ba0.5%~1%\n": "[E]", "109-117.\u4e00\u4f4d34\u6b72\u9577\u671f\u4f7f\u7528\u975c\u8108\u6ce8\u5c04\u6d77\u6d1b\u82f1\u7684\u7537\u6027 \uff0c\u56e0\u767c\u71d2\u3001\u5598\u3001\u547c\u5438\u56f0\u96e3\u4e00\u9031\u4f86\u6025\u8a3a\u5c31\u8a3a \uff0c\u8eab\u9ad4\u8a3a\u5bdf\u6709\u767c\u73fe\u6536\u7e2e\n\u671f\u5fc3\u96dc\u97f3 \uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u975e \uff1f\n (1) \u611f\u67d3\u539f\u6700\u5e38\u898b\u70ba\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc (Staphylococcus aureus )\n (2) \u6b64S. aureus \u6975\u5c11\u70bamethicillin\u6297\u85e5 (MRSA)\u6027\u83cc\u682a\n (3) \u6b64\u53f3\u5fc3\u5fc3\u5167\u819c\u708e \uff0c\u4ee5\u4e09\u5c16\u74e3 (tricuspid valve )\u70ba\u4e3b\u8981\u4fb5\u72af\u4f4d\u7f6e\n (4) \u76f8\u5c0d\u65bc\u975e\u975c\u8108\u85e5\u766e\u5fc3\u5167\u819c\u708e \uff0c\u6b64\u75c5\u4eba\u81f4\u75c5\u539f\u66f4\u5e38\u6709\u7da0\u81bf\u687f\u83cc (Pseudomonas aeruginosa )\u6216\u5ff5\u73e0\n\u83cc(Candida)\u611f\u67d3\u7684\u6a5f\u6703\n (5) \u82e5\u70baHIV\u611f\u67d3\u8005 \uff0c\u81f4\u75c5\u539f\u51fa\u73feHACEK group\u7684\u6a5f\u6703\u8f03\u9ad8   \nA.(1)+(2)+(3)\nB.(1)+(3)+(5)\nC.(4)+(5)\nD.(2)+(5)\nE.(1)+(2)+(3)+(4)+(5)\n": "[D]", "109-118.\u4e00\u4f4d50\u6b72\u4f4f\u9662\u63a5\u53d7\u5316\u5b78\u6cbb\u7642\u75c5\u60a3 \uff0c\u56e0\u4e2d\u6027\u7403\u4f4e\u4e0b\u767c\u71d2\u4f7f\u7528\u6297\u751f\u7d20 \uff0c\u6cbb\u7642\u671f\u9593\u767c\u751f\u8179\u7009 \uff0c\u81e8\u5e8a\u91ab\u5e2b\u61f7\u7591\u70ba\u56f0\n\u96e3\u68ad\u72c0\u687f\u83cc (Clostridium difficile )\u8178\u708e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u70ba\u975e \uff1f   \nA.\u81e8\u5e8a\u4e0a\u8a3a\u65b7\u611f\u67d3\u6027\u8179\u7009\uff0c\u9700\u5305\u62ec\u9023\u7e8c2 \u5929\u4ee5\u4e0a\u6bcf\u5929\u67093\u6b21\u4e0d\u6210\u5f62\u7cde\u4fbf\nB.\u53ef\u4ee5\u7528\u6838\u9178\u6aa2\u5b9atoxin A \u6216toxin B\u4f86\u78ba\u8a8d\u611f\u67d3\nC.\u8a3a\u65b7\u9700\u4f9d\u8cf4\u5167\u8996\u93e1\u6aa2\u67e5\u53ca\u7cde\u4fbf\u57f9\u990a\nD.\u5224\u5b9a\u6cbb\u7642\u662f\u5426\u5931\u6557\uff0c\u61c9\u81f3\u5c11\u4f7f\u75286\u5929\u85e5\u7269\u6aa2\u8996\u6cbb\u7642\u6548\u679c\u6c7a\u5b9a\nE.\u5c0d\u8f03\u56b4\u91cd\u611f\u67d3\u75c5\u60a3\uff0c\u5982\u8840\u6db2\u767d\u8840\u7403\u6578>15000/\u03bcL\uff0c\u9996\u9078\u4f7f\u7528\u53e3\u670dVancomycin\n": "[C]", "109-119.\u4e0b\u5217\u6709\u95dc\u816b\u7624\u8207\u611f\u67d3\u81f4\u75c5\u539f\u7684\u914d\u5c0d\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f    \nA.\u5b50\u5bae\u9838\u764c-\u4eba\u985e\u4e73\u7a81\u75c5\u6bd2(HPV)\nB.\u5361\u6ce2\u897f\u6c0f\u7624(Kaposi\u2019s sarcoma) \u2013\u4eba\u985e\u7b2c8\u578b\u76b0\u75b9\u75c5\u6bd2(HHV-8)\nC.T\u7d30\u80de\u8840\u764c(T-cell leukemia) \u2013 HTLV-1\nD.\u809d\u7d30\u80de\u764c- B\u578b\u809d\u708e(HBV)\nE.\u809b\u9580\u9c57\u72c0\u4e0a\u76ae\u764c(squamous cell carcinoma) \u2013\u611b\u6ecb\u75c5\u6bd2(HIV)   \n": "[E]", "110-81.\u6709\u95dcCOVID -19\u7684\u6cbb\u7642 \uff0c\u4ee5\u4e0b\u4f55\u8005\u6b63\u78ba \uff0c\u8acb\u9078\u51fa\u6700\u9069\u7576\u7684\u7b54\u6848\n(1)\u55ae\u7368\u4f7f\u7528\u6297\u75c5\u6bd2\u85e5Remdesivir\u5c0d\u75be\u75c5\u8f15 \u3001\u91cd\u75c7\u60a3\u8005\u4e4b\u9810\u5f8c\u90fd\u6709\u6975\u70ba\u986f\u8457\u4e4b\u6548\u679c \u3002\n(2)\u55ae\u682a\u6297\u9ad4Bamlanivimab + Etesevimab\u4e3b\u8981\u4f5c\u7528\u65bc\u75c5\u6bd2spike glycoprotein \uff0c\u5c0d\u65bc\u75be\u75c5\u8f15\u5fae\u6216\u4e2d\u5ea6\u800c\u6709\u91cd\n\u75c7\u5371\u96aa\u56e0\u7d20\u5982\u5e74\u7d00 \u226565\u6b72\u3001\u80a5\u80d6(BMI \u226535)\uff0c\u6709\u6162\u6027\u814e\u75c5 \u3001\u6162\u6027\u80ba\u75c5 \u3001\u5fc3\u8840\u7ba1\u75be\u75c5 \u3001\u9ad8\u8840\u58d3\u3001\u7cd6\u5c3f\u75c5\u3001\u514d\u75ab\n\u6291\u5236\u60a3\u8005 \uff0c\u65bc\u767c\u75c5\u8a3a\u65b7 3\u5929\u5167\u4f7f\u7528 \uff0c\u53ef\u964d\u4f4e\u4f4f\u9662\u548c\u6b7b\u4ea1\u4e4b\u98a8\u96aa \u3002\n(3)\u55ae\u682a\u6297\u9ad4Bamlanivimab + Etesevimab\u5c0d\u5357\u975e\u8b8a\u7570\u682a (B.1.351, \u03b2)\u548c\u5df4\u897f\u8b8a\u7570\u682a (P.1, \u03b3)\u5728\u9ad4\u5916\u4e2d\u548c\u8a66\u9a57\n\u6548\u679c\u8b8a\u5dee \uff0c\u800c\u55ae\u682a\u6297\u9ad4Casirivimab + Imdevimab\u5247\u5c0d\u524d\u8ff0\u75c5\u6bd2\u8b8a\u7570\u682a\u4e4b\u9ad4\u5916\u4e2d\u548c\u8a66\u9a57\u6548\u679c\u672a\u6539\u8b8a \u3002\n(4)IL-6 receptor blocker \u5982Tocilizumab\u5efa\u8b70\u8207dexamethasone\u5408\u4f75\u4f7f\u7528\u65bc\u56b4\u91cd\u80ba\u708e \u3002\n(5)JAK\u6291\u5236\u5291Baricitinib \uff0c\u4e0d\u53ef\u8207dexamethasone\u5408\u4f75\u4f7f\u7528 \u3002   \nA.(1)+(2)+(3)\u3002\nB.(2)+(3)+(4)\u3002\nC.(1)+(2)+(4)\u3002\nD.(2)+(3)+(5)\u3002\nE.(2)+(4)\u3002\n": "[B]", "110-82.\u63a5\u7a2e\u817a\u75c5\u6bd2\u8f09\u9ad4SARS -COV-2\u75ab\u82d7\u5076\u767c\u8840\u6813\u6027\u8840\u5c0f\u677f\u4f4e\u4e0b (thrombotic thrombocytopenia )\uff0c\u4ee5\u4e0b\u63cf\u8ff0\u4f55\u8005\n\u932f\u8aa4?   \nA.\u5927\u591a\u767c\u751f\u65bc\u63a5\u7a2e\u75ab\u82d7\u5f8c5\u81f330\u5929\u3002\nB.\u5e38\u898b\u8166\u975c\u8108\u8840\u6813\u3001\u8179\u8154\u5167\u975c\u8108\u8840\u6813\u6216\u80ba\u6813\u585e\u3002\nC.\u8868\u73fe\u8207heparin-induced thrombocytopenia\u5f88\u50cf\uff0c\u8207\u75c5\u4eba\u6700\u8fd1\u6709\u4f7f\u7528heparin\u6709\u95dc\u3002\nD.\u75c5\u4eba\u8840\u6e05\u4e2d\u53ef\u6e2c\u5230\u5c0d\u6297\u8840\u5c0f\u677f\u7b2c 4\u56e0\u5b50(platelet factor 4)\u7684\u8840\u5c0f\u677f\u6d3b\u5316\u6297\u9ad4 \uff0c\u8a72\u6297\u9ad4\u53ef\u7d93\u7531\u8207\u8840\u5c0f\n\u677fFc\u03b3\u63a5\u53d7\u5668\u800c\u6d3b\u5316\u8840\u5c0f\u677f \u3002\nE.\u6cbb\u7642\u5efa\u8b70\u4ee5nonheparin\u6297\u51dd\u8840\u5291\u6216IVIG\u3002\n": "[C]", "110-83.\u4e00\u4f4d58\u6b72\u7537\u6027\u56e0\u70ba\u9ad6\u9aa8\u9aa8\u6298\u63a5\u53d7\u624b\u8853 \uff0c\u624b\u8853\u5f8c\u767c\u751fMRSA\u611f\u67d3 \uff0c\u65bc\u4f4f\u9662\u5f8c\u63a5\u53d7\u6e05\u5275\u624b\u8853\u53cavancomycin \u6ce8\n\u5c04\uff0c\u6cbb\u7642\u4e09\u9031\u9032\u6b65\u5f8c\u51fa\u9662 \u3002\u51fa\u9662\u6642\u4f7f\u7528\u53e3\u670dlinezolid\u6cbb\u7642 \uff0c\u8acb\u554f\u5728\u9580\u8a3a\u8ffd\u8e64\u4e0b\u5217\u54ea\u4e00\u9805\u8f03\u4e0d\u91cd\u8981 ?   \nA.Linezolid\u4e0d\u53ef\u8207\u55ae\u80fa\u6c27\u5316\u9176\u6291\u5236\u5291 (monoamine oxidase inhibitor )\u6216selective serotonin re -uptake \ninhibitor\u5171\u540c\u4f7f\u7528 \u3002\nB.\u8981\u6ce8\u610f\u662f\u5426\u6709\u4e73\u9178\u4e2d\u6bd2\u73fe\u8c61\u3002\nC.\u6703\u9020\u6210QTc prolongation\u3002\nD.\u4f7f\u7528\u8d85\u904e2\u9031\u6709\u9aa8\u9ad3\u6291\u5236\u98a8\u96aa\u3002\nE.\u4f7f\u7528\u8d85\u904e4\u9031\u6709\u8996\u795e\u7d93\u548c\u5468\u908a\u795e\u7d93\u75c5\u8b8a\u4e4b\u98a8\u96aa\u3002\n": "[C]", "110-84.\u4e00\u4f4d35\u6b72\u7537\u6027\u5230\u6025\u8a3a\u5c31\u91ab \uff0c\u4e3b\u8a34\u8179\u90e8\u4e0d\u9069 \u3001\u5614\u5410\u548c\u7a00\u5927\u4fbf 5\u5929\uff0c\u767c\u71d2\u4e5f\u8d8a\u4f86\u8d8a\u56b4\u91cd \uff0c\u4e5f\u6709\u982d\u75db\u548c\u76ae\u819a\n\u75b9\u3002\u8eab\u9ad4\u8a3a\u5bdf\u9ad4\u6eab40\u00b0C \uff0c\u8840\u58d3100/70mmHg \uff0c\u5fc3\u640f62/\u5206\uff0c\u5438\u547c20/\u5206\uff0cBMI 26\uff0c\u660e\u986f\u751f\u75c5\u6a23 \u3002\u5728\u4e0b\u80f8\u548c\n\u4e0a\u8179\u90e8\u6709\u8b8a\u6de1\u7684\u7d05\u6591\u75b9 \uff0c\u4ed6\u7684\u978f\u819c\u8b8a\u9ec3 \uff0c\u7d50\u819c\u5145\u8840 \uff0c\u54bd\u90e8\u8f03\u7d05 \uff0c\u800c\u89f8\u8a3a\u6709\u809d\u813e\u816b\u5927\u548c\u58d3\u75db \u3002CBC\u8840\u8272\n\u7d2012 gm/dl\uff0c\u767d\u8840\u74034500 /cumm\uff0c\u591a\u5f62\u6838\u767d\u8840\u740368 %\uff0cband form 10 %\uff0c\u6dcb\u5df4\u740316 %\uff0c\u55ae\u6838\u74036%\uff0c\u8840\u5c0f\n\u677f90000/cumm\uff0cAST 120 u/L\uff0cALT 240 u/L\uff0c\u4e8c\u5957\u8840\u6db2\u57f9\u990a\u70ba\u683c\u862d\u6c0f\u9670\u6027\u83cc \u3002\u6700\u53ef\u80fd\u7684\u8a3a\u65b7\u53ca\u5176\u6cbb\u7642 ?   \nA.\u920e\u7aef\u87ba\u65cb\u9ad4\u611f\u67d3\uff0cciprofloxacin\u3002\nB.\u50b7\u5bd2\uff0cceftriaxone\u3002\nC.\u9000\u4f0d\u8ecd\u4eba\u75c5\uff0cciprofloxacin\u3002\nD.\u674e\u65af\u7279\u83cc\u611f\u67d3\uff0campicillin\u3002\nE.\u5e03\u6c0f\u687f\u83cc\u75c5 (brucellosis)\uff0cdoxycycline\u3002\n": "[B]", "110-85.\u88ab\u52d5\u7269\u54ac\u50b7\u6642\u6709\u6240\u805e,\u7576\u75c5\u60a3\u88ab\u54ac\u50b7\u5f8c\u5230\u91ab\u9662\u5c31\u91ab,\u4f60\u9664\u4e86\u8655\u7406\u50b7\u53e3\u5916,\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u4e0d\u6b63\u78ba?       \nA.\u72d7\u54ac\u548c\u8c93\u54ac\u7684\u81f4\u75c5\u83cc\u5305\u62ec\u91d1\u9ec3\u8272\u8461\u8404\u7403\u83cc\u3001\u5df4\u58eb\u5fb7\u687f\u83cc(Pasteurella multocida)\u548c\u53ad\u6c27\u83cc\u3002\nB.\u512a\u5148\u8003\u616e\u7684\u6297\u751f\u7d20\u662famoxicillin/clavulanate \u6216ampicillin/sulbactam\u3002\nC.\u5982\u75c5\u4eba\u6709penicillin\u904e\u654f\u53f2,\u53ef\u7528clindamycin + trimethoprim-sulfamethoxazole\u6216 fluoroquinolone\u3002\nD.\u9700\u8003\u616e\u72c2\u72ac\u75c5\u9810\u9632\u3002\nE.\u88ab\u7334\u5b50\u54ac\u50b7\u4e5f\u662f\u9078\u64c7amoxicillin/clavulanate\u6cbb\u7642, \u7121\u9700\u8003\u616e\u6297\u75c5\u6bd2\u85e5\u7684\u4f7f\u7528\u3002\n": "[E]", "110-86.\u75c5\u53f2\u8a62\u554f\u53ef\u63d0\u4f9b\u6557\u8840\u75c7\u75c5\u539f\u91cd\u8981\u7dda\u7d22, \u4ee5\u4e0b\u54ea\u4e9b\u72c0\u6cc1\u8981\u60f3\u5230\u9264\u7aef\u87ba\u65cb\u9ad4\u75c5\u4e4b\u98a8\u96aa ?\n(1)\u6d2a\u6c34\u6c3e\u6feb\u5f8c\n(2)\u5728\u6eaa\u6d41\u6cb3\u5ddd\u6d3b\u52d5\n(3)\u5eda\u5e2b\n(4)\u5f9e\u4e8b\u8fb2\u7530 \u3001\u7378\u91ab\u6216\u755c\u7267\u5de5\u4f5c\n(5)\u5230\u4e09\u6eab\u6696\u6ce1\u8db3\u90e8\u6eab\u6cc9   \nA.(1)+(2)+(4)\u3002\nB.(3)+(4)+(5)\u3002\nC.(1)+(3)+(4)\u3002\nD.(1)+(2)+(3)+(4)\u3002\nE.(1)+(2)+(3)+(4)+(5)\u3002\n": "[D]", "110-87.\u8003\u91cf\u6297\u751f\u7d20\u7684\u7279\u6027\u53ca\u6297\u85e5\u6027\u554f\u984c, \u5728\u53f0\u7063\u76ee\u524d\u7d93\u9a57\u6027\u6297\u751f\u7d20\u5728\u4e0b\u5217\u54ea\u4e9b\u60c5\u6cc1\u4e0d\u5efa\u8b70\u4ee5 fluoroquinolone \u7576\u4f5c\n\u7b2c\u4e00\u7dda\u6cbb\u7642 ?(1)\u6025\u6027\u5316\u81bf\u6027\u6241\u6843\u708e (2)\u6025\u6027\u8180\u80f1\u708e (3)\u8db3\u766c\u5408\u4f75\u4e0b\u80a2\u8702\u7aa9\u7d44\u7e54\u708e (4)\u6025\u6027\u8166\u819c\u708e (5)\u6025\u6027\u8179\u7009   \nA.(1)+(4)+(5)\u3002\nB.(1)+(2)+(5)\u3002\nC.(2)+(3)+(5)\u3002\nD.(1)+(2)+(3)+(4)+(5)\u3002\nE.(1)+(2)+(3)+(4)\u3002\n": "[D]", "110-88.\u6709\u4e00\u4f4d23\u6b72\u7537\u6027\u56e0\u9ad8\u71d2\u4e0d\u9000\u4e00\u9031\u800c\u4f86\u4f4f\u9662, \u4ed6\u65bc\u4e09\u9031\u524d\u5168\u8eab\u9577\u6eff\u6c34\u75d8, \u65bc\u4e8c\u9031\u524d\u6c34\u75d8\u5df2\u6f38\u7d50\u75c2 \u3002\u4f4f\u9662\u8eab\u9ad4\n\u8a3a\u5bdf\u9ad4\u6eab40\u00b0C, \u8840\u58d3140 /50mmHg, \u5fc3\u8df3136 /min,\u547c\u543822/min, \u7d50\u819c\u767c\u7d05, \u80f8\u90e8 X\u5149\u6aa2\u67e5\u6c92\u6709\u660e\u986f\u80ba\u6d78\u6f64\u73fe\n\u8c61, CBC\u5448\u73feHgb 12 gm /dL, WBC18000 /cumm, neutrophil 82 %, band form 6%, lymphocyte 10 %, \nmonocyte 2%, \u5c3f\u6db2\u6aa2\u67e5\u5448\u73feRBC10 -20, WBC 5-10, \u86cb\u767d(-), \u4ee5\u4e0b\u54ea\u4e00\u9805\u4e0d\u6b63\u78ba ?   \nA.\u61c9\u884c\u5b8c\u6574\u7684\u8eab\u9ad4\u8a3a\u5bdf\u3002\nB.\u53ef\u80fd\u6703\u6709\u5fc3\u96dc\u97f3\u3002\nC.\u61c9\u884c\u81f3\u5c11\u5169\u5957\u8840\u6db2\u57f9\u990a\u3002\nD.\u61c9\u884c\u5fc3\u81df\u8d85\u97f3\u6ce2\u6aa2\u67e5\u3002\nE.\u75c5\u4eba\u6700\u53ef\u80fd\u6709\u8166\u819c\u708e\u3002\n": "[E]", "110-89.\u4e00\u4f4d65\u6b72\u75c5\u4eba\u4f4f\u9662\u9032\u884c\u81bd\u7d50\u77f3\u624b\u8853\uff0c\u8853\u5f8c3\u5929\u767c\u751f\u9662\u5167\u611f\u67d3\u80ba\u708e\uff0c\u8acb\u554f\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f    \nA.\u9020\u6210\u75c5\u4eba\u767c\u751f\u9662\u5167\u80ba\u708e\u4e3b\u8981\u4f86\u81ea\u65bc\u53e3\u54bd\u55c6\u54b3(oropharyngeal aspiration)\u3002\nB.\u9032\u884c\u4e0a\u8179\u90e8\u624b\u8853(upper abdominal surgery)\u589e\u52a0\u6b64\u75c5\u4eba\u767c\u751f\u9662\u5167\u80ba\u708e\u7684\u98a8\u96aa\u3002\nC.\u6b64\u75c5\u4eba\u70ba\u767c\u751f\u65e9\u767c\u6027\uff08early onset\uff09\u80ba\u708e\uff0c\u81f4\u75c5\u539f\u4e3b\u8981\u70ba\u547c\u5438\u9053\u5e38\u5728\u83cc\uff0c\u5982\u80ba\u708e\u7403\u83cc\u6216\u611f\u5192\u687f\u83cc\u3002\nD.\u82e5\u6b64\u75c5\u4eba\u63d2\u7ba1\u4f7f\u7528\u547c\u5438\u5668 \uff0c\u5728\u57f9\u990a\u672a\u767c\u73fe\u7279\u5b9a\u6297\u85e5\u81f4\u75c5\u539f\u4e14\u75c5\u4eba\u81e8\u5e8a\u6539\u5584 \uff0c\u5efa\u8b70\u6297\u751f\u7d20\u77ed\u671f\u6cbb\n\u7642\uff088\u5929\uff09 \u4ee5\u6e1b\u5c11\u5f8c\u7e8c\u6297\u85e5\u6027\u83cc\u79fb\u751f \u3002\nE.\u8853\u524d\u4f7f\u7528\u9810\u9632\u6027\u6297\u751f\u7d2072\u5c0f\u6642\u53ef\u4ee5\u964d\u4f4e\u624b\u8853\u75c5\u4eba\u767c\u751f\u9662\u5167\u611f\u67d3\u7684\u6a5f\u6703\u3002   \n": "[E]", "110-90.\u6839\u64da\u7f8e\u570b\u75be\u75c5\u7ba1\u5236\u5c40\u7684\u5efa\u8b70 \uff0c\u5c0d\u65bc\u61f7\u5b55\u8005 \uff0c\u5305\u62ec\u9ad8\u98a8\u96aa\u611f\u67d3\u4e4b\u61f7\u5b55\u5a66\u5973 \uff0c\u4e0b\u5217\u4f55\u8005\u662f\u4e0d\u5efa\u8b70\u63a5\u7a2e\u7684\u75ab\u82d7\u7d44\n\u5408\uff1f\u9078\u9805\uff1a(1)B\u578b\u809d\u708e\u75ab\u82d7 \uff08HBV vaccine \uff09(2)\u5e36\u72c0\u76b0\u75b9\u75ab\u82d7 \uff08Varicella -zoster vaccine \uff09(3)\u9ebb\u75b9\u3001\u5fb7\u570b\n\u9ebb\u75b9\u3001\u816e\u817a\u708e\u75ab\u82d7 \uff08MMR vaccine \uff09(4)\u6d41\u611f\u75ab\u82d7 \uff08Influenza \uff09(5)\u767d\u5589\u3001\u767e\u65e5\u54b3\u3001\u7834\u50b7\u98a8\uff08Td/Tdap \nvaccine\uff09   \nA.(1)+(2)\u3002\nB.(2)+(3)\u3002\nC.(3)+(4)\u3002\nD.(4)+(5)\u3002\nE.(3)+(5)\u3002\n": "[B]", "110-91.\u4e00\u4f4d\u63a5\u53d7\u8840\u6db2\u5e79\u7d30\u80de\u79fb\u690d (Hematopoietic Stem Cell Transplantation )\u7684\u75c5\u4eba\uff0c\u5728\u79fb\u690d\u5f8c100\u5929\u767c\u751f\u611f\n\u67d3\uff0c\u8acb\u554f\u5728\u6b64\u6642\u671f\u4e4b\u5e38\u898b\u4e4b\u81f4\u75c5\u539f\u7d44\u5408 \uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u6700\u6b63\u78ba ?(1)Escherichia \ncoli(2)Aspergillus (3)Cytomegalovirus (4)Clostridium difficile (5)Encapsulated \nbacteria(6)Toxoplasma (7)Varicella zoster virus   \nA.(2)+(3)+(6)\u3002\nB.(1)+(3)+(4)+(5)\u3002\nC.(2)+(4)+(5)\u3002\nD.(5)+(6)+(7)\u3002\nE.(1)+(4)+(7)\u3002\n": "[A]", "110-92.\u4e0b\u5217\u6709\u95dc\u65bcHerpesvirus\u7522\u751f\u4e4b\u75be\u75c5\u914d\u5c0d\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576?    \nA.Herpes simplex virus type 1\uff1aHerpangina\u3002\nB.Varicella-zoster virus : Ramsay Hunt syndrome\u3002\nC.Epstein-Barr virus : B cell lymphoma\u3002\nD.Human herpesvirus type 8 : Kaposi\u2019s sarcoma\u3002\nE.Epstein-Barr virus : Oral hairy leukoplakia\u3002\n": "[A]", "110-93.\u4e0b\u5217\u6709\u95dc\u65bc\u6297\u751f\u7d20\u8207\u5176\u4ed6\u85e5\u7269\u7522\u751f\u4e4b\u4ea4\u4e92\u4f5c\u7528\u914d\u5c0d\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576?    \nA.Metronidazole\u4f75\u7528Ethanol\u767c\u751fdisulfiram-like reaction\u3002\nB.Macrolides\u4f75\u7528Fluoroquinolones\u6703\u589e\u52a0\u5fc3\u5f8b\u4e0d\u6574(arrhythmias)\u7684\u98a8\u96aa\u3002\nC.Tetracyclines\u4f75\u7528Warfarin\u6703\u52a0\u5f37Warfarin\u6297\u51dd\u8840\u529f\u80fd\u589e\u52a0\u51fa\u8840\u7684\u98a8\u96aa\u3002\nD.Rifampin\u6703\u52a0\u5f37\u8377\u723e\u8499\u4f5c\u7528\uff0c\u53e3\u670d\u907f\u5b55\u85e5(oral contraceptive)\u61c9\u6e1b\u91cf\u4f7f\u7528\u3002\nE.Linezolid\u6703\u589e\u52a0adrenergic\u5347\u58d3\u85e5\u7684\u4f5c\u7528\uff0c\u767c\u751f\u4e0d\u6613\u63a7\u5236\u7684\u9ad8\u8840\u58d3\u3002\n": "[D]", "110-94.\u6709\u95dc\u65b0\u51a0\u80ba\u708e (Coronavirus disease 2019, COVID-19)\u4e4b\u6558\u8ff0\uff0c\u4e0b\u5217\u4f55\u8005\u6700\u4e0d\u9069\u7576?    \nA.\u81f4\u75c5\u539fSARS-CoV-2\u5c6c\u65bcRNA\u75c5\u6bd2\uff0c\u4eba\u985e\u611f\u67d3\u51a0\u72c0\u75c5\u6bd2\u4ee5\u547c\u5438\u9053\u75c7\u72c0\u70ba\u4e3b\u3002\nB.SARS-CoV-2\u6f5b\u4f0f\u671f\u4e00\u822c\u4ecb\u65bc2\u81f314\u5929\uff0c\u5927\u90e8\u5206\u70ba4\u52305\u5929\u3002\nC.\u81e8\u5e8a\u75c7\u72c0\u767c\u751f\u524d\u6975\u5c11\u5177\u6709\u50b3\u67d3\u6027\uff0c\u5927\u591a\u6578\u611f\u67d3\u8005\u662f\u63a5\u89f8\u5230\u6709\u75c7\u72c0\u8005\u800c\u767c\u751f\u50b3\u67d3\u3002\nD.\u7d04\u67095%\u60a3\u8005\u6703\u767c\u751f\u547c\u5438\u8870\u7aed\u6216\u6557\u8840\u6027\u4f11\u514b\u7b49\u6975\u56b4\u91cd\u611f\u67d3\uff0c\u9700\u52a0\u8b77\u6cbb\u7642\u3002\nE.\u5be6\u9a57\u5ba4\u6aa2\u67e5\u6dcb\u5df4\u7403\u6e1b\u5c11(lymphopenia)\u5408\u4f75D-dimer\u5347\u9ad8\u8207\u6b7b\u4ea1\u7387\u5448\u6b63\u76f8\u95dc\u3002\n": "[C]", "110-95.\u6709\u95dc\u547c\u5438\u5668\u76f8\u95dc\u80ba\u708e\u4e4b\u9810\u9632\u63aa\u65bd\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u975e?    \nA.\u5e8a\u982d\u62ac\u9ad8\uff0c\u4ee5\u6e1b\u5c11\u55c6\u5165\u6a5f\u6703\u3002   \nB.\u5e38\u898f\u5236\u9178\u5291\u4f7f\u7528\uff0c\u589e\u52a0\u80c3pH\u503c\u4ee5\u6e1b\u5c11\u4e0a\u6d88\u5316\u83cc\u53e2\u3002\nC.\u9577\u671f\u63d2\u7ba1\u75c5\u4eba\uff0c\u8a55\u4f30\u93ae\u975c\u5291\u6bcf\u65e5\u4e2d\u65b7\u3002\nD.\u4eba\u54e1\u843d\u5be6\u624b\u90e8\u885b\u751f\u53ca\u7121\u83cc\u64cd\u4f5c\u3002\nE.\u63a7\u5236\u8840\u7cd6\u4ee5\u6539\u5584\u5bbf\u4e3b\u514d\u75ab\u3002\n": "[B]", "110-96.\u4e0b\u5217\u6709\u95dc\u6297\u751f\u7d20\u7684\u4e3b\u8981\u6291\u5236\u6a5f\u8f49\u914d\u5c0d\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576\uff1f    \nA.Cephalosporin \u2013\u6291\u5236\u7d30\u80de\u58c1\uff08Cell wall\uff09\u5408\u6210\u3002\nB.Clindamycin \u2013\u6291\u5236\u86cb\u767d\u8cea\uff08Protein synthesis\uff09\u5408\u6210\u3002\nC.Macrolide \u2013\u6291\u5236DNA\u5408\u6210\u3002\nD.Sulfonamide \u2013\u6291\u5236\u8449\u9178\uff08Folate\uff09\u5408\u6210\u3002\nE.Rifampin - \u6291\u5236RNA\u5408\u6210\u3002\n": "[C]", "111-81.\u4e00\u4f4d46\u6b72\u7537\u6027\u6709\u767c\u71d2 \u3001\u754f\u5bd2\u3001\u54b3\u55fd\u5e36\u9ec3\u75f0 5\u5929\uff0c\u56e0\u547c\u5438\u56f0\u96e3\u52a0\u5287 1\u5929\u7531\u6025\u8a3a\u6536\u5165\u9662 \u3002\u75c5\u4eba\u5728\u6025\u8a3a\u5ba4\u56e0\u547c\u5438\n\u7a98\u8feb\u800c\u88ab\u63d2\u7ba1\u4e14\u63a5\u4e0a\u547c\u5438\u5668 \uff0c\u6025\u8a3a\u5df2\u62bd\u4e8c\u5957\u8840\u6db2\u57f9\u990a \uff0c\u4f7f\u7528\u7d93\u9a57\u6027\u6297\u751f\u7d20\u6cbb\u7642 \u3002\u5165\u9662\u9ad4\u6eab39 \u2103\uff0c\u8840\n\u58d386/50 mmHg \uff0c\u5fc3\u640f132/min\uff0c\u547c\u543828/min\uff0cBMI 28.5\uff0c\u807d\u8a3a\u5728\u5de6\u53f3\u5169\u5074\u4e0b\u80ba\u53ef\u807d\u5230\u652f\u6c23\u7ba1\u97f3 \u3002\u5be6\u9a57\u5ba4\n\u6aa2\u67e5\u8840\u7d05\u7d2011 g/dL\uff0c\u767d\u8840\u74034200 /cumm\uff0c\u8840\u5c0f\u677f95000 /cumm\uff0c\u80f8\u90e8X\u5149\u6aa2\u67e5\u5448\u73fe\u4e8c\u5074\u4e0b\u80ba\u548c\u5de6\u80ba\u4e2d\u8449\u6709\n\u5be6\u8cea\u5316\u73fe\u8c61 \u3002\u9664\u4e86\u6c23\u7ba1\u5167\u62bd\u5438\u75f0\u6db2\u9001Gram stain\u548c\u57f9\u990a\u5916 \uff0c\u6b64\u6642\u4e0b\u5217\u90a3\u4e00\u9805\u6aa2\u67e5\u662f\u6700\u5408\u9069\u8981\u518d\u505a\u7684 \uff1f   \nA.\u652f\u6c23\u7ba1\u93e1\u6aa2\u67e5\u53ca\u5b9a\u91cf\u7d30\u83cc\u57f9\u990a\u3002\nB.Legionella \u548cpneumococcus\u5c3f\u6297\u539f\u3002\nC.Legionella\u8840\u6e05\u6297\u9ad4\u3002   \nD.\u80ba\u5207\u7247\u6aa2\u67e5\u3002\nE.\u4e0d\u9700\u8981\u518d\u6aa2\u67e5\u3002\n": "[B]", "111-82.\u6211\u570b2022 \u5e745\u6708\u958b\u59cb\u9762\u5c0d\u5927\u91cfCOVID -19\u793e\u5340\u611f\u67d3\u8005 \uff0c\u9632\u6cbb\u7b56\u7565\u6f38\u6b21\u9032\u5165\u8207\u75c5\u6bd2\u5171\u5b58\u7684\u968e\u6bb5 \uff0c\u6b64\u6642\u6709\n\u95dcCOVID-19\u7684\u6cbb\u7642 \uff0c\u4e0b\u5217\u4f55\u8005\u6b63\u78ba \uff0c\u8acb\u9078\u51fa\u6700\u9069\u7576\u7684\u7b54\u6848\n(1)Remdesivir \u662fRNA-dependent RNA polymerase\u6291\u5236\u5291 \uff0c\u5c0d\u75be\u75c5\u8f15 \u3001\u91cd\u75c7\u60a3\u8005\u55ae\u7368\u4f7f\u7528\u4e4b\u9810\u5f8c\u7686\u6709\u986f\n\u8457\u4e4b\u6548\u679c \u3002\n(2)Nirmatrelvir /ritonavir (Paxlovid )\u80fd\u963b\u6b62\u75c5\u6bd2\u86cb\u767d\u9176\u8907\u88fd \uff0critonavir\u662fcytochrome P450 3 A4 (CYP3A4)\u7684\n\u5f37\u6291\u5236\u5291 \uff0c\u53ef\u6e1b\u7de9Nirmatrelvir\u88ab\u809d\u81dfcytochrome P450\u5206\u89e3\u4ee3\u8b1d\u7684\u901f\u5ea6 \uff0c\u800c\u589e\u5f37\u5176\u6548\u679c \u3002\n(3)Molnupiravir\u5247\u85c9\u7531\u5176\u6210\u4efd\u7684\u6838\u82f7\u985e\u4f3c\u7269 \uff0c\u8b93\u75c5\u6bd2\u7684\u8907\u88fd\u9176\u5728RNA\u8907\u88fd\u6642\u7522\u751f\u6709\u7f3a\u9677\u7684RNA \uff0c\u56e0\u6709\u57fa\u56e0\n\u7a81\u8b8a\u7b49\u8003\u91cf \uff0c\u4e0d\u5efa\u8b70\u4f7f\u7528\u65bc\u5b55\u5a66 \u3002\n(4)Paxlovid \u548cMolnupiravir\u4e3b\u8981\u65bcCOVID -19\u767c\u75c5\u65e9\u671f \uff0c\u75c7\u72c0\u8f15\u5fae\u4f46\u6709\u767c\u751f\u91cd\u75c7\u6216\u6b7b\u4ea1\u4e4b\u9ad8\u98a8\u96aa\u8005 \u3002\n(5)Paxlovid\u6709\u5f88\u591a\u85e5\u7269\u4ea4\u4e92\u4f5c\u7528\u53ca\u7981\u5fcc\u75c7 \uff0c\u60df\u814e\u529f\u80fd\u53ea\u8981eGFR >30\u5c31\u4e0d\u9700\u8abf\u6574\u5291\u91cf \u3002   \nA.(1)+(2)+(3)\u3002\nB.(1)+(2)+(3)+(4)\u3002\nC.(2)+(3)+(4)\u3002\nD.(2)+(3)+(4)+(5)\u3002\nE.(1)+(2)+(3)+(4)+(5)\u3002\n": "[C]", "111-83.\u4e00\u4f4d51\u6b72\u5973\u6027\u65bc 3\u5929\u524d\u56e0\u5641\u5fc3 \u3001\u5614\u5410\u3001\u53f3\u5074\u8170\u808b\u75bc\u75db\u548c\u9ad8\u71d2\u4f4f\u9662 \uff0c\u5728\u6025\u6027\u814e\u76c2\u814e\u708e\u7684\u8a3a\u65b7\u4e0b\u5165\u9662\u5373\u958b\u59cb\u63a5\n\u53d7Ceftriaxone\u6cbb\u7642 \u3002\u56e0\u70ba\u75c5\u4eba\u9ad8\u71d272\u5c0f\u6642\u4e0d\u9000 \uff0c\u4f60\u503c\u73ed\u88ab\u547c\u53eb\u53bb\u770b\u75c5\u4eba \uff0c\u6b64\u6642\u75c5\u4eba\u8eab\u9ad4\u8a3a\u5bdf\u9ad4\n\u6eab39\u2103\uff0c\u8840\u58d3106/60 mmHg \uff0c\u8108\u640f110/min\uff0c\u547c\u543818/min\uff0cBMI 27\uff0c\u53f3\u5074\u808b\u810a\u89d2\u58d3\u75db \u3002\u5165\u9662\u6642\u5c3f\u6db2\u57f9\u990a\n\u767c\u73fe\u5927\u65bc10 \u2075\u83cc\u843d/mL\u7684E. coli\u4e14\u5c0dceftriaxone\u6709\u654f\u611f\u6027 \uff0c\u8840\u6db2\u57f9\u990a\u9670\u6027 \u3002\u8acb\u554f\u4e0b\u5217\u90a3\u4e00\u9805\u662f\u6700\u9069\u7576\u7684\u8655\n\u7f6e\uff1f   \nA.\u814e\u81df\u96fb\u8166\u65b7\u5c64\u651d\u5f71\u6aa2\u67e5\u3002\nB.\u5c3f\u6db2\u57f9\u990a\u3002\nC.\u6297\u751f\u7d20\u6539\u70bagentamicin\u3002\nD.\u6297\u751f\u7d20\u6539\u70baamoxicillin/clavulanate\u3002\nE.\u7d66\u9000\u71d2\u85e5\uff0c\u89c0\u5bdf\u5373\u53ef\u3002\n": "[A]", "111-84.\u4e00\u4f4d50\u6b72\u7537\u6027\u56e0\u70ba\u80ba\u7d50\u6838\u75c5\u5df2\u7d93\u63a5\u53d7\u4e8c\u500b\u6708\u7684\u6297\u7d50\u6838\u6cbb\u7642 \uff0c\u4ed6\u4f7f\u7528\u7684\u85e5\u7269\u5305\n\u62ecrifampin\uff0cisoniazid \u548cethambutol \uff0c\u958b\u59cb\u6642\u5c31\u56e0\u75db\u98a8\u767c\u4f5c\u800c\u672a\u4f7f\u7528pyrazinamide \uff0c\u75f0\u6db2\u7d50\u6838\u83cc\u5206\u96e2\u682a\u5c0d\n\u7b2c\u4e00\u7dda\u6297\u7d50\u6838\u85e5\u7269\u90fd\u5177\u654f\u611f\u6027 \u3002\u4ed6\u7684\u904e\u53bb\u75c5\u53f2\u53ea\u6709\u9ad8\u8840\u58d3 \u3001\u6162\u6027\u75db\u98a8\u77f3\u95dc\u7bc0\u708e\u4f75\u53cd\u8986\u6025\u6027\u767c\u4f5c \uff0c\u6709\u4f7f\n\u7528lisinopril\u548callopurinol \u3002\u4f86\u9662\u8eab\u9ad4\u8a3a\u5bdf\u751f\u547d\u5fb5\u8c61\u90fd\u6b63\u5e38 \uff0c\u819d\u548c\u624b\u8173\u4e8c\u5074\u95dc\u7bc0\u6709\u75db\u98a8\u8b8a\u5316 \uff0c\u5728\u624b\u8098\u6709\u75db\u98a8\n\u77f3\u3002\u80f8\u90e8X\u5149\u6aa2\u67e5\u7121\u958b\u6d1e\u75c5\u7076 \uff0c\u6700\u8fd1\u75f0AFB\u662f\u9670\u6027 \u3002\u8acb\u554f\u75c5\u4eba\u8981\u518d\u63a5\u53d7rifampin \u548cisoniazid\u6cbb\u7642\u591a\u4e45 \uff1f   \nA.4\u500b\u6708\u3002\nB.7\u500b\u6708\u3002\nC.10\u500b\u6708\u3002\nD.12\u500b\u6708\u3002\nE.\u53ef\u4ee5\u505c\u85e5\u4e86\u3002   \n": "[B]", "111-85.\u4e00\u4f4d48\u6b72\u7537\u6027\u4e8c\u5929\u524d\u5728\u6d77\u908a\u6d89\u6c34\u8e29\u5230\u9b5a\u9264\u800c\u81f4\u5de6\u8173\u5e95\u53d7\u50b7 \uff0c\u56e0\u767c\u71d2\u53ca\u5de6\u8173 \u3001\u5de6\u8db3\u75bc\u75db\u52a0\u5287\u800c\u7d93\u7531\u6025\u8a3a\u5165\n\u9662\uff0c\u4ed6\u767c\u73fe\u7d05\u816b\u75bc\u75db\u5f80\u4e0a\u64f4\u6563\u81f3\u5de6\u819d \uff0c\u4ed6\u6709C\u578b\u809d\u708e\u4f75\u809d\u786c\u5316 \uff0c\u5e73\u6642\u670d\u7528propranolol\u548c furosemide \u3002\u5165\u9662\n\u8eab\u9ad4\u8a3a\u5bdf\u6eab\u5ea639 .5\u2103\uff0c\u8840\u58d390/60 mmHg \uff0c\u8108\u640f72/min\u547c\u543822 /min\uff0c\u5de6\u8db3\u548c\u5de6\u8173\u81f3\u819d\u90e8\u6709\u6c34\u816b \uff0c\u56b4\u91cd\u58d3\n\u75db\uff0c\u76ae\u819a\u6709\u51fa\u8840\u6027\u6c34\u6ce1 \uff0c\u5468\u908a\u767d\u8840\u740320000 /cumm,\u4e2d\u6027\u740385\uff05\uff0c immature band form 10\uff05\uff0c \u800c\u6dcb\u5df4\n\u74035\uff05\uff0c \u7dca\u6025\u5916\u79d1\u6e05\u5275\u624b\u8853\u986f\u793a\u70ba\u58de\u6b7b\u6027\u808c\u7b4b\u819c\u708e \uff0c\u6e05\u5275\u7d44\u7e54Gram stain \u986f\u793a\u6709\u5f4e\u66f2\u7684\u683c\u862d\u6c0f\u9670\u6027\u83cc \uff0c\u4ee5\n\u4e0b\u54ea\u4e00\u9805\u662f\u6700\u53ef\u80fd\u7684\u81f4\u75c5\u539f ?   \nA.Erysipelothrix rhusiopathiae\u3002\nB.Listeria monocytogenes\u3002\nC.Mycobacterium marinum\u3002\nD.Vibrio vulnificus\u3002\nE.Legionella pneumophila\u3002\n": "[D]", "111-86.\u4e00\u4f4d24\u6b72\u7537\u6027\u5927\u5b78\u751f \uff0c\u5e73\u5e38\u5065\u5eb7 \uff0c\u56e0\u868a\u5b50\u53ee\u54ac\u5f8c \uff0c\u5de6\u8173\u7d05\u816b\u5230\u9580\u8a3a\u4f86 \uff0c\u8eab\u9ad4\u8a3a\u5bdf\u9ad4\u6eab37 .3\u2103 \uff0c\u8840\n\u58d3120/72 mmHg \uff0c\u8108\u640f72/min\uff0c\u547c\u543814/min\uff0c\u5728\u5de6\u8173\u6709 3\u00d75\u516c\u5206\u7d05\u816b \uff0c\u89f8\u6478\u6709\u6eab\u71b1 \uff0c\u4f46\u7121\u5316\u81bf\u73fe\u8c61 \uff0c\u4e5f\u7121\n\u6dcb\u5df4\u7d50\u816b\u75db \u3002\u4e0b\u8ff0\u6700\u5408\u9069\u7684\u6297\u751f\u7d20 :   \nA.moxifloxacin\u3002\nB.ciprofloxacin\u3002\nC.linezolid\u3002\nD.cephalexin\u3002\nE.doxycycline\u3002\n": "[D]", "111-87.\u7334\u75d8 (monkeypox) 2022 \u5e746\u6708\u81f3\u5c11\u572827\u500b\u975e\u6d32\u4ee5\u5916\u570b\u5bb6\u767c\u73fe\u4e26\u901a\u5831\u4e16\u754c\u885b\u751f\u7d44\u7e54 (WHO)\u3002\u4e0b\u5217\u6558\u8ff0 \uff0c\u4f55\n\u9805\u7d44\u5408\u6700\u6b63\u78ba ?\n(1) \u7334\u75d8\u7531DNA\u75c5\u6bd2\u9020\u6210 \uff0c\u75c7\u72c0\u8207\u5929\u82b1\u985e\u4f3c \uff0c\u904e\u53bb\u4e3b\u8981\u767c\u73fe\u65bc\u9130\u8fd1\u71b1\u5e36\u96e8\u6797\u7684\u4e2d\u975e\u548c\u897f\u975e\u570b\u5bb6 \u3002\u5929\u82b1\u75ab\u82d7\n\u5c0d\u7334\u75d8\u670985 %\u4fdd\u8b77\u529b\u3002\n(2) \u50b3\u64ad\u4e3b\u8981\u662f\u900f\u904e\u5bc6\u5207\u63a5\u89f8\u5230\u547c\u5438\u5206\u6ccc\u7269\u611f\u67d3\u7684\u76ae\u819a\u75c5\u7076\u6216\u6c59\u67d3\u7684\u7269\u9ad4 \u3002\u6f5b\u4f0f\u671f\u53ef\u5f9e 5\u81f321\u5929\uff0c\u4f46\u5927\n\u591a6\u81f313\u5929\u3002\n(3) \u75c7\u72c0\u5982\u767c\u71d2 \u3001\u982d\u75db\u3001\u808c\u8089\u816b\u8139\u548c\u9178\u75db \u3001\u865b\u812b\uff0c\u4e00\u822c\u5148\u5f9e\u81c9\u90e8\u51fa\u75b9 \uff0c\u518d\u9010\u6f38\u64f4\u6563\u5230\u624b \u3001\u8db3\u7b49\u8eab\u9ad4\u5176\u4ed6\u90e8\n\u4f4d\u3002\u76ae\u75b9\u5f9e\u6591\u4e18\u75b9 \u3001\u5c0f\u6c34\u76b0\u8f49\u8b8a\u70ba\u81bf\u76b0 \uff0c\u7d0410\u5929\u5f8c\u7d50\u75c2 \uff0c2\u81f33\u9031\u6d88\u5931\u3002\n(4) \u7334\u75d8\u662f\u4eba\u755c\u5171\u901a\u50b3\u67d3\u75c5 \uff0c\u60df\u8fd1\u671f\u5f88\u591a\u65b0\u589e\u500b\u6848\u662f\u7d93\u6027\u884c\u70ba\u50b3\u64ad \uff0c\u5728\u6703\u9670\u90e8\u75c5\u7076\u5e38\u9700\u8207\u6885\u6bd2 \u3001\u8edf\u6027\u4e0b\u75b3\n\u548c\u5e36\u72c0\u6ce1\u75b9\u9451\u5225 \u3002\n(5) \u7334\u75d8\u75c5\u4eba\u5728\u7167\u8b77\u4e0a \uff0c\u53f0\u7063CDC\u5efa\u8b70\u6536\u6cbb\u65bc\u5177\u7368\u7acb\u885b\u6d74\u4e4b\u55ae\u4eba\u75c5\u623f \u3002\u5728\u9032\u884c\u6703\u5f15\u8d77\u6c23\u6eb6\u81a0\u7684\u91ab\u7642\u8655\n\u7f6e(aerosal generating procedues )\u9700\u6709\u7a7a\u6c23\u50b3\u67d3\u9632\u8b77\u63aa\u65bd (airborne precaution )\uff0c\u4e14\u8981\u7a7f\u6234\u9069\u7576\u9632\u8b77\u88dd\n\u5099\u3002   \nA.(1)+(2)+(3)+(5)\u3002\nB.(1)+(2)+(3)\u3002\nC.(1)+(2)+(4)\u3002\nD.(1)+(2)+(3)+(4)+(5)\u3002\nE.(1)+(3)+(4)+(5)\u3002\n": "[D]", "111-88.\u63a8\u5ee3\u9152\u7cbe\u4e7e\u6d17\u624b\u53ef\u4ee5\u5927\u5927\u964d\u4f4e\u9662\u5167\u611f\u67d3\u7684\u767c\u751f\uff0c\u4ee5\u4e0b\u6558\u8ff0\u4f55\u8005\u6b63\u78ba\uff1f    \nA.\u9152\u7cbe\u4e7e\u6d17\u624b\u6bcf\u6b21\u4f7f\u7528\u9152\u7cbe\u91cf1\u6beb\u5347\u5373\u53ef\u3002\nB.\u9152\u7cbe\u4e7e\u6d17\u624b\u53ef\u6e05\u9664\u5bc4\u751f\u87f2\u87f2\u5375\u3002\nC.\u9152\u7cbe\u4e7e\u6d17\u624b\u53ef\u6e05\u9664\u8178\u75c5\u6bd2\u3001\u8afe\u7f85\u75c5\u6bd2\u3002\nD.\u9152\u7cbe\u4e7e\u6d17\u624b\u53ef\u6e05\u9664\u6d41\u611f\u75c5\u6bd2\u3001\u65b0\u51a0\u75c5\u6bd2\u3002   \nE.\u4ee5\u4e0a\u7686\u6b63\u78ba\u3002\n": "[D]", "111-89.\u5728\u53f0\u7063\u8840\u7cd6\u63a7\u5236\u4e0d\u826f\u7684\u60a3\u8005\u4e2d \uff0cKlebsiella pneumoniae\u662f\u91cd\u8981\u4e14\u5e38\u898b\u7684\u8178\u6e90\u6027\u81f4\u75c5\u83cc \uff0c\u7d93\u5e38\u9020\u6210\u809d\u81bf\n\u760d\u3001\u6ccc\u5c3f\u9053\u611f\u67d3\u7b49\u75be\u75c5 \uff0c\u4ee5\u4e0b\u76f8\u95dc\u6558\u8ff0 \uff0c\u4f55\u8005\u6b63\u78ba \uff1f   \nA.\u81e8\u5e8a\u4e0awild type K. pneumoniae \u53ef\u7528Ampicillin\u6cbb\u7642\u3002\nB.\u82e5\u6aa2\u9a57\u7d50\u679c\u70baExtended spectrum beta -lactamase (ESBL) -producing K. pneumoniae \u56e0\u5c0d\u7b2c\u4e00\u7dda\u6297\n\u751f\u7d20\u6709\u6297\u85e5\u6027 \uff0c\u5efa\u8b70\u4f7f\u7528Ceftriaxone\u6cbb\u7642 \u3002\nC.\u81e8\u5e8a\u4e0a\u5c0d\u65bcESBL-producing K. pneumoniae \u611f\u67d3\u5efa\u8b70\u4f7f\u7528imipenem \u6216ertapenem\u6cbb\u7642\u3002\nD.\u53ef\u7522\u751fNDM -1 carbapenemase \u7684K. pneumoniae\u53ef\u7528Tigecycline \u548cTrimethoprim /Sulfamethoxazole \n(TPM-SMX)\u6cbb\u7642\u3002\nE.\u5728\u53f0\u7063\u9020\u6210\u809d\u81bf\u760d\u6216\u773c\u5167\u708e\u7684\u81f4\u75c5\u83cc\u76f8\u5c0d\u6297\u85e5\u6027\u8f03\u9ad8 \uff0c\u5927\u591a\u662f\u5c6c\u65bcESBL -producing K. \npneumoniae \u3002\n": "[C]", "111-90.\u4e0b\u5217\u793e\u5340\u6027\u80ba\u708e\u81f4\u75c5\u539f\u8207\u5bbf\u4e3b\u56e0\u5b50\u4e4b\u914d\u5c0d\uff0c\u4f55\u8005\u6700\u4e0d\u9069\u7576?    \nA.Alcoholism \u2013 Streptococcus pneumoniae\u3002\nB.Bronchiectasis \u2013 Pseudomonas aeruginosa\u3002\nC.Post-Influenza illness \u2013 Stapylococcus aureus\u3002\nD.Exposure to bird \u2013 Chlamydia trochomatis\u3002\nE.Exposure to sheep \u2013 Coxiella burnetii\u3002\n": "[D]", "111-91.\u6709\u95dc\u6297\u751f\u7d20\u6cbb\u7642\u8207\u6557\u8840\u75c7\u81f4\u75c5\u539f\u7684\u914d\u5c0d ,\u4e0b\u5217\u54ea\u4e9b\u7d44\u5408\u662f\u6b63\u78ba\u7684 ?\n(1) Ceftriaxone - Neisseria meningitidis \n(2) Penicillin - Group A Streptococcus \n(3) Clindamycin - Rickettsia \n(4) Ceftazidime- Enterococcus   \nA.(1)+(2)\u3002\nB.(2)+(3)\u3002\nC.(1)+(3)\u3002\nD.(2)+(4)\u3002\nE.(1)+(4)\u3002\n": "[A]", "111-92.\u6709\u95dcFilariae(\u8840\u7d72\u87f2)\u611f\u67d3\u4eba\u9ad4\u9014\u5f91\uff0c\u4e0b\u5217\u4f55\u8005\u70ba\u662f?    \nA.insect vector bite\u3002\nB.larvae skin penetration\u3002\nC.ingest egg from mouth\u3002\nD.metacercaria in fish\u3002\nE.cercariae skin penetration from water\u3002\n": "[A]", "111-93.\u4e0b\u5217\u6709\u95dc\u96b1\u7403\u83cc(Cryptococcus)\u7684\u63cf\u8ff0\uff0c\u4f55\u8005\u70ba\u975e?    \nA.C.gattii\u5728\u9ce5\u985e\u7cde\u4fbf(\u5982\u9d3f\u5b50)\u4e0d\u5bb9\u6613\u767c\u73fe\u3002\nB.\u5728HIV\u611f\u67d3\u65cf\u7fa4\uff0cmemory B cell IgM\u7684\u4e0b\u964d\uff0c\u5177\u6709\u8f03\u9ad8\u7684\u611f\u67d3\u98a8\u96aa\u3002\nC.Cryptococcal Ag\u53ef\u4ee5\u6709\u6548\u7684\u8a3a\u65b7\u80ba\u90e8\u611f\u67d3 (pulmonary cryptococcosis )\uff0c\u5177\u6709\u5f88\u597d\u7684\u654f\u611f\u6027\u8207\u5c08\u4e00\n\u6027\u3002\nD.\u80ba\u90e8\u96b1\u7403\u83cc\u611f\u67d3\u7684\u6cbb\u7642\u4ee5fluconazole 200-400mg/\u5929\u70ba\u671f3-6\u500b\u6708\u3002   \nE.\u80ba\u5916\u611f\u67d3(\u5982\u8166\u819c\u708e)\u4ee5amphotericin B deoxycholate 0.5-1 mg/kg/\u5929\uff0c\u505a\u70ba\u8d77\u59cb\u6cbb\u7642\u3002\n": "[C]", "111-94.\u4e0b\u5217\u6709\u95dcCOVID-19\u6cbb\u7642\u85e5\u7269\u8207\u5176\u6a5f\u8f49\u7684\u914d\u5c0d\uff0c\u4f55\u8005\u70ba\u975e?    \nA.Remdesivir\uff1aInhibit viral RNA polymerase\u3002\nB.Tocilizumab\uff1aIL-6 monoclonal Ab\u3002\nC.Molnupiravir\uff1aRibonucleoside analog\u3002\nD.Baricitinib\uff1aTNF-\u03b1 inhibitor\u3002\nE.Nirmatrelvir/Ritonavir\uff1aprotease inhibitor\u3002\n": "[D]", "111-95.\u4e0b\u5217\u6709\u95dc\u8207\u6027\u75c5\u8868\u5fb5(syndrome)\u81f4\u75c5\u539f(pathogen)\u4e4b\u914d\u5c0d\uff0c\u4f55\u9019\u70ba\u975e?    \nA.Epididymitis\uff1aChlamydia trachomatis\u3002\nB.Bartholinitis \uff1aTrichomonas vaginalis\u3002\nC.Infertility \uff1a Neisseria gonorrhoeae\u3002\nD.Genital warts\uff1aHuman herpes virus type 8\u3002\nE.Genital ulcers \uff1a Haemophilus ducreyi\u3002\n": "[D]", "111-96.\u4e00\u4f4d30\u6b72\u7537\u6027\uff0c\u8def\u4e0a\u4e0d\u614e\u88ab\u72d7\u54ac\u50b7\uff0c\u88ab\u9001\u81f3\u6025\u8a3a\u8655\u7f6e\uff0c\u4e0b\u5217\u6558\u8ff0\u4f55\u8005\u4e0d\u6b63\u78ba?    \nA.\u5e38\u898b\u81f4\u75c5\u539f\u70baStaphylococcus aureus\u3001Pasteurella multocida\u3001Anaerobe\u7b49\u3002\nB.\u82e5\u81f4\u75c5\u539f\u70baCapnocytophaga canimorsus\u5f15\u8d77\u4e4b\u6557\u8840\u75c7\uff0c\u8840\u6db2\u57f9\u990a\u9700\u8981\u81f314\u5929\u3002\nC.\u9996\u9078\u6cbb\u7642\u70baamoxicillin/clavulanate \u6216ampicillin/sulbactam\u3002\nD.\u82e5\u5c0dpenicillin\u904e\u654f\uff0c\u53ef\u4f7f\u7528macrolide\u6cbb\u7642\u505a\u70ba\u66ff\u4ee3\u3002\nE.\u9700\u8a55\u4f30\u662f\u5426\u6709Rabies\u9810\u9632\u8655\u7f6e\u4e4b\u9700\u8981\u3002\n": "[D]"}